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STUDIES TOWARD THE CARBANION-ACCELERATED 6π 
ELECTROCYCLIZATION. 
POLYFUNCTIONAL BORONATES. 
 
Erich Altenhofer 
Dr. Michael Harmata, Dissertation Supervisor 
 
ABSTRACT 
 The 6π electrocyclization remains an important class of pericyclic reactions which 
provides access to substituted six-membered rings from uncyclized triene substrates.  It 
was conceived that a rate acceleration of this ring closure could be accomplished via 
anion generation adjacent to the 6π system.  In efforts to study the carbanion-accelerated 
6π electrocyclization, triene substrates were prepared from cross-coupling reactions 
between a 2-boryl allylic sulfone and dienyl electrophiles.  In addition to its application 
towards triene synthesis, the alkylation chemistry of the 2-boryl allylic sulfone was 
explored.  The deprotonation of sulfones and subsequent alkylation is trivial, however, it 
was unclear how the reactivity of a sulfone would change as a function of a Lewis-acidic 
boronic ester.  The development of an alkylation procedure would allow for alkylated 
products to undergo ring-closing metathesis, generating value added organoboron 
compounds that would ultimately be used to demonstrate the effectiveness polyfunctional 
boronates toward the synthesis of polycyclic systems. 
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CHAPTER ONE 
Studies toward the Carbanion-Accelerated 6π Electrocyclization 
1.1 Introduction 
Pericyclic reactions such as the 6π electrocyclization are a powerful methodology for 
the synthesis of complex structures from relatively simple substrates in one concerted 
step. An electrocyclization of a 1,3,5-hexatriene allows for the rapid synthesis of 
cyclohexadienes, which are common motifs in natural products.1 Unfortunately, there are 
a few reasons why this methodology remains an underdeveloped area in synthetic 
chemistry. The relatively high activation energy needed to promote ring closure of 1,3,5-
hexatrienes presents the first challenge.  To overcome the energy barrier necessary for 
ring closure, often harsh reaction conditions ranging from 100-150 oC are required 
(Scheme 1).  In addition, the central double bond of the triene must be in the cis 
configuration or electrocyclic ring closure is not possible. Moreover, the synthesis of 
trienes possessing the required geometry to undergo cyclization presents another 
challenge.  
 
Scheme 9. Thermal 6π Electrocyclization 
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In efforts to overcome limitations associated with this reaction, two noteworthy 
approaches have been developed.  Trauner and co-workers demonstrated the effect of 
electron-withdrawing groups (EWG) present on the 6π system.  Installation of an ester or 
ketone in conjugation with the triene resulted in significantly enhanced rate accelerations 
of 2-substituted trienes in the presence of a Lewis acid.2  Treatment of hexatriene 3 with 
dimethylaluminum chloride allowed for cyclization to occur at ambient temperature 
(Scheme 2).  
 
Scheme 2. Lewis acid-Catalyzed Electrocyclization 
Not only does the identity of the EWG affect the rate acceleration, but its exact 
position on the triene alters the rate acceleration. A computational study of this effect was 
done by Fu, Liu and co-workers.  By altering the electronic nature of the triene with 
electron acceptors (capto) and electron donors (dative), specific combinations of 
acceptor/donor locations were found to dramatically increase the rate acceleration.  This 
effect is known the captodative effect, which alters the electronic nature of the triene by 
establishing a push/pull system. In their computational studies, three noteworthy 
combinations: 2-acceptor-3-donor, 2-acceptor-5-donor and 3-acceptor-5 donor- 
substituted hexatrienes were found to enhance the rate acceleration for ring closure 
(Figure 1).3  
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Figure 1. Captodative Substitution Patterns 
In agreement with these theoretical calculations, work by Funk and co-workers 
demonstrated the enhanced rate acceleration of trienecarbamates resembling a 2-
acceptor-3-donor triene (Scheme 3).4 Ring closure of the trienecarbamate 5 was observed 
within 1 hour at 110 oC.  In addition, it was also reported the aminotriene 5 lacking the 
carbonyl took 12 hours to cyclize at 120 oC, owing to the lack of captodative substitution. 
 
Scheme 3. 6π Electrocyclization of Triencarbamates  
Perhaps the most pronounced effect of this push-pull type system was 
demonstrated in a more recent publication by Magomedov and co-workers.  The 
alkylation of alpha- lithiated sulfones with cyclobutenones gives rise to ketones 12 
(Scheme 4).5  In this reaction, the initial alkylated product 9 undergoes ring opening 
giving the O-lithiated hexatriene intermediate 10 which undergoes 6π electrocyclization 
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when warmed from -78 oC to room temperature.
 
Scheme 4. Rapid Electrocyclization of 2-acceptor-3-donor 6π System 
To achieve a rate enhanced 6π electrocyclization, we conceived an idea that alters 
the electronic nature in a similar, yet unique way, when compared to current methods.  
Our goal is to induce a rate acceleration of a triene as a result of anion generation via 
deprotonation alpha to an EWG adjacent to the 6π system.  Using the acidic α-sulfonyl 
protons, it is conceivable that anion generation will cause a rate acceleration of the 1,3,5-
hexatriene (Scheme 5). Once a rate acceleration was established, the focus of the study 
would shift towards making this process asymmetric.  Asymmetric induction can be 
achieved by employing a chiral EWG, chiral base6, chiral additive7, or a chiral phase-
transfer catalyst.8  The retrosynthetic plan for the preparation of triene substrates bearing 
alkyl substituents and acidic protons at the 2-position relied on a Suzuki-Miyaura (SM) 
catalyzed cross-coupling reaction between a 2-metallated allylic sulfone 16 and various 
(Z)-iodobutadienes 17.  This strategy would be beneficial in that a wide range of 
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variously substituted trienes could be accessed by simply changing the substitution 
pattern on the iodobutadiene. 
 
Scheme 5. Anion-Accelerated 6π Electrocyclization and Retrosynthetic Strategy 
 
1.2 Synthesis of 1,3,5-Hexatrienes 
1.2.1 Synthesis of a 2-Stannyl Allyic Sulfone  
 A Stille coupling approach was initially chosen as a means to access trienes 
primarily because the synthesis of 19 was reported in the literature and was 
straightforward as demonstrated by Wesquet and co-workers.9  Despite the low 
regioselectivity of the hydrostannation, the 2-stannyl allylic sulfone 18 was prepared 
quickly from inexpensive reagents (Scheme 6).  The resulting yield suffered from 
unwanted regioisomers as well as distannylation in some cases. 
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Scheme 6. Molybdenum-Catalyzed Hydrostannation of 18 
Before using the organostannane 20 in cross-coupling chemistry with precious 
(Z)-iodobutadienes, it was considered important to be able to repeat known reactions 
reported by Wesquet and co-workers.9  However, it became clear early on that there was 
something inherently wrong with the organostannane.  Despite several attempts to repeat 
reported chemistry with the 20, little progress was made with this approach (Table 1).   
Table 1. Attempts to Engage 19 in known Chemistry 
 
To further prove the problem was a function of organostannane substrate and not 
something experimental, Entry 1 was repeated with vinyl tri-butyltin, which resulted in a 
95% yield of the coupled product. Given the bizarre behavior of the organostannane, it 
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was of interest to explore other cross-coupling approaches using a variant of the 2-
metalled allylic sulfone. 
1.2.2 Synthesis of a 2-Boryl Allylic Sulfone 
With little success in the cross-coupling chemistry of organotin 20, a Suzuki-
Miyaura cross-coupling approach towards the synthesis of 1,3,5-hexatrienes was pursued.  
The use of boronic esters and their analogues over organotin compounds remains popular 
for several reasons.  Boronic esters are easily handled, air-stable solids and are relatively 
non-toxic, as opposed to organotin compounds.10 A quick perusal in the literature 
revealed synthesis of bis(pinacol)boronic ester analogue 25 was already reported 
(Scheme 7).11   
 
Scheme 7.  Synthesis of 2-boryl Allylic Sulfone 25 
Treatment of 2-isopropenylboronic acid pinacol ester 23 with freshly prepared 
tosyl iodide resulted in the radical addition of the iodide across the double-bond.12  
Elimination of the iodide under refluxing conditions gave the thermodynamically more 
stable, non-conjugated isomer 25 in fair yield.    Refluxing for fewer than 8 days resulted 
8 
 
in an incomplete conversion of the initially formed kinetic isomer 26 to the desired 
thermodynamic isomer 25. 
1.2.3 Suzuki-Miyaura Cross-Coupling of 2-boryl Allylic Sulfone 
With boronic ester 25 in hand, attention was turned to the preparation of 
appropriate electrophilic cross-coupling partners.  Synthesis of 1,3,5-hexatrienes with the 
central double bond geometry cis requires the preparation of (Z)-iodobutadienes.  Using a 
procedure developed by Stork and co-workers13, aldehydes 27 and 30 could be converted 
to the corresponding Z-iodides via a Wittig olefination using a non-stabilized phosphorus 
ylide that was generated by treatment of iodomethylenetriphenylphosphonium iodide 
with an equivalent of base. It is important to note that lower Z/E selectivities are observed 
when bases possessing a potassium counterion are employed.  The authors also observed 
lower diastereomeric ratios in the absence of hexamethylphosphoramide (Scheme 8). 
 
Scheme 8. Synthesis of (Z)-iodobutadienes  
The geometric isomers were inseparable on column chromatography and were 
used as pure mixtures for cross-coupling reactions.  Due to their rapid decomposition, the 
iodides were used for cross-coupling reactions immediately after their purification.   
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Iodides used after several days of storage resulted in unsuccessful cross-coupling 
reactions.  The phenyl and methyl substituents on dienes 29 and 30 respectively were 
incorporated as they would help their corresponding trienes adopt the necessary s-cis 
conformation prior to electrocyclization. Furthermore, it is important that the phenyl 
group on 31 occupy the trans position relative to the methyl group, as large cis 
substituents at the 6-position hinder electrocyclization. 
 With both the electrophilic iodobutadienes and the 2-boryl allylic sulfone in hand, 
initial palladium catalyzed cross-coupling reactions were attempted.  Using palladium (II) 
chloride and a bulky phosphine ligand (Table 2), cross-coupling was only observed at 
temperatures over 100 oC.  Unfortunately, the high reaction temperatures necessary to 
promote cross-coupling also caused the newly generated trienes to undergo thermal 
electrocyclization in-situ (Table 2, Entries 1-2, 4). It was clear from 1H NMR spectra the 
products were cyclic due to the presence of methylene protons which appeared as triplets 
at 2.62 and 2.40 and shared the same coupling constant where J = 8 Hz.  Attempts to 
avoid thermal cyclization by lowering reaction temperatures stalled the reaction, which 
led to decomposition (Table 2, Entry 3).   Formation of product 32 was successful; 
however, some unknown, inseparable impurity was always present after chromatographic 
isolation.  However, formation of adduct 33 occurred in a higher yield. This could be an 
effect of the 2-donor-5-acceptor captodative substitution pattern which was lacking on 
cycloadduct 32. 
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Table 2.  Preliminary Cross-Coupling Results of Un-optimized Reaction 
 
The results above indicate that a more mild cross-coupling procedure was needed to 
prevent in situ electrocyclization.  A quick look through the literature revealed an 
abundance of procedures that allowed for cross-coupling to proceed at ambient 
temperature.  A means of tuning the reactivity of the substrate was achieved by 
modifying the identity of the organoboron moiety and components of the reaction.  More 
specifically, the catalyst system was modified by varying the source of palladium, the 
nature of coordinated ligands, the strength of base, and the solvent system. Although the 
reactivity of the free boronic acids has proven to be effective for SM cross-coupling, ester 
11 
 
derivatives are typically preferred for their increased stability towards moisture/air, 
making them easier to handle.  The search for optimal cross-coupling conditions began 
with a survey of various organoboron derivatives of the 2-boryl allylic sulfone.   
1.3 Synthesis and Reactivity of Organoboron Derivatives 
To better understand the reactivity of organoboron derivatives in the SM cross-
coupling reaction, general knowledge of the catalytic cycle is necessary.  The mechanism 
of the catalytic cycle is depicted in Scheme 9.  The Suzuki-Miyaura (SM) cross-coupling 
reaction between boronates and electrophiles proceeds in three steps which include 1) 
oxidative addition of the electrophilic coupling partner to a catalytically active 
palladium(0) species, 2) transmetallation between the nucleophilic organoboron reagent 
and palladium (II) intermediate and 3) reductive elimination, which forms the new 
carbon-carbon bond and regenerates the palladium(0) catalyst.  The catalytic cycle begins 
with an oxidative addition of the electrophilic organic halide coupling partner to the 
catalytically active palladium(0) species, forming the palladium(II) intermediate I.  This 
addition is facilitated by the ability of the leaving group on the organic halide to stabilize 
a negative charge.  The neutral boron atom of species A accepts hydroxide from the base, 
forming the -ate species B in situ, which undergoes transmetallation with palladium(II) 
intermediate II.  The newly generated palladium(II) intermediate III  then undergoes 
reductive elimination, releasing the newly formed coupled product and regenerating more 
palladium(0). 
12 
 
 
Scheme 9. Palladium-Catalyzed Suzuki-Miyaura Catalytic Cycle 
In addition to formation of a new carbon-carbon bond generating the coupled product, 
there are additional pathways that can lead to side-product formation.  The three most 
common side products result from oxidation of the organoboron substrate to the 
corresponding alcohol, oxidative coupling, and protodeborylation (Scheme 10).  
Oxidation and oxidative coupling are caused by presence of peroxides and oxygen inside 
the reaction vessel and can typically be removed through various purification and 
degassing techniques.  Protodeborylation, however, is a side product resulting from the 
reactivity of the organoboron reagent itself.  More specifically, protodeborylation can 
occur once the catalytically active “-ate” species B forms in-situ under basic conditions.  
13 
 
Once formed, B can either react with water forming the unwanted deoborylated material, 
or react as shown in Scheme 9 and transmetallate with palladium complex II, which 
leads to product formation. 
 
Scheme 10. Side Product Formation 
Protolytic cleavage can be mitigated by masking the organoboron reagent, facilitating 
transmetallation through highly active palladium(II) pre-catalysts, or moderating the 
release of active species B.  In the following text, a summary of these common 
techniques employed to prevent side product formation will be reviewed. 
1.3.1 Stabilization through Masking Groups 
 As previously mentioned, boronic esters are generally the preferred reagent over 
their parent acids due to the decreased Lewis acidity of the resulting boron atom provided 
by the electron rich alkoxy ligands.  As a result of the increased electron density, the 
boron moiety gains added stability towards air and moisture.  This added stability is also 
reflected in solution as the organoboron reagent is less reactive towards attack from 
hydroxide.  An improvement of this masking effect was demonstrated by the use of a 
diethanolamine (DEA) boron ligand, which bears a neighboring nitrogen capable of 
14 
 
chelating to the boron, forming an even more stable “ate” complex (Figure 2).14 The term 
“masking agent” is a more appropriate term over “protecting group” as the masking agent 
is hydrolyzed in situ, forming the free acid under the required basic conditions instead of 
requiring a separate deprotection step.   
 
Figure 2.  Donor Ligands Decrease Lewis-Acidity on Boron Atom. 
1.3.2 Facilitating Transmetallation through Palladium Pre-Catalyst 
One problem associated with the SM-catalyzed, cross-coupling reaction occurs 
during the transmetallation step between the organoboron reagent and palladium catalyst.  
As previously mentioned, side product formation can result if the organoboron reagent 
undergoes protolysis at a rate faster than transmetallation.  The preparation of highly 
reactive catalysts that generate the reactive phosphine-ligated palladium species in-situ is 
one solution that addresses this problem.  As a result of the instability of palladium(0) 
towards air and moisture, often a palladium(II) source is used and reduced in situ to its 
catalytically active phosphine ligated palladium(0) species.  To bypass the need for an in 
situ reduction, Buchwald and co-workers have developed palladium pre-catalysts that 
rapidly form phosphine ligated palladium(0) under mildly basic reaction conditions 
(Scheme 11).15 
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Scheme 11. Comparative Transmetallation Step 
This clever approach allows for both the use of a highly reactive source of palladium(0) 
while also maintaining the stability of palladium(II).  The authors demonstrated the 
effectiveness of this pre-catalyst by showing it allowed for cross-coupling reactions to 
occur with certain aryl boronic acids that are notorious for undergoing protodeboronation 
under normal circumstances. 
1.3.3 Moderation of the Release of Free Boronic Acid 
 Controlling the rate at which the free acid is released upon hydrolysis in situ is 
perhaps the most creative approach used to avoid protodeborylation.  This can be 
achieved through the use of two popular masked organoboron reagents; N-
methyliminodiacetic acid (MIDA) boronates and potassium trifluoroborates.  
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Scheme 12. Hydrolysis of MIDA and Potassium Trifluoroborate 
Due to the nature of the MIDA masking group, acid liberation can be made slow by using 
mild bases or rapid through the use of strong bases.16  When release of free acid is slow, 
[catalyst]:[boronic acid] is increased, thereby allowing for transmetallation to 
predominate over protolysis pathways with water.17 A similar effect can be observed with 
potassium trifluoroborate salts.  Potassium organotrifluoroborates can be conveniently 
prepared from their corresponding acids or esters by reaction with potassium bifluoride.  
The resulting salts represent an ideal masking group for boronic acids as they are 
increasingly more stable and can be hydrolyzed in-situ with a mild base (Scheme 12).18  
One drawback is the liberation of HF, which is corrosive to glassware.  
1.3.4 Synthesis and Comparison of Organoboron Derivatives 
Given the popularity 19 of potassium organotrifluoroborates and their easy 
synthesis, it was chosen as a masking group for the low temperature cross-coupling 
conditions with alkenyl iodides.  Although one cannot screen every possible catalyst 
system for a given potassium trifluoroborate substrate, promising work by Molander and 
co-workers offered a set of conditions likely to work in our case in that they successfully 
coupled less reactive alkenyl bromides with their potassium trifluoroborates.  Using 10% 
PdCl2(dppf) catalyst and mild cesium carbonate base, cross-coupling of potassium 
trifluoroborates with alkenyl bromides was accomplished at 80 oC (Scheme 13). 20   
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Scheme 13.  Trifluoroborate Coupling with Alkenyl Bromides. 
To further explore potential options for the optimal organoboron derivative, the 
MIDA, DOBA and ester derivatives of 38 were prepared in addition to the potassium 
trifluoroborate.  Using the same procedure for the synthesis of boronate 25, a phenyl 
sulfone analogue was made in effort to address alkylation issues that will be discussed in 
Chapter 2.  Sulfone analogue 38 was prepared in a similar fashion to the p-Tol sulfone 
shown in Scheme 7.  In contrast to tosyl iodide used in the initial synthesis of 25, 
phenylsulfonyl iodide decomposes rapidly at ambient temperatures making purification 
troublesome. For this reason, the phenylsulfonyl iodide was prepared and used in situ 
(Scheme 14).   
 
Scheme 14.  Synthesis of Phenyl Sulfonyl Analogue 38 
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Boronic ester 38 was converted to the potassium trifluoroborate 39 by treatment 
with potassium bifluoride in methanol (Scheme 15)21.   The potassium trifluoroborate 
could be hydrolyzed to the parent acid 40 in under four hours by stirring with silica.22 
Each ester 41-43 was prepared from 40 under normal esterification procedures using a 
Dean-Stark apparatus.   
 
 
Scheme 15.  Synthesis of Organoboron Derivatives 
With each derivative in hand, their relative reactivities were examined through a simple 
cross-coupling reaction with p-iodoacetophenone (Table 3).  Under the mild conditions 
originally developed by Molander and co-workers, the trifluoroborate derivative provided 
the cross-coupled product in the highest yield (Table 3, Entry 1).  Although each 
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derivative most likely requires its own unique base, ligand and solvent system, this 
benchmark gave a rough approximation of their reactivities in a relative sense.  It was  
Table 3.  Benchmark Test of Organoboron Derivatives. 
 
anticipated that the MIDA boronate 43 would offer a higher yield than the boronic acid  
40 due its ability to keep [catalyst]:[free acid] high; however, the recovered yield was  
significantly lower than the free acid (Table 3, Entry 3). Furthermore, the DOBA 
boronate 42 and the ester displayed lower reactivity than the free acid 40, which was also 
not what was expected.  However, it should be restated that the optimal conditions for 
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each derivative to function effectively is dependent on the reaction conditions (e.g. base, 
solvent, ligand, etc.).  Although this table does not demonstrate the potential of each 
derivative at its maximum efficiency, it does suggest that under mild conditions, the 
trifluoroborate seems to be the best choice. 
Given the promising results of the cross-coupling between the potassium 
trifluoroborate 39 and the aromatic iodide, its reactivity with other aromatic electrophiles 
was examined (Scheme 16).  As expected from general knowledge of the SM cross-
coupling reaction, the reactivity of the electrophilic partner is increased as a result of the 
identity of the leaving group, bromides being less reactive.
 
Scheme 16.  Leaving Group Effect. 
Although the effect is not great, triflates tend to provide higher yields in cross-coupling 
reactions.  Given the instability of vinyl triflates, future cross-coupling reactions were 
carried out with iodides.  
1.4 SM Cross-Coupling of Potassium Trifluoroborate 39 with Aromatic Iodides 
Although initial intentions for the cross-coupling of aromatic iodides with 39 was 
diagnostic in a sense, we realized this was also a unique route towards the synthesis of 2-
stryl compounds.  Although there are other procedures in the literature for the synthesis 
of 2-aryl allylic system, this method was unique in that it utilized a SM cross-coupling 
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reaction between two relatively inexpensive starting materials.23  For this reason, the 
scope of the coupling reactions was carried out with several aromatic iodides (Table 4). 
Table 4.  Reaction Scope. 
Cross-coupling was effective with ortho, meta, and para substituents.  There is not much 
difference between electrophiles with strong electron withdrawing substituents.  
Furthermore, we were able to couple pyridyl iodides, which is significant due to the 
presence of nitrogen in natural products, which gives this procedure possible application.  
It should be noted that coupling of 1,4-diiodocompounds using two equivalents of 
boronate led to incomplete conversion to di-coupled products even at extended reaction 
times.  Our synthetic approach in making 2-aryl allylic sulfones is unique in that products 
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55 and 56 can have application towards the synthesis of polycyclic molecules, that will 
be discussed in Chapter 2. 
1.5 SM Coupling of Trifluoroborate 39 with (Z)-iodobutadienes 
Having successfully demonstrated the effectiveness of the new mild procedure to 
couple 39 with aromatic systems, the procedure was applied to alkenyl systems towards 
the synthesis of 1,3,5-hexatrienes.  Since Stork’s procedure gave inseparable Z/E 
mixtures of iodobutadienes 29 and 31, we decided to prepare iodobutadienes from a 
procedure that would give pure Z-iodobutadienes.  Although high Z/E ratios were 
obtained, it was hypothesized that the presence of E-iodobutadiene, although small, was 
detrimental to the yield.  Using a known procedure24, pure Z-iodobutadiene 60 was 
prepared in three steps from the commercially available propargyl alcohol 57 (Scheme 
17).    
 
Scheme 17.  Synthesis of Z-iobutuadiene 58. 
Using the newly developed cross-coupling procedure between potassium trifluoroborate 
39 and Z-iodide 60, the results were significantly improved.   Cross-coupling was 
successful at 80 oC, giving rise to uncyclized product 61 albeit with trace amounts of 
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cyclized material.  However, this was not a problem as they were easily separated on 
column chromatography.  In addition, the 1H NMR spectra contained less impurities at a 
crude level when compared to previous reactions done at elevated temperatures.  Despite 
the success of cross-coupling chemistry, treatment of the newly formed triene with 
lithium diisopropylamide (LDA) led to recovery of starting material (Scheme 18). 
 
Scheme 18.  Synthesis of 1,3,5-hexatriene  
It was envisioned that the presence of an anion adjacent to the π-system would allow for 
electrocyclization to occur once warmed to ambient temperature.   In addition to using 
SM cross-coupling reactions, 1,3,5-hexatriene 66 was prepared via cuprate addition to 
allene sulfone 64; however, substrate 66 failed to cyclize at room temperature when 
treated with LDA (Scheme 19).25   
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Scheme 19.  Synthesis of 1,3,5-hexatriene 64 via Cuprate Addition to Allene Sulfone 
1.6 One-Pot Synthesis of 1,3-cyclohexadienes 
Although the experimentation with the carbanion-accelerated 6π- 
electrocyclization of 1,3,5-hexatriees was not fruitful, the cross-coupling chemistry of the 
2-boryl allylic sulfone was still of interest, as it would serve a future purpose in 
generation of polycyclic products to be discussed in Chapter 2.  Furthermore, we still 
desired to find a procedure that would allow for cross-coupling at room temperature. A 
protocol developed by Weeber and co-workers that utilized silver oxide and 
triphenylarsine  allowed for room temperature SM cross-coupling between aryl boronic 
acids and 2-halo-2,3-butadieneoates.26   In addition, this procedure was also utilized in a 
SM cross-coupling reaction between a boronic ester and a bromobutadiene in the total 
synthesis of (+)-fostriecin.27  The coupling chemistry of boronic ester 38 with aryl 
iodides provided quantitative of yields in some cases using this relatively mild procedure 
(Table 5).  During the synthesis of palytoxin, Kishi and co-workers also observed a rate 
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enhancement in SM cross-coupling reactions where silver oxide promoted the coupled 
products in 5 minutes at ambient temperatures.28 
Table 5.  Silver Oxide Assisted Cross-Coupling at Room Temperature 
 
Surprisingly, under these reaction conditions, aryl iodides coupled with the ester 38 gave 
quantitative yields in under 2 hours at room temperature. Unfortunately, bromides were 
unreactive, and product 67, bearing an o-methoxy substituent, required five days to reach 
completion.  Although the need to prepare 1,3,5-hexatriene substrates was no longer 
necessary for any further studies, we were curious as to whether these conditions could 
be applied to alkenyl substrates as demonstrated by Sasaki and co-workers towards the 
total synthesis of (-)-exiguolide.29  Allylic alcohol 58 underwent coupling in good yield 
with ester 38 resulting in a 74% yield (Scheme 20).  Unfortunately, the use of dienyl 
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iodides such as 29 resulted in a messy reaction mixture.  The intended coupled product, 
69, was never observed. Although there was evidence for the formation of the 
corresponding cyclized product, attempts to isolate and purify the material were 
unsuccessful.
 
Scheme 20.  Low Temperature SM Cross-Coupling 
1.7 Cross-Coupling of Secondary Alkyl Potassium Trifluoroborates 
1.7.1 Introduction 
The majority of SM cross-coupling reactions have been limited to the use of sp2 or sp 
hybridized boronates as the nucleophilic partner.  However, it has been recently 
demonstrated that cross-coupling between alkyl organoboron reagents can be achieved, 
which broadens the applicability of this already powerful methodology in synthesis.  
More specifically, the cross-coupling of secondary boronic esters is a relatively new area 
to this methodology that needs development.  Much like the problems associated with 
sp2-hybridized substrates discussed in the previous section, secondary boronic esters can 
undergo slow transmetallation which gives rise to protodeborylation as well as β-hydride 
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elimination.  To overcome the issues associated with the cross-coupling of secondary 
organoboron species, the organoboron species can be stabilized by an electron donor 
group in an intramolecular fashion.  Suginome and co-workers demonstrated the 
transmetallation step can be facilitated by coordination of a neighboring amide to the 
boron atom (Scheme 21).30  In this example, cross-coupling of optically enriched α-
(acylamino)benzylboronic ester 70 with bromobenzene resulted in product 72 with 
inversion of configuration.  Several years later, Molander and co-workers showed the 
same chemistry could be accomplished with a non-benzylic substrate and less reactive 
aryl chlorides31.  Under similar conditions used by Suginome, Molander demonstrated the 
alkyl boronic ester 73 possessing a β-amide group could undergo cross-coupling with 
chloride 74 in good yield with inversion of configuration.    
 The hydrogenated derivative of sulfone 38, sulfone 76 (Scheme 21), bears a 
sulfonyl oxygen at the 5-position relative to the boron atom similar to compounds 70 and 
73.  It was of interest to explore whether these sulfonyl oxygen atoms could provide the 
necessary nucleophlicity to donate electrons to the neighboring boron atom.  This ability 
to donate electron density to boron would then allow for the facilitation of the 
transmetallation step, and potentially allow for cross-coupling of this secondary boronic 
ester.  Furthermore, it was also thought that incorporation of a basic nitrogen in 
compound 77 by substitution of the phenyl sulfone group for a 2-pyridyl derivative might 
be another route by which intramolecular coordination to the boron atom could be 
achieved.  Since the secondary boronates 76 and 77 would be synthesized by 
hydrogenation of their corresponding alkenes, the use of an asymmetric hydrogenation 
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catalyst would also allow access to enantiomerically enriched compounds, which would 
add to the significance of this reaction. 
 
 
Scheme 21.  Cross-Coupling of Secondary Potassium Trifluoroborates. 
1.7.2 Synthesis of Secondary Boronates 
 With 2-boryl allylic sulfone 38 in hand, access to the alkyl derivative 76 was 
achieved via hydrogenation.  Initial attempts to hydrogenate the double bond using 
activated palladium on carbon under a hydrogen atmosphere resulted in incomplete 
conversion of starting material and recovery of deborylated material (Table 6).  
It was thought the palladium catalyst was being poisoned by some process involving 
sulfur, leading to incomplete conversions.  To mitigate catalyst poisoning, small amounts 
of oxidant were added.  However, despite its effectiveness in keeping the catalyst “alive,” 
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the yield was significantly lower (Table 6, Entry 6).  The only effective solution to this 
problem was addition of fresh catalyst every 24 hours (Table 6, Entry 4).   
Table 6.  Hydrogenation of 38. 
 
Switching to Wilkinson’s catalyst proved to be a more reliable and reproducible 
procedure in which complete conversion of 38 to 76 could be observed within a 24 hour 
period (Scheme 22).   The potassium trifluoroborate 78 was prepared from the ester using 
the same chemistry previously mentioned. 
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Scheme 22.  Hydrogenation of 37 using Wilkinson’s Catalyst. 
The 2-pyridyl analogue 81 was prepared via regioselective copper-catalyzed 
hydroboration of propargyl sulfone 80 where the polar sulfone moiety acts as a directing 
group, which accounts for the addition of boron to the internal carbon rather than the 
terminal position.32  Hydrogenation of the resulting vinyl boronate with Wilkinson’s 
catalyst (Scheme 23) gave the reduced product along with an impurity that could not be 
removed by chromatographic methods.  The impurity was carried through to the next step 
and removed during the conversion of boronic ester 77 to the potassium trifluoroborate 
83. 
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Scheme 23.  Synthesis of 2-pyridyl(sulfonyl) Analogue 83. 
 The secondary potassium trifluoroborates were subjected to coupling conditions 
which were known to work with the unsaturated analogue (Table 7, Entry 1); however, 
coupling was never observed. The same catalyst systems adopted by Suginome (Entry 2) 
and Molander (Entry 3) also proved unsuccessful for cross-coupling.  Furthermore, the 
silver oxide/triphenylarsine catalyst system, which worked well with boronic ester 38, 
also failed to provide coupling with secondary esters 76 and 77 (Scheme 24).   
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Table 7.  Cross-Coupling Attempts with Secondary Potassium Trifluoroborates 78 and 
83. 
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Scheme 24.  Cross-Coupling Attempts with Secondary Boronates 76 and 77. 
Ultimately, the solution to this problem will require extensive screening of 
reaction conditions.  In search for the best catalyst/ligand system that provides cross-
coupling of the secondary organoboron compounds, collaborative efforts with Merck Inc. 
are currently in progress.  
The cross-coupling of 2-boryl allylic sulfones and various iodobutadienes towards 
triene synthesis has been demonstrated.  Under high temperature cross-coupling 
conditions, the initially formed trienes undergo cyclization in situ forming cyclic products 
32 and 33 (Table 2).  To study whether a carbanion accelerates this process, a low 
temperature procedure was developed which allowed for the isolation of uncyclized 
substrates 61 AND 66. Unfortunately, treatment of these substrates with LDA results in 
recovery of uncyclized starting material, indicating the presence of an anion on these 
particular substrates has no effect. 
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CHAPTER TWO 
 Polyfunctional Boronates 
2.0 – Introduction 
With the growing popularity of organoboron compounds in synthesis, it becomes 
ever more important to both develop new methodologies involving this valuable class of 
molecules and discover new synthetic routes to provide easier access to these 
compounds.  Perhaps the most widely known transition-metal catalyzed reaction is the 
SM cross-coupling between organoboron reagents and various electrophiles. Despite the 
great impact the SM cross-coupling reaction has made on synthetic organic chemistry, it 
should be noted that chemistry of organoboron compounds is not limited exclusively to 
palladium- catalyzed processes.  Carbon-carbon bond formation can also be achieved 
through rhodium-catalyzed33  processes.  Moreover, carbon-nitrogen and carbon-oxygen 
bond formation can be achieved through the copper catalyzed Chan-Lam reaction.  In 
addition, there exist several chemical transformations involving carbon-boron bonds that 
are not catalyzed by transition metals.  Given the array of chemistry that can be done with 
organoboron compounds, the development of polyfunctional organoboron reagents would 
be valuable contribution to synthetic chemistry. 
A polyfunctional molecule should include multiple functional groups that are 
capable of accomplishing some chemical transformation without interfering with each 
other.  In this way, multiple transformations can be made to a molecule in a stepwise or 
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in some cases, tandem, fashion.  Probably the greatest obstacle in developing a 
polyfunctional reagent is functional group chemoselectivity and compatibility.  To some 
degree, the functional groups present must not have the same chemical reactivities.  To 
better illustrate the concept of polyfunctional boronates, a few examples taken from 
literature will be reviewed. 
Walsh and co-workers nicely demonstrate the concept of a bifunctional boronate 
in their preparation of an organoboron compound capable of undergoing a tandem 
allylation/transition metal cross-coupling reaction towards the synthesis of 1,4-dicarbonyl 
compounds, allylic amines and α-amino ketones  (Scheme 25)34.  Substrate 84, which 
possesses both an allylic acetate and vinyl boronic ester, is capable of undergoing both 
Tsuji-Trost allylation chemistry in addition to SM cross-coupling.  The fact that each step 
occurs chemoselectively makes this bifunctional boronate reagent especially useful. 
 
Scheme 25.  One-Pot Palladium Catalyzed Allylation/Coupling with Bifunctional 
Boronate 84. 
Using a suitable catalyst, they were able to promote the Tsuji-Trost allylation reaction 
with morpholine instead of some palladium-catalyzed transmetallation chemistry with the 
boronic ester.  It should also be noted that the bulky bis(pinacol) ester on the boron atom 
does not slow down or block allylation despite its steric properties.  
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 In a more recent report, Walsch and co-workers demonstrated the application of a 
bifunctional boronate towards the synthesis of a unique class of polyoxygenated 
compounds (Scheme 26).35  2-Keto-1,3-diols are a unique structural feature found in 
natural products that remain synthetically challenging to access.   
 
Scheme 26.  One-Pot Expoxidation/Oxidation of Bifunctional Boronate 87. 
In the first step, the epoxidation of the allylic alcohol results in formation of an anti-
epoxy alcohol 88 without decomposition of the boronic ester.  Once oxidized to the 
parent alcohol, ketone formation results in the ring opening of the adjacent epoxide, 
which gives rise to the anti diol 89 with stereocontrol. 
The preparation and reactivity of α-metallated boronic esters is another avenue 
which exploits the diversity of boronic esters as a synthetically useful bifunctional 
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reagent.  Knochel and coworkers demonstrated the use of 1,1-heterobimetallics
 
Scheme 27.  1,1-boron, copper Bimetallics as Bifunctional Reagents. 
in tandem alkylation/oxidation reactions36 towards the generation of functionalized 
ketones. It was first found that (Z)-α-iodoalkenyl boronic esters react with zinc generating 
1,1-boron, zinc bimetallic species 91 (Scheme 27).   The zinc insertion does not occur 
stereoselectively and results in some Z/E mixture.  After transmetallation of the zinc 
species with CuCN, the newly formed organocuprate intermediate can be trapped with 
various α,β-unsaturated carbonyls. These reagents are significant in that the same carbon 
bears two metals with very different electronic profiles: copper being electron rich and 
nucleophilic and the boron Lewis acidic.  Although the stereochemistry of the double 
bond is not well defined, this methodology allows for the synthesis of functionalized 
ketones bearing vinyl boronic esters.  In this particular case, oxidation of product 92 can 
give rise to diketones in 76% overall yield.  
2.1 Alkylation of a 2-boryl Allyic Sulfone 
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Despite the reported synthesis of 2-boryl allylic sulfone 25, there was a complete 
absence of chemistry reported with this molecule in the literature.  Interested in pursuing 
bifunctional boronate reagents, exploring further applications of this small molecule was 
of interest.  Since the advent of the Julia olefination, it is well established that sulfur-
stabilized carbanions are generated via deprotonation of allylic sulfones and may be 
trapped with suitable electrophiles.  Given this notion, it was not clear whether sulfone 25 
could undergo alkylation under identical conditions with the primary concern being that 
the Lewis-acidic boron atom would interact with the anionic lithium amide base or the 
neighboring sulfone-stabilized carbanion (Scheme 28).  This hypothesized interaction 
was thought to make the two functional groups incompatible with each other.  
Furthermore, there was also a precedent for a similar “-ate” species forming in situ under 
basic conditions.37 
 
Scheme 28.  Possible Pathways Leading to Undesired “ate” Complex Formation. 
Although there are some reports in the literature involving the alkylation of 
organoboron compounds, none using the 2-boryl allylic system existed.  Whiting and co-
workers prepared β-boronate carbonyl derivatives like 96 (Scheme 29).38  Treatment of 
96 with an equimolar amount of LDA resulted in the nucleophilic attack of the enolate 
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oxygen on the neighboring boron atom, presumably forming “ate” complex 97.  Evidence 
for “ate” formation was obtained by 11B NMR, which showed a 11B resonance at -2 ppm, 
which is typical for a trialkoxy, monoalkyl boron species.  The stable “ate” complex was 
found to collapse after warming to ambient temperature in the presence of methyl iodide, 
giving rise to the alkylation product 98 in an 80% yield.  Unfortunately, treatment of 
ketone or sulfoxide derivatives of ester 96 with LDA resulted in the formation of enolates 
that precipitated and were unreactive towards methyl iodide, even at elevated 
temperatures.    
 
Scheme 29.  Alkylation of β-boronate Ester 96 with Iodomethane. 
 Due to the electronic nature of boron, α-protons on 1,1-diboronic esters are acidic 
enough to be deprotonated and form boron-stabilized carbanions.39  Early work by 
Matteson and co-workers demonstrated that 1,1-diboronic ester 99 could be treated with a 
hindered lithium amide base, lithium 2,2,6,6-tetramethylpiperidine (LiTMP), and result in 
the formation of a boron-stabilized anion.  The resulting anions were alkylated with 
various primary alkyl bromides and iodides, in addition to various carbonyl compounds.  
It was found that a hindered base and bulky boronic ester were necessary to prevent any 
undesirable interaction between the base and boron.  Using tetramethylethylenediamine 
(TMEDA), presumably to increase the reactivity of the α-lithiated 1,1-diboronic ester, 
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alkylation with iodobutane in THF resulted in an 86% yield of the alkyl 1,1-diboronic 
ester 100 (Scheme 30). 
 
Scheme 30.  Alkylation of 1,1-Diboronic Ester 99. 
As is evident from the literature, the extent to which alkylation chemistry of 
organoboron compounds has been studied did not seem entirely thorough.  The gap of 
knowledge in the literature prompted research regarding the alkylation chemistry of 
sulfone 25.  The work from Whiting was encouraging in that he showed alkylation is 
possible in compounds bearing boronic esters; however, their work was limited to enolate 
chemistry.  Our primary goals were to (1) determine if sulfone 25 could be deprotonated 
and alkylated with various electrophiles and (2) to control the alkylation in a manner that 
would make this methodology synthetically useful.  As earlier mentioned, powerful 
methodologies exist that use boronic esters to achieve a variety of chemical 
transformations.  Therefore, it seemed obvious to develop a procedure that would provide 
new routes to access functionalized boronates. 
2.1.1 Preliminary Alkylation Experiments 
Treatment of sulfone 25 with excess lithium hexamethyldisilazide (LiHMDS) at -78 
oC and quenching the anion with excess methyl iodide afforded the dialkylated product 
102 in 55% yield (Scheme 31).  We initially chose to use excess reagents for the 
alkylation of 25 primarily because the exact concentration of LiHMDS was not known, 
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and it was unclear if an additional equivalent of base was consumed by the boronic ester 
before deprotonation occurred. 
 
Scheme 31.  Alkylation of 2-boryl Allylic Sulfone 25. 
To achieve monoalkylation, 25 was treated with an equivalent of LiHMDS, stirred for an 
hour at -78 oC and quenched with excess methyl iodide.  Analysis of the crude mixture 
using 1H NMR revealed a 1:1 ratio of starting material to monoalkylation (Table 8).  The 
alpha sulfonyl proton corresponding to product 102 appeared as a quartet around 4.1 ppm 
and was slightly downfield from the two alpha sulfonyl protons of 25, which appear at 
3.9 ppm.  Using 2.2 equivalents of base gave a 69:30 ratio of monoalkylation to 
dialkylation (Entry 2). 
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Table 8.  Alkylation Selectivity. 
 
 Perhaps a more confusing result can be seen in Entry 3, where 4.2 equivalents of base 
resulted in formation of monoalkylated sulfone 101 as the major product.  Not only is it 
unclear why a large excess of base is necessary to achieve alkylation, but this procedure 
appears to be impractical in that it is not reproducible when compared to the result 
observed in Scheme 31.  These inconsistencies make it difficult to draw any strong 
conclusions from data.  A closer examination of the 1H NMR spectra at a crude level 
revealed evidence for alkylation at the p-tolyl methyl substituent.40  To eliminate this 
issue entirely, phenylsulfonyl analogue 38 (Table 9) was used in further studies.  Much 
like the p-tolyl derivative, unexpected product ratios of the phenylsulfonyl derivative 38 
were still observed under identical conditions.  An equimolar amount of LiHMDS led to 
greater percentage of monoalkylation over recovered starting material (Table 9, Entry 1) 
when compared to the former study.  Furthermore, under conditions of excess base, an 
almost complete conversion was observed (Table 9, Entry 3).  High importance was 
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placed on solving this selectivity issue as it would make this procedure more attractive in 
future alkylations with more precious electrophiles.  
Table 9.  Alkylation Selectivity of Phenylsulfonyl Derivative 38. 
 
 At first, it was not certain whether these results were the consequence of 
incomplete anion formation or the reactivity of the resultant sulfone-stabilized anion 
formed after deprotonation.  To obtain data that would answer these questions, several 
independent deuterium quench experiments were conducted with sulfone 38 and 
LiHMDS. In each experiment, sulfone 38 was treated with a different amount of base at -
78 oC and allowed to warm to ambient temperature over the course of one hour before 
being quenched with deuterated methanol.  The newly formed deuterated product 
mixtures were analyzed by 1H NMR spectroscopy.  The recovered starting material 
displayed a singlet at 3.93 ppm corresponding to two α-sulfonyl protons (Figure 3).  The 
mono-deuterated species displayed a singlet at 3.92 ppm corresponding to one α-sulfonyl 
proton.  The percentage of di-deuterated species was determined by subtracting the 
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combined percentages of starting material and mono-deuterated material from the overall 
amount 2-boryl allylic sulfone species present in the crude proton NMR.  These 
calculations were made under the assumption that vinylic protons for all three sulfone 
species were responsible for the two vinylic protons appearing at 6.10 and 5.79 ppm.   
 
Figure 3.  Crude 1H NMR of Deuterium Quench Experiment. 
A visual representation of the reaction profile can be seen in the deuterium study 
shown in Figure 4 where the resulting product compositions are plotted as a function of 
base equivalents.  Analysis of the data reveals several qualitative observations.  
Regardless of the amount of base used, there is always an equilibrium mixture of all three 
species.  Even under equimolar conditions, there is evidence for a di-deuterated species.  
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Furthermore, when 1.2 equivalents of base is used, there is an equal mixture of mono- 
and di-deuterated species.  Although these initial results suggest that it may be difficult to 
control the selectivity of the alkylation, it seems the reactivity of the resulting anion is not 
completely diminished by the boronic ester. 
  
 
Figure 4.  Deuterium Quench Study of 38. 
A perusal through the literature revealed an interesting study by Pine and co-
workers in which methyl phenyl sulfone was deprotonated and alkylated with various 
alkyl bromides.41  As it turns out, sulfonyl stabilized carbanions, unlike their carbonyl 
derivatives, tend to alkylate in an unselective fashion, often allowing for mixtures of 
mono, di, and polyalkylated products.  On average, a 3.6:1 ratio of 106:107, 
corresponding to the mono and dialkylated products was observed when an equimolar 
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amount of base was used (Table 10).   The results shown in Table 10 are strikingly 
similar to what was observed in deuterium quench studies with sulfone 38 (Tables 8-9).   
The authors that conducted the alkylation study proposed a pathway that accounts for the 
product composition observed under equimolar conditions through a series of proton 
exchanges (Scheme 32). 
    Table 10. Alkylation of Methyl Phenyl Sulfone. 
 
Using the pathway proposed by Pine and co-workers, a rationalization can be 
made that accounts for the formation of dialkylated product, even when an equimolar 
quantity of base is used.  Monoalkylation is clearly achieved through deprotonation of 38 
resulting in sulfone-stabilized carbanion 38a, which reacts with an iodomethane, giving 
rise to monosubstituted product 103.  Since the added methyl substituent of 103 makes its 
resulting proton less acidic41 than 38, it is unlikely that formation of 104 results from a 
second deprotonation of 103 from LiHMDS.  However, proton exchange between 
unreacted 38a and 103 results in formation of an unstable monosubstituted carbanion 
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103a, which is expected to react quickly with available electrophile, giving rise to 
dialkylated product 104. Since monoalkylation is the major product under equimolar 
conditions, it is likely that 38a alkylates at a faster rate relative to proton exchange with 
104.  However, addition of excess base may change this preference and increase the 
likelihood for the formation of species 103a.   
 
Scheme 32.  Dialkylation Resulting from Equimolar Quantity of Base. 
 
 
 
2.1.2 Dialkylation of 2-boryl Allyic Sulfone 38 
At this point it was clear that this reaction would require extensive optimization in 
order to achieve monoalkylation selectively.  Before undertaking this task, it was of 
interest to see if dialkylation could be forced by simply using excess base.  Under 
unoptimized conditions, a solution of 38 and excess electrophile was treated with 4.2 
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equivalents of LiHMDS, and allowed to warm to ambient temperature over 30 minutes 
(Table 11).  Exclusive dialkylation can be achieved using methyl iodide; however, as the 
size of the carbon chain on the electrophile increased, a preference for monoalkylation 
was observed (Entry 2). Presumably, the added steric hindrance of monoalkylated 
intermediates that now possessed α-sulfonyl substituents interfered with the incoming 
electrophile.   In agreement with data reported by Pine and co-workers, the allylic and 
benzylic substrates led to a preference for dialkylation over monoalkylation (Entries 8-9).  
Due to the size of the benzyl substituent, all of the dialkylated product recovered was in 
the isomerized form 116b’.  Experiments resulting in b/b’ product compositions were a 
kinetic result and not an isomerization of b to b’ as the ratios remained constant even 
after months of storage at room temperature.  Alkylation with 2-phenethyl and 3-
phenylpropyl substrates gave rise to the highest combined yields of 75% (Entries 10-11), 
with the latter showing an unexpectedly high preference for dialkylation.   
  
 
 
 
 
 
 
 
 
 
 
49 
 
Table 11.  Dialkylation of 38 Using Excess Base. 
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While alkylation reactions were repeated to assure reproducibility, in some cases, traces 
of oxidized monoalkylated products could be isolated after chromatography (Scheme 33). 
Ketone side products were only observed for benzyl and heptyl substrates, but only in 
isolated incidents. The ketone was present in crude 1H NMR spectra prior to purification 
on silica, which implies the products were oxidized under the reaction conditions rather 
than through some silica-mediated process.  One possibility that could lead to oxidized 
alkylation products may result from the presence of N-oxides formed between LiHMDS 
and advantentitous oxygen inside the reaction vessel.  Since ketone formation was 
sporadic and often not observed, it was decided not to devote any further efforts to 
address this issue. 
 
Scheme 33.  Presence of Oxidized Products 
 
2.1.3 Optimization of Alkylation Procedure 
 Since it is clear from Table 10 that excess base does not drive the reaction to form 
exclusively dialkylated products, efforts were shifted towards developing a procedure 
that allowed for selective monoalkylation.  For the purposes of using this methodology in 
a convergent synthesis, monoalkylation is ultimately more useful. Before beginning 
optimization studies, it was crucial that we determine the exact titre of the base under 
study since excess base would lead to lower monoalkylation composition.  Since the 
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direct titration of lithium amide bases required special dyes, lithium amide bases were 
prepared by deprotonation with n-butyllithium (nBuLi) of known concentration.  This 
method is usually preferred because nBuLi can be directly titrated with diphenylacetic 
acid or N-pivaloyl-o-toluidine, which are commercially available.  Using 1.1 equivalents 
of base with respect to the 2-boryl allylic sulfone 38, a series of bases were screened in 
the alkylation with iodide 119 (Table 12).   
Table 12.  Effect of Base in the Alkylation of 38 with Primary Iodide 119. 
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When comparing lithium amide bases (Entries 1-4), it was found that the more 
sterically hindered bases, lithium 2,2,6,6-tetramethylpiperidine (LiTMP) and lithium tert-
butyltritylamine (LiTBTA), led to lower yield of monoalkylated product 120a.  However, 
LDA, being slightly less bulky than LiTMP, allowed for monoalkylation to occur in 73% 
yield.  This results contrasts the poor selectivity observed by Pine and co-workers in 
alkylation experiments with nBuLi.  It is worth a brief reminder that sulfone 38 has 
distinct structural differences from methyl phenyl sulfone that can explain for the 
different reactivity.  A clean reaction was not observed with nBuLi most likely due to 
some interaction between relatively unhindered base and boron.  An interesting result 
was observed when LiHMDS was prepared from nBuLi and hexamethyldisilazide 
(HMDS) (Entry 4). When the freshly prepared base was used, a 60% yield of the 
monoalkylation was achieved, which is surprisingly more effective when compared to 
initial results with methyl iodide in Table 9.  It should be noted that in alkylation 
experiments, it was common for trace (2-4%) amounts of starting material to be present 
in crude 1H NMR spectra.   Under the conditions shown in Table 12, calcium and 
potassium hydride were unreactive with sulfone 38.  It is known that tight ion pairing 
between the sulfone stabilized carbanion and base cation can lead to a decreased 
reactivity.  It was envisioned that formation of a weaker ion-pair via K or Na analogues 
of HMDS base would increase the reactivity.  However, lower yields were observed in 
cases where NaHMDS and KHMDS bases were used in place of LiHMDS (Entries 7-9). 
Lastly, the use of additives hexamethylphosphoramide (HMPA) and 1,3-dimethyl-
3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) to break up coordinated lithium 
complexes had no effect on the reaction and were not used in further reactions. This 
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result further indicates that the carbanion-lithium ion pair formed after deprotonation is 
not so tight as to hinder the reactivity of the carbanion.  
Although a good yield of monoalkylated product 120a could be achieved using 
LDA in tetrahydrofuran (THF), we decided to determine if the identity of solvent would 
influence the outcome of alkylation.  As can be seen in Table 13, 38 is completely 
unreactive in solvents other than THF.  To verify successful anion generation, 38 was 
treated with LDA in diethyl ether and the resulting yellow solution was quenched with 
deuterated methanol.  The proton NMR showed complete conversion of 38 to the mono-
deuterated species.   
Table 13.  Solvent Study. 
 
 
54 
 
This result tells us deprotonation is indeed taking place, however, the resulting anion is 
unreactive in these solvents. 
The ideal concentration for the alkylation was found by treating varying 
concentrations of 38 in THF with LDA at  -78 oC and trapping the anion with 
iodopropane.  After allowing each reaction to stir for three hours at ambient temperature, 
the reaction progress was determined by crude 1H NMR spectra and the isolated yields of 
110a were recorded.  Beginning in dilute conditions (Table 14, Entry 1), the reaction 
appears sluggish, but approaches completion once the concentration reaches 0.07 M.  
Instead of reaching a plateau, the reaction begins to stall once the concentration becomes 
too high, resulting in diminished yields (Entries 4-5). 
Table 14.  Concentration Study. 
 
 Initial alkylation experiments with 2-boryl allylic sulfone were conducted by 
treatment with base at -78 oC, adding electrophile, and removing the reaction from the 
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cold bath where it was then allowed to stir for three hours at ambient temperature.  
However, it was unclear at what exact temperature the alkylation took place.  To 
determine the temperature range which the anion of 38 alkylates, four separate 
experiments were designed.  In each experiment, 38 was deprotonated, treated with 
electrophile, and warmed to a desired temperature (Table 15).  The data in Table 15 
suggests that alkylation occured even at -78 oC, but must be warmed to a range between 
25 and 0 oC to be complete within three hours. 
Table 15.  Temperature Dependence. 
 
 Having established an alkylation protocol between 38 and primary alkyl iodides 
that allows for selective monoalkylation, it was necessary to explore the scope of this 
reaction with electrophilic substrates.  Using the optimized alkylation protocol, 38 was 
deprotonated and allowed to react with primary alkyl bromides and chlorides (Table 16, 
Entries 2-3).  The yields were not collected; however, the crude masses and product 
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compositions indicate that alkyl bromides are reactive to some degree.  Unfortunately, a 
significant amount of mass was lost during the process.  This effect was highlighted 
during attempts to alkylate 38 with butyl chloride.  After workup, neither starting 
material nor product were observed in crude 1H NMR spectra.  In addition, the mass 
balance observed for alkyl chlorides and bromides was significantly low.   The data in 
Table 16 suggest less reactive substrates facilitate product decomposition.  This 
conclusion was further validated in a control experiment without addition of electrophile.  
Allowing the anion of 38 stir at ambient for three hours followed by quenching with 
ammonium chloride resulted in a 95% recovery of starting material, which was pure by 
crude 1H NMR.   
Table 16.  Identity of Leaving Group. 
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2.1.4 Alkylation of 37 under Optimized Conditions 
Given the poor reactivities displayed by bromides and chlorides, the scope of the 
alkylation was explored with primary iodides (Table 17).  In general, moderate to good 
yields can be achieved using the alkylation protocol developed for 38 and primary 
iodides. Furthermore, allyl and benzyl bromide could give rise to monoalkylated products 
in 44% yield (Entries 6-7).  Unfortunately, the less reactive secondary iodides are 
completely unreactive under the optimized procedure.  It was also found that 
trimethylsilyl chloride was sufficiently reactive to afford 125a in 62% yield (Entry 14).  
The larger distance in a silicon-chloride (202 pm) bond when compared to that of a 
carbon-chloride (176 pm) can account for the observed reactivity with trimethylsilyl 
chloride.  The success of alkylation experiments with 38 prompted the synthesis of 
alkylated products which would allow for further functionalization.  Iodides bearing 
terminal double bonds (Entries 8-11) were prepared from the corresponding alcohols and 
the resulting dienes were used in ruthenium catalyzed metathesis reactions, which will be 
discussed in the following section.   
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Table 17.  Substrate Scope in Alkylation Experiments with Boronate 38. 
 
Furthermore, 120a, which possesses an aryl iodide, has the ability to undergo 
intramolecular SM cross-coupling chemistry.  The chemistry associated with these 
alkylation products marks the beginning of this work regarding bifunctional boronates.   
During the purification of products shown in Table 17, a loss of product mass was 
observed after flash chromatography.  Certainly, one expects a loss of mass during any 
purification as impurities are removed; however, in some cases a significant drop in yield 
was observed after purification.  For instance, a clean alkylation having a 90% crude 
yield would drop to 60% yield after chromatography. It was immediately suspected that 
the silica gel itself was destroying products during chromatography. Before any 
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considerable work was undertaken, we ruled out the silica as being “bad” as similar 
results were obtained even when the source of silica was changed.  To corroborate this 
silica-mediated hypothesis, Whiting and co-workers made a similar claim in which they 
observed de-esterification of their boronic esters after chromatography42. To investigate 
this matter further, experiments were designed that would simulate flash chromatography 
in attempts to find the source of the problem (Table 18).  Passing boronate 38 through a 
flash column using parameters developed by Still and co-workers43 results in only a 66% 
recovery of 38 (Entry 1).  This clearly shows that some element of flash chromatography 
is detrimental to boronate 38, proving the initial hypothesis. We thought that neutralizing 
the acidic silica gel by adding 1-3% triethylamine would prevent this decomposition; 
however, only a slight improvement was made (Entry 2) and presence of the ketone side 
product became an issue.  Since compressed air is used in flash chromatography, we 
thought that stirring a solution of 38 exposed to an air balloon would cause 
decomposition; however, the starting material was recovered quantitatively. Even 
subjecting a stirred slurry of 38 in silica to a constant stream of oxygen had no effect.  It 
is difficult to arrive to a definite conclusion from these results.  However by comparing 
Entry 1 to Entries 2-5, it is clear that there is some element of the flash process that 
degrades boronate 38 that cannot be repeated under stirring conditions.  Although neutral 
alumina was not used in purification steps, it was also found to completely destroy 
boronate 38. 
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Table 18.  Decomposition of 38 through Flash Chromatography. 
 
 
2.2 - Cross Metathesis Chemistry with 2-boryl Allylic Sulfone 
In conjunction with the alkylation chemistry discussed in the previous section, the 
next goal was to prepare alkylated products which could then be used in further 
ruthenium-catalyzed, cross-metathesis chemistry.  The success of the metathesis would 
establish a bifunctional boronate capable of undergoing alkylation/metathesis sequence in 
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generation of value-added cyclic boronates.  In addition, the intermolecular cross-
metathesis of 38 with terminal olefins would also prove useful as long as high 
diastereomeric ratios could be achieved.  
The formation of new carbon-carbon bonds through ruthenium-catalyzed cross-
metathesis is a methodology widely used in synthesis.  The ruthenium-based alkylidene 
complex 127, initially developed by Grubbs and coworkers often suffered from 
sensitivity to moisture and air (Figure 5).44  This led to the development of complexes 
12845 and 129,46 which are stable to air and even water, thus increasing their reactivity 
through the substitution of phosphine ligands with more basic N-heterocyclic carbenes 
(NHC).  The second generation Hoveyda-Grubbs catalyst 129 utilizes a bidentate ligand 
which forms an oxygen chelate, making this complex phosphine free.  This catalyst is 
also known to show increased thermal stability and is often used when harsh reaction 
conditions are employed. It is worth mentioning that molybdenum-based catalysts 
 
Figure 5.  Ruthenium Based Olefin Metathesis Catalysts. 
are often more reactive towards electron rich olefins but lack the stability of the modern 
second generation ruthenium catalysts and are not seen as frequently in literature.  In 
addition to their added stability and increased reactivity towards olefins, perhaps the most 
notable property of these catalysts is their functional group tolerance.  The well-behaved 
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nature of ruthenium-based catalysts makes their use applicable to heteroatom-substituted 
dienes.47  Having prepared alkylated compounds with unsaturated electrophiles, we 
became interested in ruthenium-catalyzed ring closing metathesis (RCM) towards the 
generation of cyclic boronates.  It was later discovered that this type of work was already 
established on similar substrates possessing boronic ester substituted double bonds 
(Scheme 34).48 
 
Scheme 34.  RCM of Alkenylboronates. 
Although this work demonstrates that the ruthenium catalyst is compatible with olefins 
bearing boronic esters, it was still unclear if this chemistry would work with similar 
substrates that possessed a phenylsulfonyl moiety.  It is known that certain carbonyl 
substrates may decrease the activity of ruthenium complexes towards metathesis (Scheme 
35).49  During attempts to cyclize diene 132, it was found that the interaction between the 
carbonyl oxygen and neighboring ruthenium carbene was strong enough to prevent RCM.  
It was anticipated that a similar interaction could come into effect during the RCM of 
substrate 121a as a result of sulfonyl oxygen atoms coordinating too strongly to the 
neighboring catalyst as shown in structure 134.  
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Scheme 35.  Deactivation of Catalyst Resulting from Coordination to Adjacent Electron 
Donors. 
 
2.2.1 Synthesis of Functionalized Cyclic Boronates 
Fortunately, it was found that the alkylated product 121a undergoes RCM with 
catalyst 128 giving the five-membered carbocycle 135 in a high yield (Scheme 36).  
Formation of cyclohexene 136 from 122a could be accomplished under the mild 
procedure used for the cyclopentene derivative, albeit with a lower yield.  As expected, 
the formation of six-membered ring is slower than its five-membered analogue. 
Increasing the catalyst load to 10% had little effect on the reaction; therefore, 5% catalyst 
loading was used, as it was thought to be more efficient. Furthermore, the high yield 
obtained in the presence of mild reaction conditions and relatively high concentrations 
suggests the reaction would perform well with a variety of substrates.  Given the initial 
success, it was decided to build a series of alkylated intermediates, to serve as substrates 
to explore the scope of the ring-closing metathesis. More specifically, we wanted to 
determine what effect substituents or heteroatoms would have on the RCM. 
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Scheme 36.  RCM of Substrates 121a and 122a with Catalyst 128. 
 
2.2.2 Synthesis of Alkylated Substrates for the RCM  
Given the initial success in the RCM of alkenylboronic esters 121a and 122a, a 
series of unique alkylation products were prepared that contained various structural 
features that would help determine the scope of the RCM.  Using the optimized 
procedure for the alkylation of 38, metathesis substrates 137-147 were prepared with 
moderate to good yields (Table 19).  Substrates 137 and 138 were prepared to help 
determine if the substitution on the double bond hinders metathesis.  Furthermore, the 
effect of allylic substituents was to be studied using substrates 139-142.  A successful 
RCM with cyclic substrates 143 and 144 would provide access to bicyclic products with 
benzo-fused ring systems, which are a common motif in natural products.  And lastly, we 
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were interested in preparing azepine and oxepines from substrates bearing heteroatoms 
(Entries 9-10).   
Table 19.  Alkylation of 38 with Unsaturated Iodides. 
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2.2.3 Initial Attempts at RCM with Alkenylboronates 
With the successful ring-closing of substrates 121a and 122a providing their 
respective five-and six-membered carbocycles, substrate 123a was subjected to the initial 
unoptimized conditions.  Unfortunately, after a careful analysis of the reaction mixture, 
only the six-membered product 136 was formed rather than the expected cycloheptene 
148.  In addition, 37% of unreacted, undimerized starting material was recovered 
(Scheme 37).  There were many features of this result that raised concern.  Recovering 
undimerized starting material may indicate that the catalyst is not turning over and 
perhaps being consumed through some unknown process.  In addition, it was not initially 
clear how the reaction could result in formation of 136.   
 
Scheme 37.  Initial Attempt to Prepare Cycloheptene from RCM of Substrate 123a. 
It was later discovered that formation of the cyclohexene side product was likely 
due to the isomerization of the less substituted double bond on 123a involving a 
ruthenium hydride species.50  The actual mechanism for this process has not yet been 
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determined, but there are two proposed variants.  Prunet and co-workers propose a π-allyl 
complex between the ruthenium catalyst and olefin may result in isomerization rather 
than metathesis.51  An alternative mechanism proposed by Grubbs and co-workers 
derives from a catalytically active ruthenium-hydride formed in situ.  Under this notion, 
olefins undergo isomerization through a hydrometallation/β-hydride elimination 
mechanism catalyzed by a ruthenium hydride species.52  Using the hydrometallation/β-
hydride mechanism, the isomerization of 123a to the thermodynamically more stable 
disubstiuted olefin is shown in Scheme 38.  The exact structure of the ruthenium-hydride 
is unknown and for the sake of simplicity is given a general structure.  It is believed that 
either the ruthenium hydride is present as an impurity carried over from the catalyst 
synthesis or formed in situ as a result of high temperatures and dilution.  Upon 
coordination to the less hindered olefin of 123a, hydrometallation occurs generating 
intermediate II, which then undergoes beta elimination, forming the more 
thermodynamically stable internal olefin III.  Once formed, internal olefin III may then 
undergo RCM with catalyst 128. leading to cyclohexene 136.   
 While searching for a new RCM procedure that would effectively solve the 
isomerization issue, we found that olefin isomerization under normal metathesis 
conditions is quite common, even in simple diene substrates.  Using sub-stoichiometric 
equivalents of an oxidant, Grubbs’ and co-workers were able to suppress olefin 
isomerization in metathesis reactions with the second generation catalyst 128.  Among 
several oxidants examined, 1,4-benzoquinone was found to completely block olefin 
isomerization during RCM of diallyl ether.53 
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Scheme 38.  Ruthenium Hydride Isomerization Mechanism 
2.2.4 Optimization of RCM 
Using 1,4-benzoquinone as an additive, the results of the RCM of 123a with 
Hoveyda-Grubbs second generation catalyst 129 are shown in Table 20. We decided to 
heat the substrate to 110 oC in toluene to help drive the reaction forward and as a 
consequence, the Hoveyda-Grubbs second generation catalyst was used for its increased 
thermal stability.   
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Table 20.  Suppression of Olefin Isomerization via Addition of Oxidant. 
 
To avoid self-dimerization, reactions were conducted under high dilution.  As a control 
experiment, the substrate was subjected to this more robust set of conditions in the 
absence of 1,4-benzoquinone (Entry 1), which resulted in complete conversion of 123a to 
the undesired cycloheptene 136.  Adding 10% of 1,4-benzoquinone allowed for the 
formation of the seven-membered ring; however, the isomerization was still prevalent 
(Entry 2).  For substrate 123a, it was found that two equivalents of the oxidant were 
required to completely block the formation of the isomerized product.   In an effort to 
increase the yield, it was thought the concentration could be increased; however, doing so 
stalled the reaction and resulted in an incomplete product conversion. Incomplete product 
conversions were also observed when the reaction temperature was reduced.  
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2.2.5  Scope of RCM 
          With a set of conditions that led to complete product conversions while preventing 
olefin isomerization, the scope of RCM with alkenylboronate substrates was explored 
(Tables 21-22).  Ring-closing of diene 137, possessing a vinyl methyl substituent, 
proceeded smoothly, forming the tetrasubstituted cyclopentene 149 in good yield (Entry 
1).  Unfortunately, formation of the tetrasubstituted cyclohexene products from dienes 
138 and 139 were not possible.  The slower rate of ring formation for the larger 
cyclohexene in combination with the added sterics of the olefin made ring-closing 
impossible. Fortunately, RCM with substrates bearing allylic substituents was possible in 
substrates 140-142.  When compared to the yield observed with unsubstituted diene 122a, 
allylic substituents appear to promote ring closure.  This effect is most pronounced in the 
RCM of substrate 143, which was converted to cyclohexene 152 in a 90% yield (Entry 
6). 
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Table 21.  RCM of Substrates Bearing Vinylic and Allylic Substituents. 
 
In hopes of preparing benzo-fused cyclic boronates, styrl substrates 143 and 144 
were subjected to the optimized RCM conditions (Table 22).  Similar to the effects 
observed with substrates possessing allylic substitution, the yields of the six- and seven-
membered benzo-fusing products 153 and 154 were improved relative to their 
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unsubstituted analogues.  The added rigidity of the aromatic rings in these substrates may 
allow for a more organized transition state at some point during metathesis.  
Incorporation of N-tosyl amine on substrate 145 led to an increase in yield when 
compared to the formation of the carbocyclic derivative 148. 
Table 22.  Synthesis of Benzo-fused and Heterocyclic Boronates. 
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Heteroatoms are known to facilitate coordination to the ruthenium catalyst, thereby 
increasing their reactivity in metathesis reactions.  The ability to prepare cyclic amines 
using this methodology is significant in that azepines are a class of heterocycles found in 
natural products and are structurally similar to benzodiazepines, which are common class 
of pharmaceutical drugs.   Unfortunately, the reactivity of oxygen analogue 146 was 
completely different than amine 145. Subjecting ether 146 to RCM conditions did not 
result in oxepine formation (Entry 10).  Given this type of RCM with allyl ethers is well 
documented in formation of oxygenated heterocycles54, this result came as a surprise.  It 
is possible that the lone pair on the ethereal oxygen coordinates strongly to the metal 
center, leading to ligand exchange with a chloride, which ultimately forms a new 
ruthenium complex incapable of catalyzing metathesis.  As it turns out, substrates 
containing oxygen had a similar effect on intermolecular metatheses, which will be 
discussed in the following section. In anticipation of the sluggish formation of an eight-
membered ring, it was thought a nitrogen heteroatom should be incorporated in substrate 
147; however, only starting material was recovered under these RCM conditions (Entry 
13).  It is worth mentioning that undimerized starting materials were recovered in cases 
with unreactive substrates, which may indicate catalyst decomposition or simply be a 
result of high dilution. 
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2.2.6  Intermolecular Cross-Metathesis Chemistry of 2-boryl Allyic Sulfone 
It was also worth investigating the ability of boronate 38 to undergo cross-
metathesis in an intermolecular fashion with reactive olefins.  Similar chemistry was 
previously reported by Grubbs and co-workers with boronate 23 (Scheme 39).55 
 
Scheme 39.  Intermolecular Cross-Metathesis with 2-isopropenyl Pinacol Boronate. 
Using excess 156, high Z/E selectivities were observed for metathesis products.  Under 
identical conditions, cross-metathesis of sulfone 38 with monosubstituted olefins 
proceeded in high yields, but low diastereoselectivity with a narrow class of substrates. 
(Table 23).   The lower selectivities observed with boronate 38 are a result of the added 
steric environment brought on by the phenylsulfonyl moiety, lowering the preference for 
the Z isomer.   Using 1-hexene and 4-phenyl-1-butene, we were able to achieve good 
yields, albeit a low (5:1) Z/E ratio.  However, substrates possessing heteroatoms were 
entirely unreactive.  Except in the case of styrene, only pure hydrocarbons were found to 
be reactive.  It is known that allylic oxygen atoms enhance the rate of reactivity in 
metathesis reactions with ruthenium catalysts most likely through formation of a complex 
prior to metathesis.56  This effect is even more pronounced when allylic hydroxy group is 
present.  The rationalization for the enhanced reactivity can be attributed to a pre-
complexation between the heteroatom and the ruthenium metal center prior to metathesis.   
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Table 23.  Cross-Metathesis of 37 with Olefins. 
Attempts to force cross-metathesis using harsh reaction conditions led to recovery of 160 
presumably resulting from multiple ruthenium-hydride catalyzed double bond migrations 
prior to metathesis (Scheme 40).   Addition of benzoquinone unfortunately led to 
recovery of starting material. 
 
Scheme 40.  Unusual Intramolecular Cross-Metathesis Product 
 
2.3  Radical Isomerization of Alkylated Intermediates 
 In addition to the alkylation chemistry discussed in previous sections, the 
reactivity of the 2-boryl allylic sulfone provided by the phenylsulfonyl group could be 
further explored in radical isomerizations.   Treatment of sulfone 161 (Ar = pTol) with a 
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radical initiator under refluxing conditions in acetic acid/water results in isomerization to 
the more thermodynamically stable olefin 163 (Scheme 40).57   
 
Scheme 40.  Radical Isomerization of Allylic Sulfone 161. 
Under acidic conditions, sodium p-tolylsulfinate forms radical species in situ.  This then 
undergoes radical addition to 161 forming intermediate 162.    Elimination results in the 
formation of the more substituted prenyl isomer 163.   Much like all previous work with 
the sulfone 38, it was not known if a procedure taken from literature would be applicable 
to a molecule which bears a Lewis-acidic boronic ester.   For instance, we thought using 
acetic acid/water as a solvent might result in hydrolysis of the boronic ester to the parent 
acid.  Fortunately, treatment of alkylated boronates (Table 24) with excess sodium phenyl 
sulfinate in an acetic acid/water solvent resulted in isomerization to the more substituted 
olefin.  Despite the desilylation of 125a, good to excellent yields were observed in all 
isomerizations.  We expected that 115a might cyclize through a radical chain mechanism; 
however, 164 was recovered as a single product. 
 
 
77 
 
Table 24.  Radical Isomerization of Alkylated Substrates. 
 
 The stereochemistry of the major isomerized products was determined via 
Nuclear Overhauser Effect Spectroscopy (NOESY).  As a representative example, the 
two-dimensional 1H-1H NOE spectra for the diastereomeric mixture of 168 is shown in 
Figure 6.  The triplets appearing between 6.0 - 7.0 ppm on the horizontal axis correspond 
to the vinylic protons of 168, Ha and Hb, and the singlets around ~ 4 ppm on the vertical 
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axis correspond to the α-sulfonyl protons.  The vinylic hydrogen that is spatially close to 
α-sulfonyl hydrogens will display an overlap signal on the two-dimensional spectra, 
corresponding to the E isomer.  The absence of any signal at the intersection of the two 
red lines verifies that the isomer in larger population, indicated by the larger peak, 
corresponds to the Z isomer. 
 
Figure 6.  1H-1H NOE Spectra of 168 Diastereomeric Mixture. 
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2.4 Application of Polyfunctional Boronates  
To demonstrate the utility of the polyfunctional boronate 38, we decided to 
prepare the 5,7,7-tricyclic core of the natural product ingenol highlighted in Figure 7.  
Ingenol, a diterpenoid isolated from Euphorbia ingens, is a significant natural product in 
that its derivatives display cytotoxic properties. Ingenol mebutate is a derivative approved 
in 2012 by the Food and Drug Administration for the topical treatment of precancerous 
skin lesions.  Originally, production of ingenol was limited to the inefficient extraction 
from milkweed plant sources. However, Baran and co-workers58 reported an efficient 
total synthesis of (+)-ingenol from (+)-3-carene in just 14-steps, which was a major 
improvement from the initial 37-step route.   
 
Figure 7.  Structure of Ingenol and FDA Approved Derivative. 
This synthesis represents a dramatic achievement in that a scalable synthetic route to 
ingenol was previously considered unlikely. 
 Although our plan was not to develop an efficient synthesis of ingenol, we wanted 
to demonstrate the utility of our methodology towards a biologically relevant target.  
Beginning from the seven-membered boronate 148, the alkoxyallylic sulfone 170 was 
prepared though a Chan-Lam reaction (Scheme 41).59   
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Scheme 41.  Synthesis of Ingenol Core Structure. 
Alkylation of sulfone 170 with unsaturated iodide 171 proceeded smoothly to give 172 in 
good yield.  Treatment of 172 with a Lewis acid resulted in generation of alkoxyallylic 
cation, which was trapped by the tethered diene, resulting in the formation of (4 + 3)-
adduct 173 as the major diastereomer.60  Reduction of ketone 173 to alcohol 174 resulted 
in a crystalline solid that could be analyzed by X-ray spectroscopy to determine the 
relative configuration of the major cycloadduct.  It can be seen from the X-ray crystal 
structure of 174 (Figure 8) that the stereochemistry of the product does not match that of 
the natural product.  The stereochemistry of the bicyclo[4.4.1]undecane ring system is 
cis- rather than trans-fused.  The natural product possesses a strained trans-fused bicyclic 
system, which is one of the greatest challenges in construction of ingenol.  Despite the 
undesired stereochemical outcome during the (4 + 3)-cycloaddition step we demonstrated 
the utility of value-added boronate 148 in preparing a tricyclic system. 
81 
 
 
Figure 8.  X-ray Crystal Structure of Alcohol 174. 
2.4.1 Synthesis of Polycyclic Systems. 
 In addition to the class of cyclic boronates prepared from the RCM of alkylated 
products (Tables 21-22), we also wished to access cyclic systems through intramolecular 
SM cross-coupling reactions in the same fashion and, if possible, combine each 
methodology towards polycyclic molecules.   
 Our investigation of intramolecular SM cross-coupling chemistry commenced 
with the preparation of alkylated compounds bearing aryl iodide functionality that would 
allow for cross-coupling (Table 25).  Using primary iodides and triflates with varying 
chain length, substrates were prepared that would allow for five- through eight-membered 
ring formation via intramolecular SM cross-coupling. 
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Table 25.  Synthesis of Intramolecular SM cross-coupling Substrates. 
 
Using the silver oxide-promoted SM cross-coupling conditions utilized in earlier 
studies, the benzo-fused bicyclic products were prepared (Table 26).  With the exception 
of substrate 175, the formation of six-, seven- and even eight-membered benzo-fused 
bicyclics occurred within two hours in high yields.  The formation of 177 was noteworthy 
in that earlier attempts to access this ring size via RCM were unsuccessful (Entry 5).  
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Table 26.  Intramolecular SM Cross-Coupling toward Benzo-fused Ring Systems. 
 
 
Using a combination of previously developed chemistry, we were interested in 
exploring the extent of their utility towards simple polycyclic structures.  Beginning with 
boronate 38, a series of steps involving alkylation, RCM, isomerization and 
intramolecular SM cross-coupling were applied towards the synthesis of generic 
polycycle showing in Scheme 42. 
 
Scheme 42.  General Structure of Polycyclic Products. 
 Beginning with cyclopentenyl boronate 135 (Scheme 44), initial alkylation of the 
tertiary α-sulfonyl carbon was unsuccessful with iodides due to the added steric 
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hindrance of the tertiary carbon.  However, the use of triflates 181 resulted in a 73% yield 
of the monoalkylated product 182.  Subjecting 182 to the silver oxide-assisted SM cross-
coupling procedure resulted in formation of product 184, which presumably isomerized 
to the thermodynamically stable isomer 183 in situ.  Since the molecule tends to favor the 
tetrasubstituted isomer 183, the alkylation product 182 was isomerized, then subjected to 
cross-coupling, which resulted in a 90% yield of the 5,7,6-polycyclic product 186. 
 
Scheme 43.  Synthesis of Polycycle 183. 
 The use of the polyfunctional boronate 38 is demonstrated in Scheme 43, whereby 
access to a polycyclic molecule was accomplished through a series of alkylation, 
metathesis, isomerization, and cross-coupling sequence.  This demonstration should serve 
as an example of how this methodology could have potential synthetic application. 
 The development of a procedure which allows for the alkylation of sulfone 38 has 
been demonstrated.  The ability of the sulfone, which bears a Lewis-acidic boronic ester, 
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to alkylate in good yields suggests the boronic ester is stable to towards anion generation, 
allowing the species to undergo alkylation.   It has also been demonstrated that alkylated 
products bearing terminal double bonds may undergo ring-closing metathesis which 
provides access to value-added cyclic boronates.  The ability of this boronate to undergo 
alkylation, metathesis, cross-coupling and radical isomerization has been applied to the 
synthesis of the ingenol core structure and polycyclic compounds 179-180, thereby 
demonstrating the effectiveness of polyfunctional boronates in synthesis.  
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CHAPTER 3 
Experimental Section 
3.1  General 
 All glassware and needles were oven-dried and allowed to cool in a desiccator 
prior to use. Tetrahydrofuran (THF), diethyl ether, dimethoxyethane (DME), 1,4-dioxane  
and toluene were purchased from Fisher Scientific and distilled from sodium-
benzophenone prior to use.  Dichloromethane and diisopropylamine were distilled over 
calcium hydride prior to use.  Solvents used in air sensitive reactions were degassed by 
several freeze-pump-thaw cycles.  1,4-benzoquinone was purified by sublimation at 
reduced pressure.  Organolithium bases n-butyl lithium (nBuLi) and lithium 
hexamethyldisilazide (LiHMDS) were purchased from Aldrich  .nBuLi was titrated with 
freshly recrystallized diphenylacetic acid prior to use.   2-isopropenylboronic acid 
pinacolester, was used as received from Frontier Scientific.  Products were purified by 
flash chromatography using 230-400 mesh silica purchased from Aldrich and, if 
crystalline, were recrystallized from hexane-diethyl ether until a constant melting point 
was observed.  All compounds were characterized by 1H, and 13C Nuclear Magnetic 
Resonance (NMR) spectroscopy using a 500 MHz Bruker instrument.  Proton spectra 
were reported in δ units, parts per million (ppm), relative to trimethylsilane internal 
standard (0.00 ppm).  Carbon spectra were recorded in ppm relative to solvents peaks: 
CDCl3 (77.16 ppm), (CD3)2CO (29.84 ppm), CD3CN (1.32 ppm), or (39.52 ppm) where 
DMSO was used.  Samples were further characterized using mass spectroscopy on a 
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Bruker Apex-Qe instrument.  Infrared spectra were recorded on a Thermo Nicolet 
NEXUS 670 FT-IR instrument.   
3.2  Procedures 
 
 (Z)-(4-iodobuta-1,3-dien-2-yl)benzene (29): To a slurry of 
iodomethyltriphenylphosphonium iodide (5.36 g, 10.1 mmol) in 20 mL dry THF was 
added NaHMDS (0.8 M in THF, 13.6 mL, 10.9 mmol,) and HMPA (2.1 mL).  The dark 
red solution was stirred for 5 minutes at room temperature, then cooled to -78 oC.  To the 
ylide as added atropaldehyde (1.11 g, 8.42 mmol), as a solution in THF (1.0 mL) 
dropwise.  After addition, the reaction was allowed to reach room temperature and stirred 
for 30 minutes before being quenched with aqueous NH4Cl.  The organic layer was 
separated, concentrated under rotary evaporator and the crude oil was purified by flash 
chromatography (100% hexanes) resulting in a yellow oil (600 mg, 28%).  1H NMR (500 
MHz, CDCl3) δ 7.39 – 7.29 (m, 5H), 6.96 (d, J = 8.5 Hz, 1H), 6.66 (d, J = 8 Hz, 1H), 
5.72 (s, 1H), 5.51 (s, 1H); 13C NMR (125 MHz, CDCl3)  δ 145.2, 139.6, 128.6, 134.0, 
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133.8, 128.9, 128.7, 128.6, 128.2, 126.7, 116.9, 86.7;  IR (film) νmax = 3062, 3027, 2978, 
2931, 1447, 1423, 1330, 1305, 1214, 1143, 1084 cm-1;  HRMS could not find peak. 
 
4-(tosylmethyl)-2,3-dihydro-1,1'-biphenyl (33): SM Cross-Coupling Procedure A: In a 
sealed tube containing 1.0 mL toluene and 0.1 mL water was added vinyl iodide 29 ( 50 
mg, 0.196 mmol), boronic ester 25 (94 mg, 0.292 mmol), palladium (II) chloride (0.70 
mg, 3.9 µmol), RuPhos (3.64 mg, 7.8 µmol), sodium hydroxide (25 mg, 0.62 mmol).  
The reaction was sealed and heated to 100 oC for 17 h.  The reaction was cooled to room 
temperature and extracted with dichloromethane.  The organic extracts were washed with 
brine, dried over magnesium sulfate and concentrated under reduced pressure.  The crude 
was purified via column chromatography (20% ethyl acetate/hexanes) yielding a white 
solid (48 mg, 76%). mp = 168 °C; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 8 Hz, 2H), 
7.42 (d, J = 8 Hz, 2H), 7.33 (t, J = 8 Hz, 4H), 7.23 (d, J = 8 Hz, 1H), 6.21 (d, J = 5.5 Hz, 
1H), 5.76 (d, J = 5.5 Hz, 1H), 3.87 (s, 2H), 2.62 (t, J = 10 Hz, 2H), 2.45 (s, 3H), 2.40 (t, J 
= 10 Hz, 2H); 13C NMR (125MHz, CDCl3)  δ 144.8, 140.4, 137.7, 135.7, 129.8, 129.3, 
128.8, 128.6, 127.6, 125.2, 125.1, 120.3, 64.5, 27.1, 26.0, 21.8;  IR (film) νmax = 3062, 
3027, 2978, 2931, 1447, 1423, 1330, 1305, 1214, 1143, 1084 cm-1;  HRMS calcd for 
(C20H20O2S)Na+ 347.1076; Found: 347.1079. 
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2-(2-iodo-1-(phenylsulfonyl)propan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(37): Benzenesulfinic acid (6.44 g,  39.2 mmol) was dissolved in 200 mL water and 
treated with a saturated solution of iodine (10.0 g, 39.3 mmol) dropwise.  Once the 
addition was complete, the organic layer was separated and dried over MgSO4 for 2 h in 
the dark. The red solution of sulfonyl iodide was added dropwise to a solution of 2-
isopropenyl boronic acid pinacol ester (6.0 g, 35.7 mmol) dissolved in 100 mL dry 
dichloromethane and stirred for 12 h at room temperature.  The reaction mixture was 
washed with Na2S2O3, brine and the organic layer was dried over MgSO4.  The solvent 
was removed under rotary evaporator and the remaining solid was recrystallized from 
hexanes-diethyl ether (13.2 g, 77%).  mp = 106 – 107 °C;  1H NMR (500 MHz, CDCl3) δ 
7.92 (d, J = 8 Hz, 2H),  7.65 (t, J = 7.5, 1H),  7.56 (t, J = 7.5, 2H),  4.10 (d, J = 13 Hz, 
1H),  3.84 (d, J = 13 Hz, 1H),  2.26 (s, 3H), 1.45 (s, 6H), 1.36 (s, 6H);  13C NMR (125 
MHz, CDCl3) δ 141.16, 133.88, 129.46, 127.81, 84.90, 69.56, 29.48, 24.57, 24.50;  
HRMS calcd for (C15H22BIO4S)Na+ 459.0268; Found: 459.0266. 
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4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)prop-1-en-2-yl)-1,3,2-dioxaborolane (38):  
A solution 37 (13.6 g, 31.3 mmol) in dry chloroform (125 mL) was treated with 
triethylamine (8.7 mL, 62.5 mmol) and heated to reflux for four days.  The reaction 
mixture washed with 0.5 M HCl, water and brine.  The organic layer was dried over 
MgSO4 and concentrated to give a solid which was recrystallized from hexanes-diethyl 
ether (7.3 g, 76%).  mp = 105- 107 °C; 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8 Hz, 
2H),  7.61 (t, J = 7.5 Hz, 1H),  7.51 (t, J = 7.5 Hz, 2H),  6.09 (d, J = 2.5 Hz, 1H),  5.78 (s, 
1H),  3.93 (s, 2H),  1.15 (s, 12H);  13C NMR (125 MHz, CDCl3) δ 138.90,  138.68, 
133.54, 129.14, 128.97, 84.26, 60.76, 24.78;  IR (film) νmax = 2996, 2983, 1613, 1446, 
1440, 1392, 1383, 1332,  1304, 1245, 1168, 1139, 1123, 1084, 979, 861, 768, 702, 690, 
651 cm-1;  HRMS calcd for (C15H21BO4S)Na+ 331.1145; Found: 331.1140. 
 
(3-(phenylsulfonyl)prop-1-en-2-yl)potassium trifluoroborate (39): The pinacol ester 
38 (3.0 g, 9.7 mmol) was dissolved in methanol (80 mL) and treated with an aqueous 
solution of potassium hydrogen fluoride (5.3 g, 67.9 mmol).  The slurry was stirred for 2 
h at 25 oC and the solvent was removed under reduced pressure.  The crude product was 
dissolved in boiling acetonitrile and hot filtered to remove excess potassium hydrogen 
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fluoride.  The acetonitrile was removed under reduced pressure and the resulting white 
solid could be purified by rinsing with ethyl acetate leaving behind a fluffy white solid 
(2.37 g, 85%).  mp = 214 - 215 °C;  1H NMR (500 MHz, Acetone-d6) δ 7.89 (d, J = 7 Hz, 
2H),  7.65 (t, J = 7 Hz, 1H),  7.56 (t, J = 7 Hz, 2H),  5.26  (s, 1H),  4.96 (s, 1H),  3.89 (s, 
2H);  13C NMR (125 MHz, CD3CN) 140.95, 134.02, 129.63, 129.25, 124.17, 124.16, 
118.26, 62.82;  HRMS calcd for (C9H9BF3KO2S)Na+ 310.9897; Found: 310.9895. 
 
(3-(phenylsulfonyl)prop-1-en-2-yl)boronic acid (40): Potassium trifluoroborate 39 (100 
mg, 0.347 mmol) was dissolved in 5 mL water (0.07 M) and stirred with excess silica for 
4 h at 25 oC.  Once the reaction was complete, the silica was filtered and the filter cake 
was washed several times with ethyl acetate.  The filtrate was added to a separatory 
funnel and the aqueous phase was extracted with ethyl acetate (3 x 10 mL).  The organic 
layers were collected and dried over magnesium sulfate.  The solvent was removed 
leaving behind the free acid (90 mg, 98%).  1H NMR (500 MHz, Acetone-d6) δ 7.86 (d, J 
= 7 Hz, 2H), 7.72 (d, J = 7.5 Hz, 1H), 7.62 (t, J = 7 Hz, 2H), 6.94 (s, 1H), 5.99 (d, J = 3 
Hz, 1H), 5.57 (s, 1H), 4.07 (s, 2H);  13C NMR (125 MHz, Acetone-d6) δ 140.1, 136.1, 
134.4, 129.8, 129.5, 62.1; IR (film) νmax = 3062, 3027, 2978, 2931, 1447, 1423, 1372, 
1305, 1214, 1143, 1084 cm-1; HRMS calcd for (C9H11BO4S)Na+ 249.0363; Found: 
249.0363. 
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8-(3-(phenylsulfonyl)prop-1-en-2-yl)hexahydro-[1,3,2]oxazaborolo[2,3-
b][1,3,2]oxazaborol-4-ium-8-uide (42):  Pinacol boronate 38 (614 mg, 1.99 mmol) was 
dissolved in 16 mL dry diethyl ether and treated with diethanolamine (202 µL, 2.19 
mmol) dropwise.  Stirring was continued for 2 h and the white precipitate was filtered 
and washed with diethyl ether.  The crude solid was recrystallized from ethyl acetate (469 
mg, 80%).  mp = 154 – 155 oC. 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 7.5 Hz, 2H),  
7.66 (t, J = 7.5 Hz, 1H),  7.56 (t, J = 8 Hz, 2H),  6.15  (s, 1H),  5.82 (d, J = 3.5 Hz, 1H),  
5.22 (s, 1H), 4.07 (ddd, J = 5.5 Hz, J = 9.5 Hz, J = 15.5 Hz, 2 H), 3.98 (s, 4H), 3.42 – 
3.36 (m, 2H), 2.91 – 2.86 (m, 2H), ;  13C NMR (125 MHz, CDCl3) δ 138.79, 133.86, 
131.92, 129.25, 128.33, 63.72, 62.51, 51.33;  IR (film) νmax = 3062, 3027, 2978, 2931, 
1447, 1423, 1372, 1305, 1214, 1143, 1084 cm-1; HRMS calcd for (C13H18BNO4S)Na+ 
318.0941; Found: 318.1940. 
 
6-methyl-2-(3-(phenylsulfonyl)prop-1-en-2-yl)-1,3,6,2-dioxazaborocane-4,8-dione 
(43):  Boronic acid 40 (134 mg, 0.592 mmol) and N-methyliminodiacetic acid (96 mg, 
0.651 mmol) were dissolved in 5 mL toluene/DMSO (1:1).  The solution was heated to 
120 oC for 17 h and diluted with dichloromethane.  The organic layer was separated and 
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washed with water, brine and dried over magnesium sulfate.  The solvent was removed 
under reduced pressure resulting in a solid which could be purified by washing with 
boiling hexanes and decanting (159 mg, 80%).  mp = 184 oC. 1H NMR (500 MHz, 
DMSO-d6) δ 7.84 (d, J = 7.5 Hz, 2H),  7.66 (t, J = 7.5 Hz, 1H),  7.56 (t, J = 8 Hz, 2H),  
6.15  (s, 1H),  5.82 (d, J = 3.5 Hz, 1H),  5.22 (s, 1H), 4.07 (ddd, J = 5.5 Hz, J = 9.5 Hz, J 
= 15.5 Hz, 2 H), 3.98 (s, 4H), 3.42 – 3.36 (m, 2H), 2.91 – 2.86 (m, 2H), ;  13C NMR (125 
MHz, CDCl3) δ 138.79, 133.86, 131.92, 129.25, 128.33, 63.72, 62.51, 51.33;   HRMS 
calcd for (C14H16BNO6S)Na+ 360.0683; Found: 360.0684. 
 
1-nitro-4-(3-(phenylsulfonyl)prop-1-en-2-yl)benzene (46): SM Cross-Coupling 
Procedure B: A 25 mL sealed tube was oven dried and allowed to cool under argon 
atmosphere.  The tube was charged with 4.8 mL toluene and the aryl iodide (172 mg, 
0.693 mmol), [1,1’ Bis(diphenylphosphinoferrocene] dichloropalldium (II) (28.0 mg, 34 
µmol), potassium trifluoroborate 39 (219 mg, 0.762 mmol), and cesium carbonate (677 
mg, 2.07 mmol) were added at once.  The mixture was stirred vigorously and 2.0 mL 
water was added.  The tube was purged with argon before being sealed and placed in an 
oil bath at 80 oC for 8 h. Once consumption of the iodide was determined complete via 
TLC, the reaction was transferred to a separatory funnel and diluted with 10 mL of ethyl 
acetate.  The organic layer was separated and dried over magnesium sulfate.  After 
removal of solvent, the crude product was dry loaded onto a silica column and eluted 
with 20% EtOac/Hexanes to give the product as a solid (156 mg, 74%).  mp = 134 - 135 
94 
 
°C;  1H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 9 Hz, 2H),  7.81 (d, J = 8 Hz, 2H),  7.61 
(t, J = 7.5 Hz, 1H), 7.51 – 7.47 (m, 4H),  5.75 (s, 1H),  5.40  (s, 1H),  4.28 (s, 2H);  13C 
NMR (125 MHz, CDCl3) δ 147.51, 145.32, 138.27, 135.15, 134.17, 129.31, 128.71, 
127.33, 125.46, 123.86, 61.86; IR (film) νmax = 2978, 2931, 1492, 1447, 1423, 1305 cm-1 
; HRMS calcd for (C15H13NO4S)Na+ 326.0457; Found: 326.0454. 
 
1-(4-(3-(phenylsulfonyl)prop-1-en-2-yl)phenyl)ethanone (45): SM Cross-Coupling 
Procedure B).  mp = 134 °C;  1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 9 Hz, 2H),  7.80 
(d, J = 7 Hz, 2H),  7.58 (t, J = 8Hz, 1H), 7.46 (t, J = 8 Hz, 2H),  7.38 (d, J = 7.5 Hz, 2H), 
5.70 (s, 1H),  5.32  (s, 1H),  4.28 (s, 2H), 2.58 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 
197.54, 143.40, 138.19, 136.59, 135.87, 133.96, 129.17, 128.76, 128.65, 126.57, 123.98, 
61.93, 26.77;  IR (film) νmax = 3061, 2977, 2934, 1643, 1447, 1423,1372, 1305, 1145 cm-
1; HRMS calcd for (C17H16O3S)Na+ 323.0712; Found: 323.0714. 
 
3-(3-(phenylsulfonyl)prop-1-en-2-yl)pyridine (48): SM Cross-Coupling Procedure B).  
mp = 88 °C;  1H NMR (500 MHz, CDCl3) δ 8.51 (d, J = 2.5 Hz, 1H),  8.46 (d, J = 5 Hz, 
1H),  7.80 (d, J = 8Hz, 2H), 7.62 (d, J = 8 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 
7.5 Hz, 2H), 7.18 (dd, J = 4.5 Hz, J = 7.5 Hz, 1H), 5.66 (s, 1H),  5.32  (s, 1H),  4.26 (s, 
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2H);  13C NMR (125 MHz, CDCl3) δ 149.19, 147.58, 138.21, 134.58, 134.02, 133.80, 
133.56, 129.31, 129.19, 128.65, 128.52, 123.73, 123.18, 61.77;  IR (film) νmax = 2978, 
2931, 1492, 1447, 1623, 1455, 1385, 1356, 1454, 1143, 1085 cm-1;  HRMS calcd for 
(C14H13NO2S)Na+ 282.0559; Found: 282.0556. 
 
2-fluoro-5-(3-(phenylsulfonyl)prop-1-en-2-yl)pyridine (49): SM Cross-Coupling 
Procedure B). mp = 96 °C;  1H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 2 Hz, 1H),  7.81 
(d, J = 7.5 Hz, 2H),  7.76 (dt, J = 8Hz, J = 2.5 Hz, 1H), 7.62 (d, J = 7 Hz, 1H), 7.51 (t, J 
= 8 Hz, 2H), 6.84 (dd, J = 3 Hz, J = 8.5 Hz, 1H), 5.62 (s, 1H),  5.30  (s, 1H),  4.22 (s, 
2H);  13C NMR (125 MHz, CDCl3) δ 145.71, 145.59, 139.14, 139.07, 138.26, 134.19, 
132.80, 129.34, 128.71, 123.90, 109.43, 109.13, 62.07; IR (film) νmax = 3060, 1591, 
1490, 1447, 1371, 1309, 1295, 1256, 1140, 1084 cm-1; HRMS calcd for 
(C14H12FNO2S)Na+ 300.0464; Found: 300.0463. 
 
1-(3-(phenylsulfonyl)prop-1-en-2-yl)-4-(trifluoromethyl)benzene (51): SM Cross-
Coupling Procedure B). mp = 64 °C;  1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 7 Hz, 
2H),  7.57 (t, J = 7.5 Hz, 1H),  7.49 (d, J = 9Hz, 2H), 7.44 (t, J = 7.5 Hz, 2H),  7.38 (d, J 
= 8.5 Hz, 2H), 5.67 (s, 1H),  5.33  (s, 1H),  4.27 (s, 2H);  13C NMR (125 MHz, CDCl3) δ 
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142.42, 138.41, 135.72, 133.99, 129.18, 128.72, 126.77, 125.58, 125.55, 125.52,125.49, 
124.02, 123.00, 62.07;  IR (film) νmax = 3062, 3027, 2978, 2931, 1447, 1372, 1305, 1214, 
1143, 1084 cm-1; HRMS calcd for (C16H13F3O2S)Na+ 349.0480; Found: 349.0477. 
 
1-chloro-2-methyl-4-(3-(phenylsulfonyl)prop-1-en-2-yl)benzene (53): SM Cross-
Coupling Procedure B). mp = 61 °C;  1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 7.5 Hz, 
2H),  7.57 (t, J = 7 Hz, 1H),  7.45 (t, J = 7.5Hz, 2H), 7.19 (d, J = 8 Hz, 1H), 7.06 (s, 1H), 
7.03 (dd, J = 1.5 Hz, J = 8 Hz, 1H), 5.57 (s, 1H),  5.21  (s, 1H),  4.23 (s, 2H), 2.29 (s, 
3H);  13C NMR (125 MHz, CDCl3) δ 138.52, 137.41, 136.07, 135.80, 134.35, 133.80, 
129.15, 129.04, 128.88, 128.78, 125.10, 122.23, 62.24, 20.22; IR (film) νmax = 2978, 
2931, 1492, 1447, 1423, 1380, 1372, 1305, 1214, 1143, 1084 cm-1; HRMS calcd for 
(C16H15ClO2S)Na+ 329.0373; Found: 329.0372. 
 
 
1-bromo-2-(3-(phenylsulfonyl)prop-1-en-2-yl)benzene (54): SM Cross-Coupling 
Procedure B). mp = 67 °C;  1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 7.5 Hz, 2H),  7.58 
(t, J = 7 Hz, 1H),  7.47 (t, J = 8Hz, 2H), 7.43 (d, J = 8 Hz, 1H), 7.19 (t, J = 7 Hz, 1H), 
7.11 – 7.08 (m, 2H), 5.49 (s, 1H),  5.39  (s, 1H),  4.32 (s, 2H);  13C NMR (125 MHz, 
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CDCl3) δ 141.04, 139.03, 137.36, 133.71, 132.70, 131.59, 129.53, 129.15, 128.48, 
127.51, 125.81, 121.50, 62.26; IR (film) νmax = 2978, 2954, 1493, 1442, 1425, 1305, 
1002 cm-1; HRMS calcd for (C15H13BrO2S)Na+ 358.9711; Found: 358.9708. 
 
1-(3-iodopropyl)-2-(3-(phenylsulfonyl)prop-1-en-2-yl)benzene (55): SM Cross-
Coupling Procedure B).  1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 7.5 Hz, 2H),  7.60 (t, 
J = 7 Hz, 1H),  7.49 (t, J = 7.5Hz, 2H), 7.18 (dt, J = 7 Hz, J = 1 Hz, 1H), 7.12 (d, J = 8 
Hz, 1H), 7.07 (dt, J = 7 Hz, J = 1.5 Hz, 1H), 6.97 (dd, J = 1 Hz, J = 7.5 Hz, 1H),  5.55  (s, 
1H), 5.31 (d, J = 1 Hz, 1H),  3.16 (t,  J = 7 Hz, 2H), 2.64 (t, J = 7.5 Hz, 2H), 2.04 (p, J = 
7.5 Hz, 2H);  13C NMR (125 MHz, CDCl3) δ 140.26, 139.19, 137.39, 136.45, 133.75, 
129.40, 129.24, 129.20, 128.45, 128.13, 126.24, 124.83, 63.66, 34.88, 33.76, 6.58; IR 
(film) νmax = 3072, 2977, 2931, 1640, 1447, 1423, 1380, 1372, 1306, 1213, 1143, 1085, 
1024 cm-1; HRMS calcd for (C18H19IO2S)Na+ 449.0042; Found: 449.0037. 
 
(Z)-(1-iodobuta-1,3-dien-1-yl)benzene (60): To a suspension of 
iodomethyltriphenylphosphonium iodide (1.87 g, 4.60 mmol) in THF (40 mL) was added 
nbutyl lithium (1.53 M in THF, 2.53 mL, 3.87 mmol).   Addition of the base produced a 
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yellow solution which was stirred for 5 minutes at room temperature and then cooled to -
78 oC.  To the solution of ylide was added aldehyde 59 (1.0 g, 3.87 mmol) dropwise 
which was warmed to room temperature over 1 hour.  The reaction was quenched with 
aqueous ammonium chloride and extracted with ethyl acetate (3 x 20 mL).  The organic 
extracts were washed with brine, dried over magnesium sulfate and concentrated under 
reduced pressure. The crude was dissolved in 2 mL dichloromethane and poured over 
pentane.  The precipitate was filtered through a plug of celite/silica and the pentane was 
removed leaving behind a colorless oil (713 mg, 71%).  1H NMR (500 MHz, CDCl3) δ 
7.52 (d, J = 7.5 Hz, 2H), 7.31 (t, J = 7 Hz, 2H), 7.27 (t, J = 7 Hz, 1H), 6.65 (ddd, J = 10 
Hz, J = 10 Hz, J = 17 Hz, 1H), 6.55 (d, J = 10 Hz, 1H), 5.55 (d, J = 17 Hz, 1H), 5.43 (d, J 
= 10 Hz, 1H);  13C NMR (125 MHz, CDCl3) δ 142.9, 140.2, 136.6, 128.8, 128.8, 128.4, 
122.1, 105.7;  IR (film) νmax = 3162, 3127, 2977, 2931, 1635, 1447, 1423, 1372, 1305, 
1414, 1143; HRMS calcd for (C10H9I)Na+ 279.0700; molecular ion peak not found. 
 
(Z)-((2-methylene-3-phenylhexa-3,5-dien-1-yl)sulfonyl)benzene (61): SM Cross-
Coupling Procedure B. 1H NMR (500 MHz, CDCl3) δ7.73 (d, J = 8 Hz, 2H), 7.62 (t, J = 
8 Hz, 1H), 7.46 (t, J = 8 Hz, 2H), 7.25 – 7.23 (m, 3H), 7.00 – 6.98 (m, 2), 6.78 (ddd, J = 
10.5 Hz, J = 10.5 Hz, J = 17 Hz, 1H), 6.25 (d, J = 10.5 Hz, 1H), 5.72 (s, 1H), 5.49 (s, 
1H), 5.34 (d, J = 17 Hz, 1H), 5.23 (d, J = 10.5 Hz, 1H), 3.86 (s, 2H);  13C NMR (125 
MHz, CDCl3) δ 141.2. 139.5. 138.9.134.8. 133.8. 133.7. 131.6. 129.1. 128.6. 128.5. 
128.0. 127.6. 127.2. 19.9. 61.5; IR (film) νmax = 3072, 2977, 2931, 1640, 1447, 1423, 
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1380, 1372, 1306, 1213, 1143, 1085, 1024, 968, 913, 849, 720, 689 cm-1; HRMS calcd 
for (C19H18O2S)Na+ 333.0920; Found: 333.0920. 
 
((2-(2-vinylcyclohex-1-en-1-yl)allyl)sulfonyl)benzene (66): In a flask containing vinyl 
bromide 65 (170 mg, 0.903 mmol) dissolved in 9 mL dry THF (0.1 M) was added 
magnesium turnings (66 mg, 2.70 mmol) and a crystal of iodine.  The mixture was heated 
to reflux for 1 h.  In a separate flask, allenyl sulfone 64 (61 mg, 0.301 mmol) and 
copper(I) iodide (7 mg, 15 µmol) were dissolved in 3 ml dry THF (0.1 M) and cooled to -
78 oC.  The solution of allenyl sulfone was then treated with dropwise addition of freshly 
prepared Grignard reagent.  The reaction was stirred 2 h at -78 oC then warmed to room 
temperature. The reaction was extracted with ethyl acetate (2 x 10 mL), and the organic 
extracts were dried over magnesium sulfate, and concentrated under reduced pressure.  
The crude was purified on a flash column (20% ethyl acetate/hexanes) to afford a 
colorless oil (26 mg, 30%). ; 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8 Hz, 2H), 6.19 
(t, J = 8 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 6.69 (dd, J = 11 Hz, J = 17.5 Hz, 1H), 5.32 (s, 
1H), 5.12 (d, J = 17 Hz, 1H), 5.11 (s, 1H), 4.96 (d, J = 11 Hz, 1H), 4.00 (s, 2H), 2.06 (t, J 
= 6 Hz, 2H), 1.94 (t, J = 6 Hz, 2H), 1.48 – 1.38 (m, 4H);  13C NMR (125 MHz, CDCl3) δ 
136.7, 133.7, 129.0,128.6, 124.2, 112.0, 62.0, 29.8, 24.9, 22.5, 22.1;  IR (film) νmax = 
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3063, 3027, 2933, 1604, 1495, 1479, 1447, 1422, 1372, 1305, 1267, 1242, 1146, 1111 
cm-1; HRMS calcd for (C17H20O2S)Na+ 311.0769; Found: 311.0770. 
 
1-methoxy-2-(3-(phenylsulfonyl)prop-1-en-2-yl)benzene (67): SM Cross-Coupling 
Procedure C: Boronate 38 (100 mg, 0.324 mmol), o-iodoanisole (46 µL, 0.340 mmol), 
tris(dibenzylideneacetone)dipalladium(0) (15 mg, 47 µmol), triphenylarsine (20 mg, 65 
µmol), and silver oxide (225 mg, 0.972 mmol) were added to a flask and placed under 
vacuum.  The reaction vessel was backfilled with argon and charged with degassed THF 
(3.24 mL).  The black mixture was stirred for 2 hours at room temperature, and the 
solvent was removed under reduced pressure.  The crude mixture was purified on a flash 
column using (20% EtOAc/Hexanes) resulting in a yellow solid (77 mg, 83%). 
1H NMR (500 MHz, CDCl3) δ 7.67 (d, J = 8 Hz, 2H), 7.49 (t, J = 8 Hz, 1H), 7.36 (t, J = 8 
Hz, 2H), 7.17 (t, J = 8 Hz, 1H), 7.02 (d, J = 8 Hz, 1H), 6.83 (t, J = 8 Hz, 1H), 6.63 (d, J = 
8 Hz, 1H), 5.35 (s, 1H), 5.30 (s, 1H), 4.44 (s, 2H), 3.71 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 156.0, 138.9, 136.9, 133.3, 130.7, 129.6, 128.7, 128.5, 124.1, 120.8, 110.4, 
62.3, 55.2; IR (film) νmax = 2978, 2954, 1493, 1442, 1425, 1305, 1002 cm-1; HRMS calcd 
for (C16H16O3S)Na+ 311.0712; Found: 311.0712. 
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(Z)-3-phenyl-4-((phenylsulfonyl)methyl)penta-2,4-dien-1-ol (68): SM Cross-Coupling 
Procedure C. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 7.5 Hz, 2H), 7.65 (t, J = 7.5 Hz, 
1H), 7.54 (t, J = 7.5 Hz, 2H), 7.31 – 7.28 (m, 3H), 7.23 – 7.21 (m, 2H), 6.11 (t, J = 7.5 
Hz, 1H), 5.46 (s, 1H), 5.36 (s, 1H), 4.37 (d, J = 7.5 Hz, 2H), 3.79 (s, 2H), 3.24 (sbroad, 
1H); 13C NMR (125 MHz, CDCl3) δ 142.9, 139.3, 138.6, 133.9, 133.1, 130.1, 129.4, 
128.8, 128.36, 128.2, 127.4, 126.9, 61.7, 59.8; IR (film) νmax = 3509, 3060, 3024, 2925, 
1491, 1447, 1307, 1246, 1153, 1128, 1085 cm-1; HRMS calcd for (C18H18O3S)Na+ 
337.0868; Found: 337.0868. 
 
Potassium ((2-trifluoroboratopropyl)sulfonyl)benzene (78):  To a solution of 38 (200 
mg, 0.648 mmol) in THF/MeOH (4.6 mL) was added Wilkinson’s catalyst (30 mg, 32 
µmol) and the solution was stirred in bomb reactor under hydrogen atmosphere at 350 psi 
for 24 h.  The solvent was removed and the crude residue was purified on a flash column 
(20% EtOAc/Hexanes) resulting in a white solid (153 mg, 76%). Boronate 76 (250 mg, 
0.81 mmol) was dissolved in MeOH (7 mL) and treated with potassium hydrogen 
fluoride (442 mg, 5.6 mmol, dissolved in 1 mL H2O) and stirred for 2 hours at room 
temperature.  After solvent removal, the crude product was dissolved in boiling 
acetonitrile and hot filtered to remove excess potassium hydrogen fluoride.  The 
acetonitrile was removed under reduced pressure and the resulting white solid could be 
purified by rinsing with ethyl acetate leaving behind a solid (190 mg, 82%). ( 1H NMR 
(500 MHz, Acetone-d6)  δ 7.81 (d, J = 8 Hz, 2H), 7.69 (t, J = 8 Hz, 1H), 7.62 (t, J = 8 Hz, 
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2H), 3.04 (dd, J = 14.5 Hz, J = 1.5 Hz, 1H), 2.70 (dd, J = 14.5 Hz, J = 12 Hz, 1H), 0.78 
(d, J = 7 Hz, 3H), 0.56 (s, 1H); 13C NMR (125 MHz, Acetone-d6)  δ 140.7, 133.0, 129.2, 
127.3, 61.4, 14.8;  HRMS calcd for (C9H11BF3KO2S)Na+ 313.0054; Found: 313.0055. 
 
Potassium 2-((2-trifluoroboratopropyl)sulfonyl)pyridine (83): To a solution of 81 
(508mg, 1.63 mmol) in THF/MeOH (7.0 mL) was added Wilkinson’s catalyst (75 mg, 82 
µmol) and the solution was stirred in bomb reactor under hydrogen atmosphere at 350 psi 
for 24 h. The crude residue was dissolved in MeOH (7 mL) and treated with potassium 
hydrogen fluoride (540 mg, 6.3 mmol, dissolved in 1 mL H2O) and stirred for 2 hours at 
room temperature.  After solvent removal, the crude mixture was dissolved in boiling 
acetonitrile and hot filtered to remove excess potassium hydrogen fluoride.  The 
acetonitrile was removed under reduced pressure and the resulting white solid could be 
purified by rinsing with ethyl acetate leaving behind a fluffy white solid (166 mg, 35%). 
1H NMR (500 MHz, Acetone-d6)  δ 8.77 – 8.76 (m, 1H), 8.11 (td, J = 8 Hz, 1.5 Hz, 1H), 
8.00 (d, J = 8 Hz, 1H), 7.71 – 7.68 (m, 1H), 3.28 (dd, J = 15 Hz, J = 1.5 Hz, 1H), 2.88 
(dd, J = 14 Hz, J = 12 Hz, 1H), 0.73 (d, J = 7 Hz, 3H), 0.64 (s, 1H); 13C NMR (125 MHz, 
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Acetone-d6)  δ 158.33, 150.1, 138.7, 127.3, 121.3, 57.2, 14.8;  HRMS calcd for 
(C8H10BF3KNO2S)Na+ 314.0007; Found: 314.0009. 
 
 
4,4,5,5-tetramethyl-2-(3-methyl-3-tosylbut-1-en-2-yl)-1,3,2-dioxaborolane (101):  
Dialkylation Procedure:  Borylated allylic sulfone 25 (100 mg, 0.310 mmol) was added to 
a 10 mL flask under argon atmosphere and dissolved in 3.0 mL dry THF.  The solution 
was cooled to -78°C in a dry-ice/acetone bath and treated with 4.2 equivalents of 
LiHMDS (~1 M in hexanes, 1.30 mL, and 1.30 mmol).  The solution was allowed to stir 
for 1 h before addition of methyl iodide (184 mg, 1.30 mmol). Once the addition was 
complete, the reaction as allowed to warm to room temperature over 3 hours.  The 
reaction was quenched with a saturated solution of aqueous NH4Cl and the mixture was 
extracted with EtOAc (3 x 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo.  The residue was purified on a flash column 
(20% EtOAc in Hexanes) affording 6 as a colorless semisolid (60 mg, 55% yield).  mp = 
102 – 103 oC ; 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 7.5 Hz, 2H),  7.27 (d, J = 7.5 
Hz, 2H), 5.81 (d, J = 1.5 Hz, 1H), 5. 48 (s, 1H), 2.41 (s, 3H), 1.54 (s, 6H),  1.29 (s, 12H);  
13C NMR (125 MHz, CDCl3) δ 144.21, 132.43, 131.38, 130.99, 128.98, 83.79, 67.13, 
24.86, 21.74, 21.52 ; IR (film) νmax = 2977, 2935, 1488, 1415, 1380, 1297, 1233, 1214, 
1009 cm-1; HRMS calcd for (C18H27BO4S)Na+ 373.1615; Found: 373.1610. 
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4,4,5,5-tetramethyl-2-(3-methyl-3-(phenylsulfonyl)but-1-en-2-yl)-1,3,2-
dioxaborolane (104b): Dialkylation Procedure. mp = 87 – 88°C ; 1H NMR (500 MHz, 
CDCl3) δ 7.81 (d, J = 8 Hz, 2H),  7.58 (t, J = 7 Hz, 1H), 7.48 (t, J = 8 Hz, 2H), 5.82 (d, J 
= 1.5 Hz, 1H), 5. 48 (s, 1H), 1.55 (s, 6H),  1.29 (s, 12H);  13C NMR (125 MHz, CDCl3) δ 
135.35, 133.37, 131.51, 130.96, 128.28, 83.79, 67.17, 24.84, 21.48. ;  IR (film) νmax = 
2979, 1447, 1424, 1390, 1372, 1313, 1305, 1164, 1075, 967, 854, 727, 690, 646 cm-1; 
HRMS calcd for (C17H25BO4S)Na+ 359.145882; Found: 359.245516. 
 
 
2-(3-ethyl-3-(phenylsulfonyl)pent-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(109b): Dialkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 8 Hz, 2H), 
7.56 (t, J = 7.5 Hz, 1H), 7.49 (t, J = 7.5 Hz, 2H), 5.95 (d, J = 1 Hz, 1H), 5.45 (s, 1H),  
2.13 (hex, J = 7.5, 2H), 2.00 (hex, J = 7.5, 2H),  1.25 (s, 12H), 0.98 (t, J = 7.5, 6H);  13C 
NMR (125 MHz, CDCl3) δ 136.00, 133.42, 133.15, 130.75, 128.06, 83.41, 73.15, 24.68, 
21.26, 8.27;  IR (film) νmax = 2974, 2916, 361, 2339, 1652, 1356, 1314, 1299, 1278, 
1146, 1118, 1077, 719, 694 cm-1; HRMS calcd for (C19H29BO4S)Na+ 387.177182; 
Found: 387.176806. 
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44,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)-3-propylhex-1-en-2-yl)-1,3,2-
dioxaborolane (110b) and (Z)-4,4,5,5-tetramethyl-2-(5-(phenylsulfonyl)oct-4-en-4-
yl)-1,3,2-dioxaborolane (110b’) (1 : 0.32) mixture: Dialkylation Procedure. 1H NMR 
(500 MHz, CDCl3) δ 7.99 (d, J = 8 Hz, 2H), 7.58 (d, J = 8 Hz, 2H), 7.57 (t, J = 8 Hz, 
3H), 7.51 (t, J = 8 Hz, 1H), 7.47 (t, J = 8 Hz, 2H), 5.94 (s, 1H), 5.45 (s, 1H), 2.52 (t, J = 8 
Hz, 2H), 2.15 (t, J = 8 Hz, 2H), 2.05 (td, J = 14 Hz, J = 4 Hz, 2H), 1.83 (td, J = 14 Hz, J 
= 4Hz, 2H), 1.61 – 1.46 (m, 5H), 1.40 (s, 12H), 1.37 – 1.28 (m, 5H), 1.25 (s, 12H), 0.93 
(t, J = 8 Hz, 6H), 0.91 (t, J = 8 Hz, 3H), 0.82 (t, J = 8 Hz, 3H);  13C NMR (125 MHz, 
CDCl3) δ 144.0, 140.2, 135.9, 133.2, 133.2, 133.2, 133.1, 130.9, 129.1, 128.5, 128.2, 
84.2, 83.5, 73.1, 73.0, 32.0, 31.3, 30.4, 29.3, 25.9, 25.3, 24.8, 23.4, 23.1, 22.8, 17.3, 17.2, 
14.7, 14.5. 
 
 
 
2-(3-butyl-3-(phenylsulfonyl)hept-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(111b): Dialkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8 Hz, 2H),  
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7.56 (t, J = 7 Hz, 1H),  7.46 (t, J = 8 Hz, 2H),  5.94 (d, J = 1.5 Hz, 1H),  5.94 (s, 1H),  
2.08 (td, J = 3.5 Hz, J = 13 Hz, 2H),  1.84 (td, J = 3.5 Hz, J = 13 Hz, 2H),  1.49 (m, 3H),  
1.32 (m, 5H),  1.25 (s, 12H),  0.92 (t, J = 7Hz, 6H);  13C NMR (125 MHz, CDCl3)  δ 
135.93, 133.25, 133.14, 130.91, 128.19, 83.54, 73.00, 28.80,  25.93, 24.86, 23.40, 14.11;  
IR (film) νmax = 3067, 2958, 2931, 2872, 1447, 1423, 1380, 1372, 1305, 1215, 1142, 
1084, 967, 857,720, 689 cm-1; HRMS calcd for (C23H37BO4S)Na+ 443.239782; Found: 
443.239475. 
 
 
 
 
4,4,5,5-tetramethyl-2-(3-pentyl-3-(phenylsulfonyl)oct-1-en-2-yl)-1,3,2-dioxaborolane 
(112b) and (Z)-4,4,5,5-tetramethyl-2-(7-(phenylsulfonyl)dodec-6-en-6-yl)-1,3,2-
dioxaborolane (112b’) (1 : 0.86) mixture: Dialkylation Procedure. 1H NMR (500 MHz, 
CDCl3) δ 7.99 (d, J = 8 Hz, 2H), 7.76 (d, J = 8 Hz, 2H), 7.57 (t, J = 8 Hz, 2H), 7.51 (t, J 
= 8 Hz, 2H), 7.46 (t, J = 8 Hz, 2H), 5.95 (s, 1H), 5.44 (s, 1H), 2.24 (t, J = 8 Hz, 2H), 2.16 
(t, J = 8 Hz, 2H), 2.08 (t, J = 8 Hz, 4H), 1.84 (t, J = 8 Hz, 4H), 1.52 – 1.16 (m, 26H), 1.38 
(s, 12H), 1.26 (s, 12H), 0.90 (t, J = 8 Hz, 6H), 0.87 (t, J = 8 Hz, 3H), 0.80 (t, J = 8 Hz, 
3H);  13C NMR (125 MHz, CDCl3) δ 144.2, 140.2, 135.9, 133.3, 133.1, 133.1, 130.9, 
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129.1, 128.6, 128.2, 84.2, 83.5, 73.1, 32.5, 32.4, 32.0, 31.7, 29.7, 29.1, 29.0, 28.2, 27.2, 
25.3, 24.9, 23.4, 22.6, 22.6, 22.3, 14.3, 14.2. 
 
 
2-(3-hexyl-3-(phenylsulfonyl)non-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(113b) and  (Z)-4,4,5,5-tetramethyl-2-(8-(phenylsulfonyl)tetradec-7-en-7-yl)-1,3,2-
dioxaborolane (113b’) (1 : 0.80) mixture: Dialkylation Procedure. 1H NMR (500 MHz, 
CDCl3) δ 8.00 (d, J = 2H), 7.76 (d, J = 8 Hz, 2H), 7.56 (t, J = 8 Hz, 2H), 7.51 (t, J = 8 
Hz, 2H), 7.46 (t, J = 8 Hz, 2H), 5.94 (s, 1H), 5.43 (s, 1H), 2.24 (t, J = 8 Hz, 2H), 2.17 (t, 
J = 8 Hz, 2H), 2.08 (t, J = 8 Hz, 2H), 1.83 (t, J = 8 Hz, 2H), 1.51 – 1.13 (m, 34H), 1.38 
(s, 12H), 1.26 (s, 12H), 0.90 – 0.86 (m, 9H), 0.83 (t, J = 8 Hz, 3H);  13C NMR (125 MHz, 
CDCl3) δ 144.21, 140.2, 135.9, 133.2, 133.0, 130.9, 129.1, 128.6, 128.2, 84.2, 83.5, 73.0, 
32.3, 31.8, 31.7, 31.4, 30.0, 29.9, 29.5, 29.3, 29.1, 29.0, 28.2, 27.2, 25.3, 24.8, 23.7, 22.8, 
22.7, 22.6. 
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2-(3-heptyl-3-(phenylsulfonyl)dec-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(114b) and (Z)-4,4,5,5-tetramethyl-2-(9-(phenylsulfonyl)hexadec-8-en-8-yl)-1,3,2-
dioxaborolane (114b’) (1 : 0.76) mixture: Dialkylation Procedure. 1H NMR (500 MHz, 
CDCl3) δ 8.00 (d, J = 8 Hz, 2H), 7.75 (d, J = 8 Hz, 2H), 7.58 (t, J = 8 Hz, 2H), 7.51 (t, J 
= 8 Hz, 2H), 7.47 (t, J = 8 Hz, 2H), 5.94 (s, 1H), 5.43 (s, 1H), 2.34 (t, J = 8 Hz, 2H), 2.17 
(t, J = 8 Hz, 2H), 2.08 (t, J = 8 Hz, 2H), 1.83 (t, J = 8 Hz, 2H), 1.51 – 1.11 (m, 42H), 1.38 
(s, 12H), 1.26 (s, 12H), 0.89 (t, J = 8 Hz, 9H), 0.85 (t, J = 8 Hz, 3H);  13C NMR (125 
MHz, CDCl3) δ 144.2, 140.2, 135.9, 133.2, 133.1, 133.1, 130.9, 129.1, 128.6, 128.2, 
84.2, 83.5, 73.1, 32.4, 32.0, 31.9, 31.8, 30.3, 30.0, 29.8, 29.4, 29.4, 29.3, 29.2, 29.1, 28.9, 
28.3, 27.3,  25.3, 24.9, 23.8, 22.8, 22.7. 
 
 
 
2-(3-allyl-3-(phenylsulfonyl)hexa-1,5-dien-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (115b) and (Z)-4,4,5,5-tetramethyl-2-(5-(phenylsulfonyl)octa-1,4,7-
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trien-4-yl)-1,3,2-dioxaborolane (115b’) (1 : 0.37) mixture: Dialkylation Procedure. 1H 
NMR (500 MHz, CDCl3) δ 7.89 (d, J = 8 Hz, 2H), 7.80 (d, J = 8 Hz, 2H), 7.60 (t, J = 8 
Hz, 2H), 7.52 – 7.46 (m, 4H), 5.95 (s, 2H), 5.93 – 5.87 (m, 2H), 5.44 (s, 2H), 5.14 (s, 
2H), 5.11 (s, 2H), 5.04 – 4.84 (m, 4H), 3.02 (d, J = 6Hz, 2H), 2.94 (dd, J = 14 Hz, J = 6 
Hz, 2H), 2.65 (dd, J = 14 Hz, J = 6 Hz, 2H), 2.36 – 2.33 (m, 2H), 2.66 – 2.24 (m, 2H), 
1.39 (s, 12H), 1.28 (s, 12H);  13C NMR (125 MHz, CDCl3) δ 141.9, 139.7, 137.4, 135.5, 
133.6, 133.5, 133.3, 132.6, 130.9, 129.1, 128.8, 128.3, 119.0, 116.6, 115.4, 84.4, 83.8, 
71.37, 33.9, 31.9, 31.7, 31.2, 25.2, 24.9. 
 
 
 
 
(Z)-2-(1,5-diphenyl-2-(phenylsulfonyl)pent-2-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (116b’): Dialkylation Procedure.  1H NMR (500 MHz, CDCl3) δ 7.89 (d, 
J = 7 Hz, 2H),  7.49 (t, J = 7.5 Hz, 1H),  7.40 (t, J = 7.5 Hz, 2H),  7.17 – 7.12 (m, 3H),  
7.08 – 7.05 (m, 3H),  6.98 (d, J = 7 Hz, 2H),  6.96 (d, J = 7 Hz, 2H),  3.43 (s, 2H),  2.64 
(dd, J = 9 Hz, J = 10 Hz, 2H),  2.50 (dd, J = 9 Hz, J = 10 Hz, 2H),  1.45 (s, 1H);  13C 
NMR (125 MHz, CDCl3)  δ 143.54, 141.12, 139.82, 13714, 133.05, 128.99, 128.74, 
128.51, 128.49, 128.45, 128.36, 126.42, 126.24,  84.54, 35.02, 33.81, 32.43, 25.32; IR 
(film) νmax = 3062, 3027, 2976, 2929, 2361, 2336, 1495, 1447, 1372, 1335, 1302, 1141, 
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1083, 1032, 965, 855, 749, 734, 690, 668 cm-1;  HRMS calcd for (C29H33BO4S)Na+ 
511.208482; Found: 511.208275. 
 
 
4,4,5,5-tetramethyl-2-(6-phenyl-3-(3-phenylpropyl)-3-(phenylsulfonyl)hex-1-en-2-
yl)-1,3,2-dioxaborolane (118b) and (Z)-2-(1,8-diphenyl-5-(phenylsulfonyl)oct-4-en-4-
yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (118b’) (1 : 0.20) mixture: Dialkylation 
Procedure. H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 8 Hz, 2H), 7.60 (d, J = 8 Hz, 2H), 
7.54 – 7.44 (m, 2H), 7.35 (t, J = 8 Hz, 2H), 7.28 – 7.21 (m, 10H), 7.19 – 7.12 (m, 10H), 
7.03 (d, J = 8 Hz, 2H), 5.87 (s, 1H), 5.29 (s, 1H), 2.67 – 2.50 (m, 8 H), 2.16 – 1.39 (m, 
18H), 1.33 (s, 12H), 1.27 (s, 12H);  13C NMR (125 MHz, CDCl3) δ 144.0, 142.2, 142.1, 
141.3, 139.9, 135.2, 133.2, 133.1, 133.1, 130.8, 129.1, 128.6, 128.5, 128.4, 128.4, 128.1, 
125.9, 125.9, 125.8, 84.2, 83.6, 72.7, 36.7, 35.7, 35.6, 34.8, 32.1, 31.7, 31.5, 30.6, 28.5, 
27.7, 26.4, 25.8, 25.4, 25.2, 24.9, 22.8, 14.2. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)but-1-en-2-yl)-1,3,2-dioxaborolane (104a): 
Monoalkylation Procedure: To a solution of diisopropylamine (60 µL , 0.42 mmol) in 
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THF (2.2 mL) was added nbutyl lithium (2.04 M in THF, 174 µL, 0.35 mmol)  at -78 oC 
and stirred for one hour.  The solution of lithium diisopropylamine was then treated with 
a solution of 38 (100 mg, 0.324mmol) in 1.0 mL THF and stirred for an additional hour 
before addition of electrophile (0.356 mmol).  After dropwise addition of electrophile, the 
reaction was removed from cold bath and allowed to warm to room temperature over 3 h.  
The reaction was quenched with a saturated solution of aqueous NH4Cl and the mixture 
was extracted with EtOAc (3 x 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo.  The residue was absorbed onto silica and 
purified via flash chromatography (20% EtOAc in Hexanes) affording the corresponding 
mono-alkylated product (73 mg, 70%).  mp = 104 – 105 °C ; 1H NMR (500 MHz, 
CDCl3) δ 7.81 (d, J = 8 Hz, 2H),  7.60 (t, J = 7 Hz, 1H), 7.50 (t, J = 8 Hz, 2H), 6.09 (d, J 
= 2 Hz, 1H), 5.85 (s, 1H), 4.11 (q, J = 7 Hz, 1H), 1.49 (d, J = 7.5 Hz, 3H),  1.19 (s, 6H), 
1.18 (s, 6H);  13C NMR (125 MHz, CDCl3) δ 137.70, 135.03, 133.44, 129.86, 18.74, 
84.11, 62.62, 24.87, 24.77, 13.30 ; IR (film) νmax = 2963, 2929, 1490, 1423, 1383, 1373, 
1300, 1249, 1215, 1002 ,975 cm-1; HRMS calcd for (C16H23BO4S)Na+ 345.1302 ; Found: 
345.1297. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)pent-1-en-2-yl)-1,3,2-dioxaborolane (109a): 
Monoalkylation Procedure. mp = 145 – 146 °C; 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J 
= 8 Hz, 2H), 7.58 (t, J = 7 Hz, 1H), 7.49 (t, J = 7.5 Hz, 2H), 6.14 (s, 1H), 5.87 (s, 1H), 
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3.84 (dd, J = 3.5, 11.5 Hz, 1H), 2.22 (dq, J = 7, 3.5 Hz, 1H), 1.96 (dq, J = 11.5, 7 Hz, 
1H), 1.15 (s, 12H), 0.915 (t, J = 7 Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 138.41, 
136.33, 133.30, 129.75, 128.71, 83.98, 24.77, 24.73, 20.57, 11.55; IR (film) νmax = 2977, 
2936, 1447, 1423, 1380, 1372, 1317, 1305, 1249, 1215, 1081,969, 862, 840,755, 720, 
689, 671, 651 cm-1; HRMS calcd for (C17H25BO4S)Na+ 359.1458; Found: 359.1454.  
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)hex-1-en-2-yl)-1,3,2-dioxaborolane (110a): 
Monoalkylation Procedure. mp = 84 – 85 °C; 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
7 Hz, 2H), 7.58 (t, J = 7 Hz, 1H),  7.48 (t, J = 8 Hz), 6.14 (d, J = 2 Hz, 1H), 5.90 (d, J = 
1.5 Hz, 1H),  2.12 (m, 1H),  1.97 (m, 1H),  1.38 (m, 1H),  1.25 (m, 2H), 1.14 (s, 6H), 1.13 
(s, 6H),  0.86  (t, J = 7 Hz);  13C NMR (125 MHz, CDCl3) δ 138.47, 136.51, 133.28, 
129.79,  128.70,  83.96,  67.63,  28.93, 24.79,  24.68,  20.07,  13.73;  IR (film) νmax = 
2976, 2933, 1447, 1422, 1380, 1372, 1316, 1306, 1141, 1083, 968, 852, 719, 689, 650 
cm-1;  HRMS calcd for (C18H27BO4S)Na+ 373.1615; Found: 373.1611. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)hept-1-en-2-yl)-1,3,2-dioxaborolane (111a): 
Monoalkylation Procedure.  mp = 51 – 52 oC. 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
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7.6 Hz, 2H),  7.58 (t, J = 7.5 Hz, 1H),  7.48 (t, J = 7.5 Hz, 2H),  6.14 (d, J = 2.5 Hz, 1H),  
5.89 (d, J = 1.5 Hz, 1H),  3.91 (dd, J = 12 Hz, J = 3.5 Hz, 1H),  2.16 (m, 1H),  1.98 (m, 
1H),  1.27 (m, 4H), 1.14 (s, 6H), 1.13 (s, 6H),  0.86 (t, J = 7 Hz, 3H);  13C NMR (125 
MHz, CDCl3)  δ 138.50, 136.51, 133.27, 129.79, 128.70, 83.97, 67.96, 28.92, 26.62, 
24.81,24.69, 22.40, 13.92;  IR (film) νmax = 2977, 2957, 2931, 2860, 1447, 1423, 1372, 
1306, 1268, 1213, 1145, 1084, 967, 848, 756, 720, 689, 650 cm-1; HRMS calcd for 
(C19H29BO4S)Na+ 387.1778; Found: 387.1766. 
 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)non-1-en-2-yl)-1,3,2-dioxaborolane (113a): 
Monoalkylation Procedure. mp = 40 - 43°C; 1H NMR (500 MHz, CDCl3) δ  7.80 (d, J = 8 
Hz, 2H),  7.58 (t, J = 7.5 Hz, 1H),  7.48 (t, J = 8 Hz, 2H),  6.14 (d, J = 2 Hz, 1H),  5.89 
(d, J = 1 Hz, 1H),  3.91 (dd, J = 3.5 Hz, J = 11.5 Hz, 1H),  2.17 – 2.12 (m, 1H),  2.02 – 
1.95 (m, 1H),  1.29 – 1.23 (m, 8H),  1.14 (s, 6H), 1.13 (s, 6H),  0.85 (t, J = 7 Hz, 3H);  
13C NMR (125 MHz, CDCl3)  δ 138.51, 136.51, 133.26, 129.78, 128.70, 83.96, 67.95, 
31.62,  28.90,  26.87, 26.70, 24.81, 24.69, 22.66, 14.17;  IR (film) νmax = 2955, 2927, 
2857, 1722, 1467, 1447, 1423, 1380, 1372, 1306, 1144, 1084, 967, 720, 689 cm-1;  
HRMS calcd for (C21H33BO4S)Na+ 415.2084; Found: 415.2079. 
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4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)hexa-1,5-dien-2-yl)-1,3,2-dioxaborolane 
(115a): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 7.5 Hz, 
2H),  7.59 (t, J = 7.5 Hz, 1H),  7.50 (d, J = 7.5 Hz, 2H),  6.14 (d, J = 2 Hz, 1H),  5.86 (d, 
J = 1 Hz, 1H),  5.63 (dddd, J = 7 Hz,  J = 7 Hz, J = 10 Hz, J = 13.5 Hz, 1H),  5.06 (dd, J 
= 1.5 Hz, J = 17.5 Hz, 1H),  5.01 (dd, J = 1.5 Hz, J = 10 Hz, 1H),  3.99 (dd, J = 3.5 Hz, J 
= 11.5 Hz, 1H),  2.96 – 2.91 (m, 1H),  2.79 – 2.72 (m, 1H),  1.14 (s, 6H), 1.13 (s, 6H);  
13C NMR (125 MHz, CDCl3)  δ 138.15, 136.80, 133.73, 133.45, 129.78, 128.78, 117.90,  
84.02, 67.68, 31.42, 24.80, 24.70;  IR (film) νmax = 3077, 2978, 2931, 1639, 1480, 1447, 
1419, 1379, 1372, 1355, 1305, 1259, 1144, 1082, 1025, 998, 917, 690 cm-1;  HRMS calcd 
for (C18H25BO4S)Na+ 371.1458; Found: 371.1455. 
 
 
 
4,4,5,5-tetramethyl-2-(4-phenyl-3-(phenylsulfonyl)but-1-en-2-yl)-1,3,2-
dioxaborolane (116a): Monoalkylation Procedure.  mp =112 – 113 oC;  1H NMR (500 
MHz, CDCl3) δ 7.84 (d, J = 7.5 Hz, 2H), 7.58 (t, J = 7 Hz, 1H), 7.49 (t, J = 8 Hz, 2H), 
7.21 - 7.18 (m, 2H), 7.15 – 7.12 (m, 3H), 6.06 (d, J = 2 Hz, 1H), 5.94 (s, 1H), 4.24 (dd, J 
115 
 
= 3.5 Hz, J = 12 Hz, 1H), 3.63 (dd, J = 3.5 Hz, J = 14 Hz, 1H), 3.29 (dd, J = 12 Hz, J = 
14 Hz, 1H), 1.06 (s, 6H), 1.05 (s, 6H) ;  13C NMR (125 MHz, CDCl3)  δ 138.49, 137.41, 
137.24, 133.40, 129.63, 129.36, 128.80, 128.39, 126.52, 83.97, 68.97, 33.03, 24.77, 24.49 
;  IR (film) νmax = 3060, 3015, 2922, 1620, 1506, 1473, 1450, 1421, 1382, 1301, 1275, 
1244, 1145, 1112, 1082 cm-1; HRMS calcd for (C22H27BO4S)Na+ 421.1615; Found: 
421.1610. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)hepta-1,6-dien-2-yl)-1,3,2-dioxaborolane 
(121a): Monoalkylation Procedure.   1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7 Hz, 
2H),  7.58 (t, J = 7.5 Hz, 1H),  7.48 (t, J = 7.5 Hz, 2H),  6.16 (d, J = 2 Hz, 1H),  5.89 (s, 
1H),  5.76 – 5.68 (m, 1H),  4.99 (d, J = 6 Hz, 1H),  4.96 (s, 1H),  3.93 (dd, J = 3.5 Hz, J = 
11.5 Hz, 1H),  2.90 – 2.24 (m, 1H),  2.18 – 2.07 (m, 2H),  2.00 – 1.95 (m, 1H),  1.14 (s, 
6H), 1.13 (s, 6H);  13C NMR (125 MHz, CDCl3)  δ 138.32, 136.96, 136.79, 133.31, 
129.71, 128.68, 115.98,  83.91, 67.32, 30.71, 26.13, 24.76, 24.70, 24.61;  IR (film) νmax = 
3077, 2978, 2931, 1639, 1480, 1447, 1419, 1390, 1379, 1372, 1355, 1305, 1259, 1214, 
1144, 1082, 1025, 998, 967, 917, 867, 845, 753, 818, 690 cm-1;  HRMS calcd for 
(C19H27BO4S)Na+ 385.1615; Found: 385.1610. 
 
116 
 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)octa-1,7-dien-2-yl)-1,3,2-dioxaborolane 
(122a): Monoalkylation Procedure.  1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8 Hz, 
2H),  7.58 (t, J = 7.5 Hz, 1H),  7.48 (t, J = 8 Hz, 2H),  6.14 (d, J = 2 Hz, 1H),  5.90 (s, 
IH),  5.73 (dddd, J = 6.5 Hz, J = 6.5 Hz, J = 10 Hz, J = 17 Hz, 1H),  4.97 (dd, J = 1.5 Hz, 
J = 17 Hz, 1H),  4.93 (dd, J = 1 Hz, J = 10 Hz, 1H),  3.92 (dd, J = 3.5 Hz, J = 11.5 Hz, 
1H),  2.18 (dddd, J = 3.5 Hz, J = 6.5 Hz, J = 10 Hz, J = 13.5 Hz, 1H),  2.09 – 1.96 (m, 
3H),  1.44 – 1.39 (m, 1H),  1.36 – 1.30 (m, 1H),  1.14 (s, 6H), 1.13 (s, 6H);  13C NMR 
(125 MHz, CDCl3)  δ 138.46, 138.12, 136.63, 133.31, 129.78, 128.73, 115.14, 84.01, 
67.77,  33.37, 26.47, 26.11, 24.82, 24.70;  IR (film) νmax = 3072, 2977, 2931, 1640, 1447, 
1423, 1380, 1372, 1306, 1213, 1143, 1085, 1024, 968, 913, 849, 720, 689 cm-1;  HRMS 
calcd for (C20H29BO4S)Na+ 399.1771; Found: 399.1767. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)nona-1,8-dien-2-yl)-1,3,2-dioxaborolane 
(123a): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8 Hz, 2H),  
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7.58 (t, J = 7.5 Hz, 1H),  7.48 (t, J = 8 Hz, 2H),  6.14 (d, J = 2 Hz, 1H),  5.90 (s, IH),  
5.73 (dddd, J = 6.5 Hz, J = 6.5 Hz, J = 10 Hz, J = 17 Hz, 1H),  4.96 (dd, J = 1.5 Hz, J = 
17 Hz, 1H),  4.91 (dd, J = 1 Hz, J = 10 Hz, 1H),  3.91 (dd, J = 3.5 Hz, J = 11.5 Hz, 1H),  
2.19 – 2.13 (m, 1H),  2.03 – 1.95 (m, 3H),  1.41 – 1.31 (m, 3H),  1.28 – 1.22 (m, 1H),  
1.14 (s, 6H), 1.13 (s, 6H);  13C NMR (125 MHz, CDCl3)  δ 138.66, 138.42, 136.54, 
133.28, 130.62, 130.04, 129.71, 128.69, 114.63, 83.95, 67.83, 33.47, 28.44, 26.72, 26.19, 
24.77, 24.64, 22.79;  IR (film) νmax = 3072, 2977, 2931, 1640, 1447, 1423, 1380, 1372, 
1306, 1213, 1143, 1085, 1024, 968, 913, 849, 720, 689 cm-1;  HRMS calcd for 
(C21H31BO4S)Na+ 413.1928 ; Found: 413.1923. 
 
(E)-4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)deca-1,7,9-trien-2-yl)-1,3,2-
dioxaborolane (124a): Monoalkylation Procedure.   1H NMR (500 MHz, CDCl3) δ 7.79 
(d, J = 8 Hz, 2H),  7.58 (t, J = 7.5 Hz, 1H),  7.48 (t, J = 8 Hz, 2H),  6.26 (ddd, J = 10.5, J 
= 10.5, J = 17 Hz, 1H),  6.14 (d, J = 2 Hz, IH),  6.01 (dd, J = 10.5 Hz, J = 15.5 Hz, 1H),  
5.88 (s, 1H),  5.62 (ddd, J = 7 Hz, J = 7 Hz, J = 15 Hz, 1H),  5.07 (d, J = 17 Hz, 1H),  
4.95 (d, J = 10 Hz, 1H),  3.91 (dd, J = 3.5 Hz , J = 11.5, 1H),  2.04 – 2.13 (m, 1H),  2.10 
– 1.97 (m, 3H),  1.45 – 1.40 (m, 1H),  1.39 – 1.31 (m, 1H), 1.13 (s, 12H);  13C NMR (125 
MHz, CDCl3)  δ 138.36, 137.17, 136.60, 134.23, 133.31, 131.63, 129.40, 128.70, 115.21, 
83.97, 67.81, 32.14, 26.50, 26.41, 24.78, 24.67;  IR (film) νmax = 3072, 2977, 2931, 1640, 
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1447, 1423, 1380, 1372, 1306, 1213, 1143, 1085, 1024, 968, 913, 849, 720, 689 cm-1;  
HRMS calcd for (C22H31BO4S)Na+ 425.1925; Found: 425.1925. 
 
 
 
4,4,5,5-tetramethyl-2-(5-phenyl-3-(phenylsulfonyl)pent-1-en-2-yl)-1,3,2-
dioxaborolane (117a): Monoalkylation Procedure.  mp = 98 - 99°C;  1H NMR (500 
MHz, CDCl3) δ 7.77 (d, J = 7.5, 2H),  7.57 (t, J = 7.5, 1 H),  7.47 (t, J = 8 Hz, 2H),  7.25 
(t, J = 8 Hz, 2H),  7.18 (t, J =7 Hz, 1H),  7.12 (d, J = 7.5 Hz, 2H),  6.18 (d, J = 2 Hz, 1H),  
5.86 (s, 1H),  3.90 (dd, J = 3.5 Hz, J = 11.5 Hz, 1H),  2.72 – 2.67 (m, 1H),  2.53 – 2.44 
(m, 2H),  2.38 – 2.30 (m, 1H),  1.16 (s, 6H), 1.15 (s, 6H);  13C NMR (125 MHz, CDCl3)  
δ 140.85, 138.20, 136.96, 133.36,  129.77, 128.74, 128.60, 128.56, 126.28, 84.03, 68.03, 
32.92, 28.62, 24.87, 24.74;  IR (film) νmax = 3063, 3027, 2933, 1604, 1495, 1479, 1447, 
1422, 1372, 1305, 1267, 1242, 1146, 1112, 1085, 720, 689 cm-1;  HRMS calcd for 
(C23H29BO4S)Na+ 435.1771; Found: 435.1770. 
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4,4,5,5-tetramethyl-2-(6-phenyl-3-(phenylsulfonyl)hex-1-en-2-yl)-1,3,2-
dioxaborolane (118a): Monoalkylation Procedure. mp = 65 - 66°C;  1H NMR (500 
MHz, CDCl3) δ 7.78 (d, J = 7.5, 2H),  7.58 (t, J = 7 Hz, 1H),  7.48 (t, J = 8 Hz, 2H),  7.24 
(t, J = 8 Hz, 2H),  7.16 (t, J = 7.5 Hz, 1H),  7.11 (d, J = 7 Hz),  6.12 (d,  J = 2 Hz, 1H),  
5.83 (d, J = 1.5 Hz, 1H),  3.94 (dd, J = 3.5 Hz, J = 11.5 Hz, 1H),  2.65 – 2.52 (m, 2H),  
2.34 – 2.17 (m, 1H),  2.08 – 2.01 (m, 1H),  1.68 – 1.61 (m, 1H),  1.60 – 1.52 (m, 1H),  
1.13 (s, 12H);  13C NMR (125 MHz, CDCl3)  δ 141.66, 138.10, 136.39, 133.09, 129.53, 
128.49, 128.40, 128.23, 128.15, 125.74, 83.77, 67.68, 35.36, 29.60, 28.49, 26.38, 24.56, 
24.50;  IR (film) νmax = 3062, 3025, 2975, 2932, 2860, 1603, 1496, 1453, 1446, 1416, 
1390, 1372, 1355, 1304, 1141, 1078, 1029, 966, 849, 749, 732, 700, 691 cm-1;  HRMS 
calcd for (C24H31BO4S)Na+ 449.1928; Found: 449.1928. 
 
 
2-(6-(2-iodophenyl)-3-(phenylsulfonyl)hex-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (120a): Monoalkylation Procedure.  1H NMR (500 MHz, CDCl3) δ 7.79 
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(d, J = 8 Hz, 2H), 7.77 (d, J = 8 Hz, 1H)  7.58 (t, J = 7.5 Hz, 1H),  7.49 (t, J = 8 Hz, 2H), 
7.23 (t, J = 7.5 Hz, 1H), 7.13 (d, J = 8 Hz, 1H), 7.85 (t, J = 8 Hz, 1H), 6.12 (d, J = 2 Hz, 
1H),  5.80 (s, 1H),  3.95 (dd, J = 4 Hz, J = 11.5 Hz, 1H), 2.75 – 2.63 (m, 2H),  2.27 – 2.16 
(m, 1H),  2.13 – 2.05 (m, 1H),  1.66 – 1.61 (m, 1H),  1.55 – 1.49 (m, 1H),  1.14 (s, 12H);  
13C NMR (125 MHz, CDCl3)  δ 144.42, 139.52, 138.11, 136.56, 133.36, 129.76, 129.46, 
128.71, 128.43, 127.89, 100.53, 83.98, 68.22, 40.47, 27.40, 26.38, 24.80, 24.75;  IR 
(film) νmax = 3062, 3025, 2975, 2932, 2860, 1603, 1496, 1453, 1446, 1416, 1390, 1372, 
1355, 1304, 1141, 1078, 1029, 966, 849, 749, 732, 700, 691 cm-1;  HRMS calcd for 
(C25H30BIO4S)Na+ 575.0894; Found: 575.0894. 
 
 
 
trimethyl(1-(phenylsulfonyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl)silane (125a): Monoalkylation Procedure. mp = 122 – 123 °C;  1H NMR (500 
MHz, CDCl3) δ 7.76 (d, J = 8 Hz, 2H),  7.49 (t, J = 7.5 Hz, 1H),  7.42 (t, J = 7.5 Hz, 2H),  
6.19 (s, 1H),  6.01 (s, 1H),  3.90 (s, 1H),  1.06 (s, 6H), 1.05 (s, 6H),  0.31 (s, 9H);  13C 
NMR (125 MHz, CDCl3)  δ  141.75, 134.95, 132.38, 128.47, 128.35, 84.11, 24.61, 24.54;  
IR (film) νmax = 2977, 2926, 1446, 1422, 1380, 1372, 1359, 1316, 1305, 1250, 1137, 
1112, 1085, 958, 848, 757, 714, 689, 646 cm-1;  HRMS calcd for (C18H29BO4SSi)Na+ 
403.1541; Found: 403.1538. 
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4,4,5,5-tetramethyl-2-(5-methyl-3-(phenylsulfonyl)hex-1-en-2-yl)-1,3,2-
dioxaborolane (126a): Monoalkylation Procedure.   1H NMR (500 MHz, CDCl3) δ 7.79 
(d, J = 8 Hz, 2H), 7.58 (t, J = 8 Hz, 1H), 7.49 (t, J = 8 Hz, 2H), 6.16 (d, J = 2 Hz, 1H), 
5.94 (s, 1H), 4.00 (dd, J = 12 Hz, J = 3 Hz, 1H), 2.04 (ddd, J = 17.5 Hz, J = 13 Hz, J = 
4.5 Hz, 1 H), 1.90 (ddd, J = 13.5 Hz, J = 10 Hz, J = 3.5 Hz, 1H), 1.59 – 1.53 (m, 1H), 
1.12 (s, 6H), 1.10 (s, 6H), 0.91 (d, J = 7 Hz, 3H), 0.82 (d, J = 7 Hz, 3H);  13C NMR (125 
MHz, CDCl3)  δ  138.5, 136.9, 133.24, 129.7, 128.6, 83.9, 66.2, 35.4, 25.5, 24.8, 24.5, 
23.7, 20.8;  IR (film) νmax = 2977, 2926, 1446, 1422, 1380, 1372, 1359, 1316, 1305, 
1250, 1137, 1112, 1085, 958, 848, 757, 714, 689, 646 cm-1;  HRMS calcd for 
(C19H29BO4S)Na+ 387.1771; Found: 387.1771. 
 
 
 
(5-iodo-2-methylpent-1-en-3-yl)benzene (185): To a solution of imidazole (320 mg, 
4.71 mmol) and triphenylphosphine (1.23 g, 4.71 mmol) in 40 mL dichloromethane (0.1 
M), was added the primary alcohol (3.93 mmol).  The solution was cooled to 0 oC and 
treated with iodine (1.20 g, 4.71 mmol), where it was allowed to reach room temperature 
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over the course of 1 h.  The reaction was diluted with dichloromethane and washed with 
Na2S2O3, brine and the organic layer was dried over MgSO4.  The crude was 
concentrated under reducted pressure and poured over pentane.  The precipitate was 
filtered through a plug of celite/silica and the pentane was removed leaving behind a 
colorless oil (900 mg, 75%).  1H NMR (500 MHz, CDCl3) δ 7.29 (t, J = 7 Hz, 2H),  
7.22(t, J = 9 Hz, 3H),  4.92 (s, 1H), 4.88 (s, 1H), 3.71 (t, J = 7 Hz, 1H), 3.14 – 3.10 (m, 
1H), 3.05 – 3.00 (m, 1H), 2.33 (hex, J = 7 Hz, 1H), 2.20 (hex, J = 7 Hz, 1H), 1.58 (s, 3H) 
;  13C NMR (125 MHz, CDCl3)  δ 146.6, 141.9, 128.6, 127.9, 126.8, 111.0, 52.9, 36.86, 
21.3, 5.3 ;  IR (film) νmax = 2978, 2933, 1460, 1447, 1423, 1372, 1306, 12161141, 1110 
,1084 cm-1;  HRMS calcd for (C12H15I)Na+ 309.14; Molecular Ion Peak Not Found. 
 
4,4,5,5-tetramethyl-2-(5-(phenylsulfonyl)cyclopent-1-en-1-yl)-1,3,2-dioxaborolane 
(135): RCM Procedure A: Diene 121a  (64 mg, 0.176 mmol) was dissolved in 880 µL 
dry dichloromethane (0.2M) and added to a sealed tube. The solution was treated with 
Grubbs 2nd generation catalyst (7.5 mg, 5 mol %) and the reaction vessel was sealed with 
a Teflon coated cap and heated to 45 oC for 2 h.  Solvent was evaporated and the crude 
black residue was purified on a flash column (20%  EtOAc/Hexanes) affording 135 as a 
solid (53 mg, 92%).  mp = 92 °C;  1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8 Hz, 2H),  
7.61 (t, J = 7.5, 1H),  7.50 (t, J = 8, 2H),  6.72 (s, 1H),  4.45 (dd, J =  1 Hz, J = 8.5 Hz, 
1H),  244. (dd, J = 8 Hz, J = 14.5 Hz, 1H), 2.19 – 2.11 (m, 1H), 2.29 – 2.23 (m, 1H), 2.04 
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– 1.97 (m, 1H), 1.24 (d, J = 7 Hz, 12H); 13C NMR (125 MHz, CDCl3) δ 3060, 2996, 
2919, 1957, 1700, 1613, 1447, 1426, 1392, 1365, 1331, 1266, 1168, 1085, 980, 897 cm-1;  
HRMS calcd for (C17H23BO4S)Na+ 357.1302; Found: 357.1297. 
 
4,4,5,5-tetramethyl-2-(6-(phenylsulfonyl)cyclohex-1-en-1-yl)-1,3,2-dioxaborolane 
(136): RCM Procedure A. 1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 7 Hz, 2H), 7.61 (t, 
J = 7 Hz, 1H), 7.53 (t, J = 7 Hz, 2H), 6.84 (t, J = 3 Hz, 1H), 4.03 (d, J = 5.5 Hz, 1H), 2.14 
– 2.03 (m, 3H), 1.85 – 1.76 (m, 1H), 1.74 – 1.67 (m, 1H), 1.53 – 1.48 (m, 1H), 1.26 (s, 
12H); 13C NMR (125 MHz, CDCl3)  δ 148.9, 139.2, 133.4, 129.3, 129.0, 83.8, 61.4, 25.5, 
25.0, 24.8, 22.4, 17.1;  IR (film) νmax = 2959, 1628, 1447, 1409, 1373, 1317, 1304, 1145 
cm-1;  HRMS calcd for (C18H25BO4S)Na+ 371.1459; Found: 371.1459. 
 
 
4,4,5,5-tetramethyl-2-(6-methyl-3-(phenylsulfonyl)hepta-1,6-dien-2-yl)-1,3,2-
dioxaborolane (137): Monoalkylation Procedure.  1H NMR (500 MHz, CDCl3) δ7.80 (d, 
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J = 8 Hz, 2H), 7.58 (t, J = 7 Hz, 1H), 7.49 (t, J = 7 Hz, 2H), 6.15 (d, J = 2 Hz, 1H), 5.88 
(s, 1H), 4.71 (s, 1H), 4.63 (s, 1H), 3.90 (dd, J = 3.5 Hz, J = 11.5 Hz, 1H), 2.34 – 2.30 (m, 
1H), 2.71 – 2.10 (m, 1H), 2.08 – 2.02 (m, 1H), 1.97 – 1.91 (m, 1H), 1.68 (s, 3H), 1.13 (d, 
J = 4 Hz, 12H);  13C NMR (125 MHz, CDCl3)  δ 144.1, 138.3, 136.7, 133.3, 129.7, 
128.7,111.4, 83.9, 67.6, 34.7, 24.9, 24.8, 24.6, 22.1;  IR (film) νmax = 3021, 2979, 2930, 
1447, 1423, 1305, 1216, 1145, 1085 cm-1;  HRMS calcd for (C20H29BO4S)Na+ 399.1771; 
Found: 399.1766. 
 
 
4,4,5,5-tetramethyl-2-(7-methyl-3-(phenylsulfonyl)octa-1,7-dien-2-yl)-1,3,2-
dioxaborolane (138): Monoalkylation Procedure.  1H NMR (500 MHz, CDCl3) δ 7.80 
(d, J = 8 Hz, 2H), 7.58 (t, J = 7 Hz, 1H), 7.49 (t, J = 7 Hz, 2H), 6.15 (d, J = 2 Hz, 1H), 
5.88 (s, 1H), 4.67 (s, 1H), 4.62 (s, 1H), 3.93 (dd, J = 4 Hz, J = 12 Hz, 1H), 2.18 – 2.12 
(m, 1H), 2.05 – 1.93 (m, 3H), 1.62 (s, 3H), 1.52 – 1.43 (m, 1H), 1.41 – 1.32 (m, 1H), 1.13 
(d, J = 4 Hz, 12H);  13C NMR (125 MHz, CDCl3)  δ 145.2, 138.5, 136.6, 133.3, 129.7, 
128.7, 110.5, 84.0, 67.8, 37.4, 26.6, 24.8, 24.8, 24.7, 22.4;  IR (film) νmax = 3071, 2977, 
2935, 1647, 1447, 1423, 1305, 1144, 1086 cm-1;  HRMS calcd for (C21H31BO4S)Na+ 
413.1928; Found: 413.1926. 
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4,4,5,5-tetramethyl-2-(7-methyl-6-phenyl-3-(phenylsulfonyl)octa-1,7-dien-2-yl)-1,3,2-
dioxaborolane (139): d.r. (1.00 : 0.55). Monoalkylation Procedure. 1H NMR (500 MHz, 
CDCl3) δ 7.76 – 7.74 (m, 4H), 7.56 (t, J = 8 Hz, 2H), 7.46 (t, J = 8 Hz, 4H), 7.27 – 7.23 
(m, 4H), 7.19 – 7.12 (m, 6H), 6.12 (d, J = 2 Hz, 1H), 6.09 (d, J = 2 Hz, 1H), 5.85 (s, 1H), 
5.75 (s, 1H), 4.88 (s, 1H), 4.82 (d, J = 1.5 Hz, 2H), 4.80 (s, 1H), 3.94 (dd, J = 3.5 Hz, J = 
11.5 Hz, 1H), 3.90 (t, J = 7 Hz, 1H), 3.18 (t, J = 8 Hz, 1H), 3.14 (t, J = 7.5 Hz, 1H), 2.14 
– 2.08 (m, 1H), 2.07 – 2.03 (m, 2H), 1.90 – 1.80 (m, 2H), 1.77 – 1.73 (m, 2H), 1.66 – 
1.60 (m, 1H), 1.53 (s, 3H), 1.52 (s, 3H), 1.15 (d, J = 2 Hz, 12H), 1.14 (d, J = 2.5 Hz, 
12H);  13C NMR (125 MHz, CDCl3)  δ 147.7, 146.9, 143.3, 142.8, 138.4, 138.3, 136.5, 
136.4, 133.3, 129.7, 129.7, 128.7, 128.4, 127.9, 127.7, 126.5, 126.5, 111.2, 110.6, 84.1, 
84.1, 68.0, 67.8, 52.6, 52.5, 30.2, 30.0, 25.5, 25.4, 24.9, 24.8, 24.7, 21.3, 20.7;  IR (film) 
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νmax =2977, 1447, 1423, 1372, 1616, 1305, 1144 cm-1;  HRMS calcd for 
(C27H35BO4S)Na+ 489.2241; Found: 489.2242. 
 
 
4,4,5,5-tetramethyl-2-(6-methyl-3-(phenylsulfonyl)octa-1,7-dien-2-yl)-1,3,2-
dioxaborolane (141): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.89 (d, 
J = 7.5 Hz, 4H), 7.58 (t, J = 7.5 Hz, 2H), 7.48 (t, J = 7.5 Hz, 4H), 6.13 (dd, J = 1.5 Hz, 
2.5 Hz, 2H), 5.86 (d, J = 1.5 Hz, 2H), 5.68 – 5.56 (m, 2H), 3.88 (td, J = 3.5 Hz, J = 12 
Hz, 2H), 2.15 – 2.07 (m, 4H), 2.03 – 1.93 (m, 2H), 1.32 – 1.22 (m, 4H), 1.14 (d, J = 4.5 
Hz, 24H), 0.96 (dd, J = 3 Hz, J = 7 Hz, 6H); 13C NMR (125 MHz, CDCl3)  δ144.1, 143.7, 
138.5, 138.4, 136.5, 136.5, 133.3, 129.7, 129.7, 128.7, 113.5, 113.1, 84.0, 68.2, 68.0, 
37.7, 37.6, 33.6, 33.5, 24.8, 24.8, 24.7, 24.7, 20.5, 19.7;  IR (film) νmax = 2976, 1447, 
1422, 1380, 1372, 1305, 1143, 1084 cm-1;  HRMS calcd for (C21H31BO4S)Na+ 413.1928; 
Found: 413.1927. 
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4,4,5,5-tetramethyl-2-(6-phenyl-3-(phenylsulfonyl)octa-1,7-dien-2-yl)-1,3,2-
dioxaborolane (140): d.r. (1.00 : 0.36). Monoalkylation Procedure. 1H NMR (500 MHz, 
CDCl3) δ 7.75 (d, J = 8 Hz, 4H), 7.56 (t, J = 7.5 Hz, 2H), 7.46 (t, J = 7.5 Hz, 4H), 7.30 – 
7.25 (m, 4H), 7.17 (t, J = 7 Hz, 2H), 7.12 (t, J = 7.5 Hz, 4H), 6.13 (d, J = 2 Hz, 1H), 6.09 
(d, J = 2 Hz, 1H), 5.93 – 5.84 (m, 2H), 5.83 (s, 1H), 5.75 (s, 1H), 5.04 – 4.97 (m, 4H), 
3.92 (dd, J = 3.5 Hz, J = 12 Hz, 1H), 3.90 (dd, J = 5.5 Hz, J = 10.5 Hz, 1H), 3.21 (q, J = 
7.5 Hz, 2H), 2.17 – 2.06 (m, 2H), 1.91 – 1.83 (m, 2H), 1.76 – 1.61 (m, 4H), 1.15 (s, 12H), 
1.14 (d, J = 3 Hz, 12H);  13C NMR (125 MHz, CDCl3)  δ144.1, 143.5, 141.8, 141.2, 
138.3, 138.3, 136.6, 136.5, 133.3, 129.7, 129.6, 128.7, 128.6, 127.6, 127.5, 126.5,126.4, 
115.0, 114.5, 84.0, 67.9,49.7, 49.6, 32.5, 32.5, 25.2, 25.1, 24.8, 24.8, 24.7;  IR (film) νmax 
= 3062, 3026, 2937, 1634, 1601, 1492, 1447, 1307, 1208, 1178, 1146, 1084, 1025 cm-1;  
HRMS calcd for (C26H33BO4S)Na+ 475.2085; Found: 475.2084. 
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2-(6,6-dimethyl-3-(phenylsulfonyl)octa-1,7-dien-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (142): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.78 (d, 
J = 7.5 Hz, 2H), 7.58 (t, J = 7.5 Hz, 1H), 7.48 (t, J = 7.5 Hz, 2H), 6.09 (d, J = 2.5 Hz, 
1H), 5.79 (s, 1H), 5.70 (dd, J = 11 Hz, J = 17.5 Hz, 1H), 4.91 (d, J = 3 Hz, 1H), 4.88 (dd, 
J = 1.5 Hz, J = 10 Hz, 1H), 3.80 (dd, J = 3 Hz, J = 12 Hz, 1H), 2.16 – 2.10 (m, 1H), 1.98 
– 1.90 (m, 1H), 1.30 – 1.24 (m, 1H), 1.21 – 1.17 (m, 1H), 1.15 (d, J = 3 Hz, 12H), 0.96 
(d, J = 3 Hz, 6H); 13C NMR (125 MHz, CDCl3)  δ147.7, 138.4, 136.4, 133.3, 129.7, 
128.7, 111.1, 83.9, 69.0, 39.6, 36.7, 26.7, 26.7, 24.9, 24.7, 22.2;  IR (film) νmax = 2973, 
2930, 1447, 1423, 1305, 1216, 1145, 1085 cm-1;  HRMS calcd for (C22H33BO4S)Na+ 
427.2084; Found: 427.2084. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)-4-(2-vinylphenyl)but-1-en-2-yl)-1,3,2-
dioxaborolane (143): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.84 (d, 
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J = 8 Hz, 2H), 7.58 (t, J = 8 Hz, 1H), 7.50 (t, J = 8 Hz, 2H), 7.40 (t, J = 8 Hz, 1H), 7.14 
(t, J = 7 Hz, 1H), 7.11 – 7.06 (m, 2H), 6.92 (dd, J = 11 Hz, J = 17.5 Hz, 1H), 6.03 (d, J = 
2 Hz, 1H), 5.92 (s, 1H), 5.59 (dd, J = 1.5 Hz, J = 17.5 Hz, 1H), 5.30 (dd, J = 1 Hz, J = 11 
Hz, 1H), 4.19 (dd, J = 3 Hz, J = 11.5 Hz, 1H), 3.72 (dd, J = 3 Hz, J = 14 Hz, 1H), 3.32 
(dd, J = 12 Hz, J = 14 Hz, 1H), 1.05 (d, J = 18 Hz, 12H);  13C NMR (125 MHz, CDCl3)  
δ138.6, 137.3, 137.2, 134.6, 134.4, 133.4, 130.7, 129.5, 128.8, 127.6, 127.0, 126.2, 116.5, 
83.9, 68.1, 30.7, 24.8, 24.5;  IR (film) νmax = 3066, 2978, 2932, 1481, 1447, 1424, 1390, 
1372, 1306, 1215, 1145, 1085 cm-1;  HRMS calcd for (C24H29BO4S)Na+ 447.1772; 
Found: 447.1766. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)-5-(2-vinylphenyl)pent-1-en-2-yl)-1,3,2-
dioxaborolane (144): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.77 (d, 
J = 8 Hz, 2H), 7.57 (t, J = 8 Hz, 1H), 7.49 – 7.44 (m, 2H), 7.21 – 7.15 (m, 2H), 7.10 – 
7.08 (m, 1H), 6.89 (dd, J = 11 Hz, J = 17 Hz, 1H), 6.18 (d, J = 2 Hz, 1H), 5.89 (s, 1H), 
5.60 (dd, J = 2 Hz, J = 17 Hz, 1H), 5.25 (dd, J = 1 Hz, J = 11 Hz, 1H), 3.94 (dd, J = 3.5 
Hz, J = 11 Hz, 1H), 2.74 (ddd, J = 3 Hz, J = 11 Hz, J = 15 Hz, 1H), 2.56 (ddd, J = 6 Hz, 
J = 11 Hz, J = 13.5 Hz, 1H), 2.43 – 2.36 (m, 1H), 2.30 – 2.22 (m, 1H), 1.18 (d, J = 4.5 
Hz, 12H); 13C NMR (125 MHz, CDCl3)  δ138.3, 138.2, 136.7, 136.6, 134.4, 133.4, 129.7, 
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129.7, 128.7, 127.9, 126.8, 126.0, 115.9, 84.1, 68.3, 30.6, 28.2, 24.9, 24.7;  IR (film) νmax 
= 2977, 1461, 1446, 1422, 1372, 1305, 1144  cm-1;  HRMS calcd for (C24H29BO4S)Na+ 
461.1928; Found: 461.1921. 
 
 
N-allyl-4-methyl-N-(3-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pent-4-en-1-yl)benzenesulfonamide (145): Monoalkylation Procedure. 1H NMR (500 
MHz, CDCl3) δ 7.78 (d, 8 Hz, 2H), 7.65 (d, J = 8 Hz, 2H), 7.61 (t, J = 8 Hz, 1H), 7.50 (t, 
J = 8.0 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 6.11 (s, 1H), 5.78 (s, 1H), 5.56 (dddd, J = 6.5 Hz 
J = 6.5 Hz, J = 10 Hz, J = 16.5 Hz, 1H), 5.17 (d, J = 17 Hz, 1H), 5.12 (d, J =10 Hz, 1H), 
3.94 (dd, J = 3.5 Hz, J = 10.5 Hz, 1H), 3.77 (d, J = 6 Hz, 2H), 3.23 (ddd, J = 8 Hz, J = 8 
Hz, J = 15 Hz, 1H), 3.11 (ddd, J = 4.5 Hz, J = 8.5 Hz, J = 13.5 Hz, 1H), 2.42 (s, 4H), 
2.20 – 2.13 (m, 1H), 2.16 (d, J = 2.5 Hz, 12H); 13C NMR (125 MHz, CDCl3)  δ143.5, 
137.8, 136.9, 136.7, 133.6, 132.9, 129.9, 129.8, 128.8, 127.3, 119.4, 84.2, 65.8, 50.7, 
44.8, 25.7, 24.9, 24.8, 21.7;  IR (film) νmax= 3067, 3021, 2979, 2930, 2872, 1598, 1495, 
1447, 1423, 1305, 1216, 1145, 1085, 1320, 998 cm-1;  HRMS calcd for 
(C27H36BNO6S2)Na+ 568.1969; Found: 568.1967. 
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2-(5-(allyloxy)-3-(phenylsulfonyl)pent-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (146): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.81 (d, 
J = 8 Hz, 2H), 7.59 (t, J = 6.5 Hz, 1H), 7.49 (t, J = 8 Hz, 2H), 6.12 (d, J = 2 Hz, 1H), 5.87 
– 5.80 (m, 1H), 5.84 (s, 1H), 5.22 (dq, J = 1.5 Hz, J = 17 Hz, 1H), 5.12 (dq, J = 1.5 Hz, J 
= 10.5 Hz, 1H), 4.12 (dd, J = 4 Hz, J = 11.5 Hz, 1H), 3.93 – 3.84 (m, 2H), 3.52 (ddd, J = 
4.5 Hz, J = 6.5 Hz, J = 10 Hz, 1H), 3.38 – 3.30 (m, 1H), 2.53 – 2.47 (m, 1H), 2.26 – 2.19 
(m, 1H), 1.15 (s, 12H); 13C NMR (125 MHz, CDCl3)  δ 138.3, 136.7, 134.8, 133.3, 129.7, 
128.7, 116.8, 83.9, 71.8, 66.7, 65.6, 27.2, 24.8, 24.7, 24.7;  IR (film) νmax = 3069, 2978, 
2933, 2865, 1479, 1460, 1447, 1423, 1372, 1306, 1216, 1141 cm-1;  HRMS calcd for 
(C20H29BO5S)Na+ 415.1721; Found: 415.1720. 
 
 
N-allyl-4-methyl-N-(4-(phenylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hex-5-en-1-yl)benzenesulfonamide (147): Monoalkylation Procedure. 1H NMR (500 
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MHz, CDCl3) δ 7.78 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 8.5 Hz, 2H), 7.60 (t, J = 7.5 Hz, 
1H), 7.50 (t, J = 8 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 6.09 (d, J = 2 Hz, 1H), 5.76 (s, 1H), 
5.58 (dddd, J = 6.5 Hz, J = 6.5 Hz, J = 10 Hz, J = 16.5 Hz, 1H), 5.12 (dd, J = 10 Hz, J = 
16 Hz, 2H), 3.86 (dd, J = 4 Hz, J = 11 Hz, 1H), 3.79 – 3.70 (m, 2H), 3.07 (t, J = 7.5 Hz, 
2H), 2.42 (s, 3H), 2.12 – 2.06 (m, 1H), 1.98 – 1.90 (m, 1H), 1.62 – 1.56 (m, 1H), 1.54 – 
1.47 (m, 1H), 1.16 (s, 12H); 13C NMR (125 MHz, CDCl3)  δ 143.4, 138.0, 136.9, 136.7, 
133.5, 133.2, 129.8, 129.8, 128.8, 127.3, 119.0, 84.1, 68.0, 50.9, 46.9, 25.9, 24.8, 24.8, 
24.2, 21.6;  IR (film) νmax = 3062, 2978, 2933, 1627, 1601, 1492, 1447, 1410, 1379, 
1315, 1304, 1143 cm-1;  HRMS calcd for (C28H38BNO6S2)Na+ 582.2125; Found: 
582.2124. 
 
 
4,4,5,5-tetramethyl-2-(5-(phenylsulfonyl)cyclopent-1-en-1-yl)-1,3,2-dioxaborolane 
(149): RCM Procedure 2: Diene 137 (115 mg, 0.305 mmol) was dissolved in 60 mL dry 
toluene (0.005 M) that was degassed with argon prior to use.  The solution was added to a 
sealed tube under argon atmosphere and treated with Hoveyda - Grubbs 2nd generation 
catalyst (19.1 mg, 10 mol %) and benzoquinone (66 mg, 0.610 mmol).  The tube was 
sealed with Teflon coated cap and heated to 110 oC for 24 h.  Solvent was evaporated and 
the crude black residue was purified on a flash column (20%  EtOAc/Hexanes) affording 
149 as a solid (83 mg, 78%).  mp = 107 oC; 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8 
Hz, 2H), 7.61 (t, J = 8 Hz, 1H), 7.50 (t, J = 8 Hz, 2H), 4.43 (d, J = 8.5 Hz, 1H), 2.27 (dd, 
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J = 9 Hz, J = 14.5 Hz, 1H), 2.16 – 2.03 (m, 2H), 1.89 (s, 3H), 1.82 – 1.76 (m, 1H), 1.28 
(d, J = 3.5 Hz, 12H); 13C NMR (125 MHz, CDCl3)  δ 165.6, 137.5, 133.3, 129.7, 128.6, 
83.6, 76.1, 38.9, 26.3, 25.2, 24.7, 17.3;  IR (film) νmax = 2978, 2932, 1638, 1446, 1386, 
1372, 1315, 1302, 1143, 1130 cm-1;  HRMS calcd for (C18H25BO4S)Na+ 371.1459; 
Found: 371.1455. 
 
 
4,4,5,5-tetramethyl-2-(4-(phenylsulfonyl)-1,4,5,6-tetrahydro-[1,1'-biphenyl]-3-yl)-
1,3,2-dioxaborolane (150): RCM Procedure 2. mp = 164 oC ; d.r. (1.00 : 0.34) 1H NMR 
(500 MHz, CDCl3) δ 7.97 – 7.93 (m, 4H), 7.64 (t, J = 7.5 Hz, 2H), 7.56 (t, J = 7.5 Hz, 
4H), 7.29 – 7.16 (m, 6H), 7.06 (d, J = 7 Hz, 2H), 7.03 (d, J = 8.5 Hz, 2H), 6.80 (d, J = 2 
Hz, 1H), 6.75 (s, 1H), 4.19 – 4.17 (m, 1H), 4.10 – 4.09 (m, 1H), 3.32 – 3.29 (m, 1H), 3.26 
– 3.23 (m, 1H), 2.26 – 2.23 (m, 1H), 2.17 – 2.09 (m, 1H), 1.97 – 1.78 (m, 6H), 1.30 (d, J 
= 5.5 Hz, 12H), 1.27 (d, J = 6 Hz, 12H); 13C NMR (125 MHz, CDCl3)  δ 150.8, 150.1, 
144.1, 144.1, 139.0, 138.4, 133.6, 133.5, 129.5, 129.4, 129.1, 129.1, 129.0, 128.6, 128.6, 
128.0, 127.8, 126.7, 84.1, 83.9, 62.0, 61.3, 43.3, 40.7, 27.1, 26.6, 25.1, 24.8, 24.7, 22.9, 
20.1;  IR (film) νmax = 2978, 2933, 1447, 1410, 1379, 1304, 1143, cm-1;  HRMS calcd for 
(C24H29BO4S)Na+ 447.1772; Found: 447.1771. 
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4,4,5,5-tetramethyl-2-(3-methyl-6-(phenylsulfonyl)cyclohex-1-en-1-yl)-1,3,2-
dioxaborolane (151): RCM Procedure 2.  mp = 72 oC; d.r. (1.00 : 0.75) 1H NMR (500 
MHz, CDCl3) δ 7.89 (t, J = 7 Hz, 4H), 7.63 – 7.59 (m, 2H), 7.54 – 7.50 (m, 4H), 6.63 (s, 
2H), 4.06 – 4.04 (m, 1H), 4.00 (d, J = 6 Hz, 1H), 2.19 – 2.15 (m, 1H), 2.13 – 2.11 (m, 
1H), 2.04 – 2.02 (m, 1H), 1.91 – 1.85 (m, 1H), 1.78 – 1.69 (m, 1H), 1.55 – 1.52 (m, 1H), 
1.29 (s, 24H), 1.26 – 1.25 (m, 1H) 1.24 – 1.22 (m, 1H), 1.21 – 1.20 (m, 1H), 1.17 – 1.13 
(m, 2H), 0.94 (d, J = 7 Hz, 3H), 0.88 (d, J = 7 Hz, 3H); 13C NMR (125 MHz, CDCl3)  δ 
154.2, 153.9, 139.1, 138.4, 133.4, 133.4, 129.5, 129.4, 128.9, 128.9, 83.9, 62.2, 61.6, 
31.1, 29.6, 26.2, 25.6, 25.1, 24.8, 24.7, 22.6, 20.6, 20.4, 20.4;  IR (film) νmax = 2978, 
2928, 1446, 1331, 105, 1142 cm-1;  HRMS calcd for (C19H27BO4S)Na+ 385.1615; Found: 
385.1615. 
 
 
2-(3,3-dimethyl-6-(phenylsulfonyl)cyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (152): RCM Procedure 2. mp = 90 – 92 oC ; 1H NMR (500 MHz, CDCl3) 
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δ 7.89 (d, J = 8 Hz, 2H), 7.61 (t, J = 8 Hz, 1H), 7.52 (t, J = 8 Hz, 2H), 6.46 (s, 1H), 3.98 
(d, J = 6 Hz, 1H), 2.07 – 2.02 (m, 1H), 1.88 – 1.82 (m, 1H), 1.42 (ddd, J = 4 Hz, J = 13.5 
Hz, J = 13.5 Hz, 1H), 1.30 (s, 12H), 1.22 (ddd, J = 4.5 Hz, 4.5 Hz, 14 Hz, 1 H), 0.90 (s, 
3H), 0.79 (s, 3H); 13C NMR (125 MHz, CDCl3)  δ 157.3, 138.8, 133.4, 129.5, 128.9, 
83.9, 61.9, 32.1, 31.6, 29.0, 28.4, 25.1, 24.7, 20.1;  IR (film) νmax = 2976, 2930, 1447, 
1422, 1372, 1305, 1143, 1084 cm-1;  HRMS calcd for (C20H29BO4S)Na+ 399.1771; 
Found: 399.1771. 
 
 
4,4,5,5-tetramethyl-2-(3-(phenylsulfonyl)-3,4-dihydronaphthalen-2-yl)-1,3,2-
dioxaborolane (153): RCM Procedure 2. mp = 158 oC;  1H NMR (500 MHz, CDCl3) δ 
7.55 (d, J = 8 Hz, 2H), 7.28 (t, J = 8 Hz, 1H), 7.18 (s, 1H), 7.13 (t, J = 8 Hz, 2H), 7.06 (t, 
J = 7 Hz, 1H), 6.97 (d, J = 7.5 Hz, 1H), 6.91 (t, J = 7.5 Hz, 1H), 6.70 (d, J = 7.5 Hz, 1H), 
4.24 (d, J = 8 Hz, 1H), 3.60 (d, J = 18 Hz, 1H), 3.28 (dd, J = 8.5 Hz, J = 18 Hz, 1H), 1.33 
(d, J = 4 Hz, 12H); 13C NMR (125 MHz, CDCl3)  δ 145.1, 136.8, 133.2, 132.5, 131.8, 
129.8, 129.4, 127.9, 127.8, 127.7, 126.9, 84.3, 61.2, 28.1, 25.1, 24.7;  IR (film) νmax = 
3062, 3026,  2937, 2867, 1634, 1601, 1585, 1492, 1447, 1307, 1208, 1149, 1084, 1025 
cm-1;  HRMS calcd for (C22H25BO4S)Na+ 419.1459; Found: 419.1456. 
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4,4,5,5-tetramethyl-2-(7-(phenylsulfonyl)cyclohept-1-en-1-yl)-1,3,2-dioxaborolane 
(148): RCM Procedure 2. mp = 123 oC;  1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 8 Hz, 
2H), 7.59 (t, J = 8 Hz, 1H), 7.50 (t, J = 8 Hz, 2H), 7.11 (dd, J = 4 Hz, J = 9 Hz, 1H), 4.25 
(t, J = 5 Hz, 1H), 2.81 – 2.74 (m, 1H), 2.56 – 2.53 (m, 1H), 2.34 – 2.27 (m, 2H), 1.84 – 
1.82 (m, 2H), 1.71 – 1.64 (m, 1H), 1.30 – 1.25 (m, 1H), 1.03 (d, J = 20 Hz, 12H); 13C 
NMR (125 MHz, CDCl3)  δ 156.4, 140.2, 133.2, 129.4, 128.9, 83.8, 65.9, 30.1, 26.8, 
26.3, 25.9, 24.9, 24.7;  IR (film) νmax = 2978, 2928, 2859, 1629, 1446, 1409, 1331, 1305 
cm-1;  HRMS calcd for (C19H27BO4S)Na+ 385.1615; Found: 385.1611. 
 
 
4,4,5,5-tetramethyl-2-(7-(phenylsulfonyl)-6,7-dihydro-5H-benzo[7]annulen-8-yl)-
1,3,2-dioxaborolane (154): RCM Procedure 2. mp = 128 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.78 (d, J = 8 Hz, 2H), 7.50 (t, J = 8 Hz, 1H), 7.40 (t, J = 8 Hz, 2H), 7.34 (s, 
1H), 7.12 – 7.08 (m, 3H), 7.03 – 7.02 (m, 1H), 4.61 (t, J = 7.5 Hz, 1H), 2.20 – 2.78 (m, 
2H), 2.43 – 2.39 (m, 2H), 1.31 (s, 12H); 13C NMR (125 MHz, CDCl3)  δ 14736, 141.7, 
137.7, 135.3, 133.4, 132.0, 129.7, 128.7, 128.5, 126.4, 84.3, 67.5, 31.8, 31.3, 25.1, 24.9, 
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24.7;  IR (film) νmax = 2978, 2932, 1638, 1446, 1386, 1372, 1315, 1302, 1143, 1130, 
1085 cm-1;  HRMS calcd for (C23H27BO4S)Na+ 433.1615; Found: 433.1615. 
 
4-(phenylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-2,3,4,7-
tetrahydro-1H-azepine (155): RCM Procedure 2. mp = 208 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.81 (d, J = 8 Hz, 2H), 7.65 (d, J = 8 Hz, 2H), 7.62 (t, J = 8 Hz, 1H), 7.51 (t, J 
= 8 Hz, 2H), 7.28 (d, J = 8 Hz, 2H), 7.03 (dd, J = 4 Hz, J = 8 Hz, 1H), 4.33 – 4.28 (m, 
2H), 3.98 – 3.92 (m, 2H), 3.70 (t, J = 12.5 Hz, 1H), 2.57 (ddd, J = 3.5 Hz, J = 3.5 Hz, J = 
15 Hz, 1H), 2.41 (s, 3H), 2.14 – 2.06 (m, 1H), 1.01 (d, J = 20 Hz, 12H); 13C NMR (125 
MHz, CDCl3)  δ 149.5, 143.5, 139.2, 136.5, 133.8, 129.9, 129.3, 129.2, 127.2, 84.3, 64.4, 
47.5, 46.8, 27.6, 24.9, 24.7, 21.6;  IR (film) νmax = 2977, 2925, 1636, 157, 1332, 1305, 
1143, 1094 cm-1;  HRMS calcd for (C25H32BO6S2)Na+ 540.1656; Found: 540.1656. 
 
4,4,5,5-tetramethyl-2-(1-(phenylsulfonyl)hept-2-en-2-yl)-1,3,2-dioxaborolane (158): 
Intermolecular Cross-Metathesis Procedure A:  Vinyl boronate 38 (100 mg, 0.324 mmol), 
Grubbs 2nd generation catalyst (13.7 mg, 16 µmol) and 1-hexene (80 µL, 0.648 mmol) 
were added to a flask under argon atmosphere.  The starting materials were dissolved in 
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1.62 mL dry dichloromethane, which was degassed with argon prior to use.  The flask 
was fitted with a reflux condenser and heated to reflux for 24 h.  The solvent was 
removed and the crude was purified on a flash column (20% EtOAc/Hexanes) affording 
158 as a solid (86 mg, 73%).  Z/E (1.00 : 0.18) 1H NMR (500 MHz, CDCl3) δ7.85 (d, J = 
8 Hz, 2H), 7.81 (d, J = 8 Hz, 2H), 7.60 (t, J = 8 Hz, 2H), 7.51 (t, J = 8 Hz, 4H), 6.58 (t, J 
= 7 Hz, 1H), 6.06 (t, J = 8 Hz, 1H), 4.03 (s, 2H), 3.87 (s, 2H), 2.32 (q, J = 2 Hz, 2H), 1.94 
(q, J = 4 Hz, 2H), 1.25 – 1.23 (m, 8 H), 1.19 (s, 12H), 1.13 (s, 12H), 0.84 (t, J = 7 Hz, 
6H); 13C NMR (125 MHz, CDCl3)  δ157.6, 155.3, 139.4, 138.9,133.4, 133.3, 129.1, 
129.0, 128.8, 83.9, 83.7, 62.6, 556.0, 31.5, 31.2, 30.7, 29.3, 24.9, 24.8, 24.8, 22.6, 22.2, 
13.9, 13.9;  IR (film) νmax = 2976, 2930, 2871, 1631, 1147, 1415, 1373, 1316 cm-1;  
HRMS calcd for (C19H22BO4S)Na+ 387.1772; Found: 387.1767. 
 
 
4,4,5,5-tetramethyl-2-(5-phenyl-1-(phenylsulfonyl)pent-2-en-2-yl)-1,3,2-
dioxaborolane (159): Intermolecular Cross-Metathesis Procedure A.  1H NMR (500 
MHz, CDCl3) δ 7.85 (d, J = 8 Hz, 2H), 7.60 (t, J = 8 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 7.28 
– 7.25 (m, 2H), 7.18 (t, J = 8 Hz, 1H), 7.12 (d, J = 8 Hz, 2H), 6.67 (t, J = 7 Hz, 1H), 3.97 
(s, 2H), 2.63 – 2.60 (m, 2H), 2.35 – 2.30 (m, 2H), 1.12 (s, 12H); 13C NMR (125 MHz, 
CDCl3)  δ153.6, 141.2, 139.1, 133.2, 128.9, 128.8, 128.3, 128.2, 125.9, 83.7, 55.6, 34.5, 
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31.4, 24.5;  IR (film) νmax = 2977, 2934, 1447, 1423, 1372, 1316, 1305, 1145, 1084 cm-1;  
HRMS calcd for (C23H29BO4S)Na+ 435.1772; Found: 435.1772. 
 
 
4,4,5,5-tetramethyl-2-(1-(phenylsulfonyl)but-2-en-2-yl)-1,3,2-dioxaborolane (166): 
Intermolecular Cross-Metathesis Procedure B: Vinyl boronate 38 (50 mg, 0.162 mmol), 
Grubbs 2nd generation catalyst (6.9 mg, 8 µmol) and 1-hexene (80 µL, 0.648 mmol) were 
added to a sealed tube under argon atmosphere.  The starting materials were dissolved in 
1.62 mL dry toluene which was degassed with argon prior to use.  The tube was fitted 
with a Teflon screw cap and heated to 135 oC for 12 h.  The solvent was removed and the 
crude was purified on a flash column (20% EtOAc/Hexanes) affording 16 as a solid (16 
mg, 30%).  Z/E (1.0 : 0.30) 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8 Hz, 2H), 7.82 (d, 
J = 8 Hz, 2H), 7.61 – 7.57 (m, 2H), 7.51 (t, J = 8 Hz, 4H), 6.72 (q, J = 7 Hz, 1H), 6.18 (q, 
J = 7 Hz, 1H), 4.04 (s, 2H), 3.86 (s, 2H), 1.58 (s, 3H), 1.57 (s, 3H), 1.19 (s, 12H), 1.29 (s, 
12H); 13C NMR (125 MHz, CDCl3)  δ 152.3, 149.8, 139.3, 133.5, 133.4, 129.5, 129.1, 
129.1, 129.0, 128.9, 83.8, 83.7, 62.5, 55.6, 29.8, 24.9, 24.8, 17.9, 15.3;  IR (film) νmax = 
2978, 2932, 1638, 1446, 1386, 1302 cm-1;  HRMS calcd for (C17H25BO4S)Na+ 359.1459; 
Found: 359.1458. 
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,4,5,5-tetramethyl-2-(1-(phenylsulfonyl)hexa-2,5-dien-2-yl)-1,3,2-dioxaborolane 
(164): General Radical Isomerization Procedure:  To a vial containing 115a (90 mg, 0.26 
mmol) was added a 3:2 mixture of AcOH/H2O (2 mL) and sodium benzenesulfinate (300 
mg, 1.8 mmol).  The mixture was heated to 95 oC and the resulting homogenous solution 
was stirred for 7 h.  The reaction was diluted with ether and the aqueous layer was 
separated and washed with NaHCO3, brine and dried over sodium sulfate.  The solvent 
was removed under reduced pressure and the crude was purified on a flash column (20% 
EtOAc/Hexanes) resulting in solid (80 mg, 89%). (Z/E (1.0 : 0.36) 1H NMR (500 MHz, 
CDCl3) δ 7.86 (d, J = 8 Hz, 2H), 7.81 (d, J = 8 Hz, 2H), 7.62 (m, 2H), 7.53 – 7.50 (m, 
4H), 6.11 (t, J = 7.5 Hz, 1H), 6.07 (t, J = 7.5 Hz, 1H), 5.72 – 5.64 (m, 2H), 5.00 – 4.95 
(m, 4H), 4.04 (s, 2H), 3.89 (s, 2H), 3.12 (t, J = 6.5 Hz, 2H), 2.77 (t, J = 6.5 Hz, 2H), 1.19 
(s, 12H), 1.12 (s, 12H); 13C NMR (125 MHz, CDCl3)  δ 158.3, 139.5, 133.3, 128.9, 83.6, 
58.5, 29.8, 24.9, 21.9;  IR (film) νmax = 2977, 2934, 1447, 1423, 1372, 1316, 1305, 1145, 
1084 cm-1;  HRMS calcd for (C17H25BO4S)Na+ 359.1459; Found: 359.1456. 
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4,4,5,5-tetramethyl-2-(6-phenyl-1-(phenylsulfonyl)hex-2-en-2-yl)-1,3,2-
dioxaborolane (165): General Radical Isomerization Procedure: Z/E (1.0 : 0.36) 1H 
NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8 Hz, 4H), 7.58 (t, J = 8 Hz, 2H), 7.49 (t, J = 8 
Hz, 4H), 7.28 – 7.52 (m, 2H), 7.19 – 7.11 (m, 3H), 6.59 (t, J = 7 Hz, 1H), 6.10 (t, J = 7 
Hz, 1H), 3.98 (s, 2H), 3.88 (s, 2H), 2.56 – 2.52 (m, 4H), 2.40 – 2.35 (m, 2H), 1.96 (q, J = 
7 Hz, 2H), 1.65 – 1.58 (m, 4H), 1.16 (s, 12H), 1.13 (s, 12H); 13C NMR (125 MHz, 
CDCl3)  δ 156.8, 154.6, 151.9, 139.3, 133.5, 133.4, 129.1, 129.0, 128.9, 128.6, 128.5, 
128.5, 128.4, 125.9, 125.9, 83.9, 83.7, 62.5, 55.9, 35.6, 35.5, 31.2, 31.0, 30.1, 29.8, 29.1, 
24.6, 24.8;  IR (film) νmax = 2977, 2934, 1447, 1423, 1372, 1316, 1305, 1145, 1084 cm-1;  
HRMS calcd for (C24H31BO4S)Na+ 449.1928; Found: 449.1924. 
 
 
 
4,4,5,5-tetramethyl-2-(3-methyl-1-(phenylsulfonyl)but-2-en-2-yl)-1,3,2-
dioxaborolane (167): General Radical Isomerization Procedure. 1H NMR (500 MHz, 
142 
 
CDCl3) δ 7.85 (d, J = 8 Hz, 2H), 7.60 (t, J = 8 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 4.04 (s, 
2H), 2.00 (s, 3H), 1.46 (s, 3H), 1.22 (s, 12H); 13C NMR (125 MHz, CDCl3)  δ 158.3 
139.5, 133.3, 128.9, 83.6, 58.5, 29.8, 24.9, 21.9;  IR (film) νmax = 2977, 2934, 1447, 
1423, 1372, 1316, 1305, 1145, 1084 cm-1;  HRMS calcd for (C18H25BO4S)Na+ 371.1458; 
Found: 371.1458. 
 
 
4,4,5,5-tetramethyl-2-(5-methyl-1-(phenylsulfonyl)hex-2-en-2-yl)-1,3,2-
dioxaborolane (167): General Radical Isomerization Procedure.  Z/E (1.0 : 0.56) 1H 
NMR (500 MHz, CDCl3) δ 7.86 – 7.82 (m, 4H), 7.62 – 7.59 (m, 2H), 7.51 (t, J = 7 Hz, 
4H), 6.20 (t, J = 7 Hz, 1H), 6.11 (t, J = 7 Hz, 1H), 4.03 (s, 2H), 3.89  (s, 2H), 2.23 (t, J = 
7 Hz, 2H), 1.85 (t, J – 7 Hz, 2H), 1.62 – 1.54 (m, 2H), 1.18 (s, 12H), 1.13 (s, 12H), 0.83 
(t, J = 6.5 Hz, 24H); 13C NMR (125 MHz, CDCl3)  δ 156.4, 154.2, 139.4, 139.0, 138.4, 
133.4, 133.3, 129.1, 129.0, 129.0, 128.9, 83.9, 83.7, 62.6, 56.1, 40.4, 38.4, 28.8, 28.1, 
24.9, 24.8, 22.6, 22.4;  IR (film) νmax = 2977, 2934, 1447, 1423, 1372, 1316, 1305, 1145, 
1084 cm-1;  HRMS calcd for (C19H29BO4S)Na+ 387.1771; Found: 387.1770. 
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44,4,5,5-tetramethyl-2-(1-(phenylsulfonyl)dec-2-en-2-yl)-1,3,2-dioxaborolane (169): 
General Radical Isomerization Procedure. Z/E (1.00 : 0.60) 1H NMR (500 MHz, CDCl3) 
δ 7.85 (d, J = 8 Hz, 2H), 7.82 (d, J = 8 Hz, 2H), 7.61 – 7.56 (m, 2H), 7.50 (t, J = 8 Hz, 
4H), 6.58 (s, 7 Hz, 1H), 6.06 (t, J = 7 Hz, 1H), 4.03 (s, 2H), 3.87 (s, 2H), 2.31 (q, J = 7 
Hz, 2H), 1.92 (q, J = 7 Hz, 2H), 1.31 – 1.24 (m, 20H), 1.19 (s, 12H), 1.14 (s, 12H), 0.89 
– 0.85 (m, 6H); 13C NMR (125 MHz, CDCl3)  δ 157.6, 155.3, 139.3, 138.9, 136.7, 133.8, 
133.4, 133.3, 131.5, 129.6, 129.4, 129.3, 129.1, 129.0, 128.9, 128.8, 127.7, 83.9, 83.7, 
62.6, 56.0, 31.9, 31.9, 31.5, 293.6, 29.5, 29.3, 29.2, 29.2, 29.2, 29.2, 28.6, 24.9, 24.8, 
22.8, 22.8, 14.3, 14.2, 14.2;  IR (film) νmax = 2976, 2930, 2871, 1631, 1147, 1415, 1373, 
1316 cm-1;  HRMS calcd for (C22H35BO4S)Na+ 429.2241; Found: 429.2241. 
 
 
 
4,4,5,5-tetramethyl-2-(7-(phenylsulfonyl)cyclohept-1-en-1-yl)-1,3,2-dioxaborolane 
(170): Vinyl boronate 148  (1.02 g, 2.82 mmol) was dissolved in 21 mL (5:1 
MeOH/DCM) solvent system (0.1 M), and to the solution was added triethylamine (1.6 
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mL, 11.2 mmol) and copper(II) acetate (1.02 mg, 5.60 mmol).  The resulting mixture was 
heated to 40 oC and stirred for 6 days open to air. Over the course of the reaction 
additional solvent was added as needed due to evaporation.  The mixture was diluted with 
ether and washed with water.  The organic layer was separated, dried over magnesium 
sulfate and concentrated under reduced pressure resulting in a white solid which could be 
recrystallized from a 2:1 mixture of pentane/ether (672 mg, 75%).  1H NMR (500 MHz, 
CDCl3) δ 7.87 (d, J = 8 Hz, 2H), 7.61 (t, J = 7 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 5.01 (dd, J 
= 4.5 Hz, J = 8.5 Hz, 1H), 3.78 (t, J = 5 Hz, 1H), 3.06 (s, 3H), 2.61 – 2.54 (m, 1H), 2.51 – 
2.46 (m, 1H), 2.28 – 2.20 (m, 1H), 2.09 – 2.03 (m, 1H), 1.91 – 1.74 (m, 3H), 1.28 – 1.31 
(m, 1H); 13C NMR (125 MHz, CDCl3)  δ 151.3, 139.6, 133.4, 128.8, 128.7, 104.7, 70.8, 
54.4, 27.4, 25.6, 24.7, 23.1;  IR (film) νmax = 2977, 2935, 1447, 1305, 1144 cm-1;  HRMS 
calcd for (C14H18O3S)Na+ 289.0869; Found: 289.0869. 
 
 
 
(E)-7-(hepta-4,6-dien-1-yl)-1-methoxy-7-(phenylsulfonyl)cyclohept-1-ene (172): 
Sulfone 170  (564 mg, 2.11 mmol) was dissolved in 10.5mL dry THF (0.2 M), cooled to -
78 oC, treated with nBuLi (1.53 M in THF, 1.10 mL, 2.53 mmol) and allowed to stir an 
additional 30 minutes before addition of iodide 171 (564 mg, 2.53 mmol).  The reaction 
was then allowed to reach room temperature over the course of 1 hour before being 
quenched with saturated ammonium chloride.  The aqueous layer was extracted with 
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dichloromethane (2 x 10 mL), and the organic layers were separated, dried over 
magnesium sulfate and concentrated under reduced pressure.  The resulting crude residue 
was purified on a flash column (20% EtOAc/Hexanes) affording the product as a 
colorless oil (643 mg, 84%).  1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8 Hz, 2H), 7.58 
(t, J = 8 Hz, 1H), 7.47 (t, J = 8 Hz, 2H), 6.25 (ddd, J = 10 Hz, J = 10 Hz, J = 17  Hz, 1H), 
5.98 (dd, J = 10.5 Hz, J = 15 Hz, 1H), 5.60 (p, J = 7 Hz, 1H), 5.06 (d, J = 17 Hz, 1H), 
5.00 (t, J = 7 Hz, 1H), 4.94 (d, J = 10 Hz, 1H), 3.20 (s, 3H), 2.43 – 2.36 (m, 2H), 2.12 – 
2.07 (m, 1H), 2.05 – 1.97 (m 5H), 1.79 – 1.65 (m 3H), 1.52 – 1.43 (m, 2H), 1.28 – 1.20 
(m, 1H); 13C NMR (125 MHz, CDCl3)  δ 151.5, 138.4, 137.2, 134.5, 133.2, 131.4, 130.3, 
128.2, 115.1, 105.0, 76.4, 54.2, 35.5, 33.0, 29.1, 25.5, 24.3, 22.6, 21.6;  IR (film) νmax = 
2978. 2932. 1638. 1446. 1386. 1302. 1315. 1236. 1143. 1130. 1085 cm-1; HRMS calcd 
for (C21H28O3S)Na+ 383.1651; Found: 383.1651. 
 
 
 
(3aR,8S,11aR)-1,2,3,4,5,6,7,8,9,11a-decahydro-3a,8-methanocyclopenta[10]annulen-
12-one (173): The enol ether 172 (643 mg, 1.78 mmol) was dissolved in 17.8 mL dry 
dichloromethane (0.1 M) and cooled to -78 oC.  The solution was treated with 
titanium(IV) chloride (215 µL, 1.95 mmol) and stirred 4 minutes before quenched with 
water.  After warming to room temperature, the reaction was extracted with 
dichloromethane (3 x 5 mL) and the organic layers were combined, dried over 
146 
 
magnesium sulfate, and concentrated under reduced pressure affording a colorless oil 
(293 mg, 81%).  d.r = (1.4 : 1) 1H NMR (500 MHz, CDCl3) δ 5.70 – 5.65 (m, 1H), 5.45 
(dt, J = 4.5 Hz, J = 11 Hz, 1H), 2.89 – 2.84 (m, 1H), 2.74 (s, 1H), 2.63 – 2.56 (m, 1H), 
2.41 – 2.34 (m, 1H), 2.16 – 2.10 (m, 1H), 2.02 – 1.93 (m, 2H), 1.82 – 1.67 (m, 6H), 1.61 
– 1.55 (m, 1H), 1.53 – 1.46 (m 1H), 1.44 – 1.38 (m, 1H), 1.35 – 1.30 (m 1H), 1.27 – 1.22 
(m, 1H); 13C NMR (125 MHz, CDCl3)  δ 216.1, 135.0, 128.2, 62.6, 55.3, 47.8, 39.9,25.9, 
24.6, 21.2,29.2,26.8,26.1, 22.9;  IR (film) νmax = 3026, 2937, 1634, 1447, 1307, 1208, 
1149, 1084 cm-1;  HRMS calcd for (C14H20O)Na+ 227.1406; Found: 227.1708. 
 
 
 
 
(3aR,8S,11aR,12R)-1,2,3,4,5,6,7,8,9,11a-decahydro-3a,8-
methanocyclopenta[10]annulen-12-ol (174): To a suspension of lithium  aluminum 
hydride (20 mg, 0.543 mmol) in diethyl ether at 0 oC was added ketone 173 (74 mg, 
0.362 mmol) as a solution in 1.0 mL diethyl ether.  After dropwise addition, the reaction 
was allowed to warm to room temperature over the course of 1 hour.  After the reaction 
was determined complete by TLC, it was cooled to 0 oC and 5 mL ethyl acetate was 
added slowly.  The reaction was warmed back to room temperature, and a saturated 
solution of Rochelle’s salt was added to the biphasic system which was stirred vigorously 
for one hour. The organic layer was separated from the mixture, dried over magnesium 
sulfate, and concentrated under reduced pressure.  The crude residue was purified on a 
flash column in (2.5% EtOAc/Hexanes) giving two diastereomers; one of which could be 
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recrystallized with ethanol.   1H NMR (500 MHz, CDCl3) δ 5.48 – 5.46 (m, 1H), 5.31 (d, 
J = 11 Hz, 1H), 3.81 (s, 1H), 2.71 (s, 1H), 2.10 – 2.35 (m, 3H), 1.99 – 1.88 (m, 2H), 1.86 
– 1.84 (m, 1H), 1.67 – 1.48 (m, 12H); 13C NMR (125 MHz, CDCl3)  δ 134.1, 126.7, 80.9, 
52.4, 44.9, 42.5, 10.9, 37.9, 34.9, 33.8, 31.6, 26.4, 26.1, 23.1;  HRMS calcd for 
(C14H22O)Na+ 229.1562; Found: 229.1564. 
 
 
 
 
3-(2-iodophenyl)propyl trifluoromethanesulfonate (181):  To a solution of 3-(2-
iodophenyl)propan-1-ol (440 mg, 1.7 mmol) in dichloromethane (17 mL) at -78 oC was 
added 2,6-lutidine (312 µL, 3.4 mmol) followed by dropwise addition of 
trifluoromethanesulfonic anhydride (386 µL, 1.9 mmol).  The solution was stirred for 1 h 
at -78 oC before being quenched with water slowly.  The reaction was diluted with 
dichloromethane, and washed with brine.  The organic layer was dried over magnesium 
sulfate and concentrated under reduced pressure.  The crude oil was purified on a flash 
column (100% Hexanes) affording a yellow oil (283 mg, 43%). 1H NMR (500 MHz, 
CDCl3) δ 7.83 (d, J = 8 Hz, 1H), 7.30 (t, J = 8 Hz, 1H), 7.20 (d, J = 8 Hz, 1H), 6.93 (t, J 
= 8 Hz, 1H), 4.58 (t, J = 6 Hz, 2H), 2.88 (t, J = 8 Hz, 2H), 2.17 – 2.12 (m, 2H); 13C NMR 
(125 MHz, CDCl3)  δ 142.4, 140.0, 129.73, 128.8, 128.6, 122.6, 120.1, 117.5, 114.9, 
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100.3, 76.6, 36.4, 29.68;  IR (film) νmax = 2978, 2931, 1492, 1447, 1423, 1372, 1305, 
1214, 1143, 1084 cm-1;  HRMS peak not observed. 
 
4-(2-iodophenyl)butyl trifluoromethanesulfonate (184): 1H NMR (500 MHz, CDCl3) δ 
7.82 (d, J = 8 Hz, 1H), 7.28 (t, J = 8 Hz, 1H), 7.19 (d, J = 8 Hz, 1H), 6.90 (t, J = 8 Hz, 
1H), 4.57 (t, J = 6 Hz, 2H), 2.78 (t, J = 8 Hz, 2H), 1.95 – 1.89 (m, 2H), 1.78 – 1.72 (m, 
2H); 13C NMR (125 MHz, CDCl3)  δ 143.9, 139.8, 129.51, 128.6, 128.2, 122.6, 120.1, 
117.5, 114.9, 100.6, 40.0, 28.9, 25.9;  IR (film) νmax = 2978, 2931, 1492, 1447, 1423, 
1372, 1305, 1214, 1143, 1084 cm-1;  HRMS peak not observed. 
 
2-(4-(2-iodophenyl)-3-(phenylsulfonyl)but-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (175): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.88 (d, 
J = 8 Hz, 2H), 7.75 (d, J = 8 Hz, 1H), 7.59 (t, J = 8 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 7.20 – 
7.16 (m, 2H), 6.86 – 6.83 (m, 1H), 6.06 (d, J = 2 Hz, 1H), 5.94 (s, 1H), 4.39 (dd, J = 10.5 
Hz, J = 4 Hz, 1H), 3.61 (dd, J = 14 Hz, J = 3.5 Hz, 1H), 3.43 (dd, J = 14 Hz, J = 12 Hz, 
1H), 1.12 (s, 6H), 1.09 (s, 6H); 13C NMR (125 MHz, CDCl3)  δ 139.9, 139.8, 138.6, 
137.5, 133.5, 131.4, 129.7, 128.9, 128.5, 128.1, 100.9, 84.0, 38.2, 24.9, 24.5;  IR (film) 
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νmax = 2973, 2930, 1447, 1423, 1305, 1216, 1145, 1085 cm-1;  HRMS calcd for 
(C22H26BIO4S)Na+ 547.0582; Found: 547.0577. 
 
2-(5-(2-iodophenyl)-3-(phenylsulfonyl)pent-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (176): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.80 (d, 
J = 8 Hz, 2H), 7.77 (d, J = 8 Hz, 1H), 7.58 (t , J = 8 Hz, 1H), 7.49 (t, J = 8 Hz, 2H), 7.24 
(d, J = 8 Hz,  1H), 7.17 (d, J = 8 Hz, 1H), 6.88 (t, J = 8 Hz, 1H), 6.22 (d, J = 2 Hz, 1H), 
6.00 (s, 1H), 3.99 (dd, J = 12 Hz, J = 3.5 Hz, 1H), 2.78 – 2.72 (m, 1H), 2.66 – 2. 60 (m, 
1H), 2.45 (dddd, J = 3.5 Hz, J = 6 Hz, J = 10 Hz, J = 16.5 Hz, 1H), 2.30 = 2.22 (m, 1H), 
1.18 (s, 6H), 1.18 (s, 1H); 13C NMR (125 MHz, CDCl3)  δ 143.6, 139.7, 138.2, 136.9, 
133.4, 129.7, 129.7, 128.8, 128.5, 128.2, 100.5, 84.1, 67.5, 38.0, 27.5, 24.9, 24.8;  IR 
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(film) νmax = 2973, 2930, 1447, 1423, 1305, 1216, 1145, 1085 cm-1;  HRMS calcd for 
(C22H26BIO4S)Na+ 561.0738; Found: 561.0733. 
 
 
 
 
2-(7-(2-iodophenyl)-3-(phenylsulfonyl)hept-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (177): Monoalkylation Procedure. 1H NMR (500 MHz, CDCl3) δ 7.79 (t, 
J = 8 Hz, 3H), 7.58 (t, J = 8 Hz, 1H), 7.49 (t, J = 8 Hz, 2H), 7.24 (t, J = 8 Hz, 1H), 7.15 
(d, J = 8 Hz, 1H), 6.86 (t, J = 8 Hz, 1H), 6.14 (d, J = 2 Hz, 1H), 5.89 (s, 1H), 3.92 (dd, J 
= 11.5, J = 3.5, 1H), 2.71 – 2.61 (m, 2H), 2.23 (dddd, J = 3.5 Hz, J = 6 Hz, J = 10 Hz, J = 
16.5 Hz, 1H), 2.11 – 2.03 (m, 1H), 1.60 – 1.52 (m, 2H), 1.47 – 1.40 (m, 1H), 1.37 – 1.31 
(m, 1H), 1.14 (s, 6H), 1.13 (s, 6H); 13C NMR (125 MHz, CDCl3)  δ 144.9, 139.6, 138.7, 
136.7, 133.3, 129.8, 129.5, 129.4, 128.7, 128.4, 127.8, 1100.7, 83.9, 83.8, 68.2, 40.6, 
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29.9, 263.7, 26.5, 24.8, 24.7;  IR (film) νmax = 2973, 2930, 1447, 1423, 1305, 1216, 1145, 
1085 cm-1;  HRMS calcd for (C25H32BIO4S)Na+ 589.1051; Found: 589.1045. 
 
 
1-methylene-2-(phenylsulfonyl)decahydronaphthalene (178): SM Cross-Coupling 
Procedure C. 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8 Hz, 2H), 7.59 (t, J = 8 Hz, 
1H), 7.52 – 7.47 (m, 3H), 7.16 (p, J = 7 Hz, 2H), 7.06 (d, J = 7 Hz, 1H), 5.72 (s, 1H), 
4.92 (s, 1H), 4.12 (t, J = 5 Hz, 1H), 3.21 (ddd, J = 16, J = 10.5, J = 5.5, 1H), 2.73 (ddd, J 
= 16.5, J = 11 Hz, J = 5.5 Hz, 1H), 2.57 – 2.52 (m, 1H), 2.27 – 2.19 (m, 1H); 13C NMR 
(125 MHz, CDCl3)  δ 137.9, 136.3, 135.3, 133.7, 132.9, 129.4, 128.9, 128.9, 128.7, 
128.4, 126.7, 124.7, 118.1, 67.2, 26.3, 23.1;  IR (film) νmax = 2973, 2930, 1447, 1423, 
1305, 1216, 1145, 1085 cm-1;  HRMS calcd for (C17H16O2S)Na+ 307.0763; Found: 
307.0762. 
 
 
 
 
5-methylene-6-(phenylsulfonyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulene (179): SM 
Cross-Coupling Procedure C. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8 Hz, 2H), 7.62 
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(t, J = 8 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 7.18 (t, J = 8 Hz, 1H), 7.10 (t, J = 8 Hz, 1H), 
7.03 (d, J = 7 Hz, 1H), 6.85 (d, J = 8 Hz, 1H), 5.57 (s, 1H), 5.30 (s, 1H), 3.95 (d, J = 8 
Hz, 1H), 2.78 – 2.72 (m, 1H), 2.69 – 2.65 (m, 1H), 2.32 – 2.13 (m, 1H), 1.94 – 1.87 (m, 
1H), 1.85 – 1.76 (m, 2H); 13C NMR (125 MHz, CDCl3)  δ 140.2, 137.9, 133.6, 130.1, 
129.5, 128.9, 128.4, 128.3, 128.2, 126.7, 122.9, 68.6, 32.3, 26.1, 23.5;  IR (film) νmax = 
2978, 2931, 1492, 1447, 1423, 1372, 1305, 1214, 1143, 1084 cm-1;  HRMS calcd for 
(C18H18O2S)Na+ 321.0919; Found: 321.0917. 
 
 
 
 
5-methylene-6-(phenylsulfonyl)-5,6,7,8,9,10-hexahydrobenzo[8]annulene (180): SM 
Cross-Coupling Procedure C. 1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 8 Hz, 2H), 7.65 
(t, J = 8 Hz, 1H), 7.57 (t, J = 8 Hz, 2H), 7.25 – 7.16 (m, 3H), 7.10 (d, J = 8 Hz, 1H), 5.28 
(s, 2H), 3.81 (dd, J = 12 Hz, J = 2.5 Hz, 1H), 2.72 – 2.63 (m, 2H), 2.23 – 2.18 (m, 1H), 
2.07 – 1.94 (m, 2H), 1.59 – 1.52 (m, 1H), 1.51 – 1.43 (m, 1H), 1.31 – 1.24 (m, 1H); 13C 
NMR (125 MHz, CDCl3)  δ 141.2, 141.2, 138.4, 138.1, 133.6, 130.2, 129.3, 129.1, 128.3, 
125.7, 125.1, 75.1, 34.4, 30.5,28.1, 24.5;  IR (film) νmax = 2978, 2931, 1492, 1447, 1423, 
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1372, 1305, 1214, 1143, 1084 cm-1;  HRMS calcd for (C19H20O2S)Na+ 335.1076; Found: 
335.1078. 
 
 
 
 
 
 
 
2-(5-(3-(2-iodophenyl)propyl)-5-(phenylsulfonyl)cyclopent-1-en-1-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (182): Monoalkylation Procedure. 1H NMR (500 
MHz, CDCl3) δ 7.83 (d, J = 8 Hz, 2H), 7.78 (d, J = 8 Hz, 1H), 7.58 (t, J = 8 Hz, 1H), 7.47 
(t, J = 8 Hz, 2H), 7.24 (d, J = 8 Hz, 1H), 7.19 (d, J = 8 Hz, 1H), 6.86 (td, J = 7 Hz, J  = 
1.5 Hz, 1H), 6.55 (s, 1H), 2.83 – 2.73 (m, 2H), 2.67 – 2.61 (m, 1H), 2.43 – 2.38 (m, 1H), 
2.19 – 2. 13 (m, 1H), 2.10 – 2.03 (m, 1H), 2.01 – 1.95 (m, 1H), 1.56 – 1.42 (m, 2H), 1.27 
(s, 6H), 1.24 (s, 6H); 13C NMR (125 MHz, CDCl3)  δ 154.8, 145.0, 139.6, 136.6, 133.2, 
130.8, 129.5, 128.4, 127.8, 100.6, 84.3, 83.5, 41.2, 33.7, 29.9, 25.6, 25.0, 24.9;  IR (film) 
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νmax = 2978, 2931, 1492, 1447, 1423, 1372, 1305, 1214, 1143, 1084 cm-1;  HRMS calcd 
for (C26H32BIO4S)Na+ 601.1051; Found: 601.1046. 
 
 
 
 
 
 
2-(2-(3-(2-iodophenyl)propyl)-5-(phenylsulfonyl)cyclopent-1-en-1-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (185): Radical Isomerization Procedure. 1H NMR (500 
MHz, CDCl3) δ 7.86 (d, J = 8 Hz, 2H), 7.79 (d, J = 8 Hz, 1H), 7.57 (t, J = 8 Hz, 1H), 7.47 
(t, J = 8 Hz, 2H), 7.27 – 7.24 (m, 2H), 7.16 (d, J = 8 Hz, 1H), 6.87 (t, J = 8 Hz, 1H), 4.45 
(d, J = 4.5 Hz, 1H), 2.63 (t, J = 8 Hz, 2H), 2.55 – 2.49 (m, 1H), 2.40 – 2.31 (m, 2H), 2.19 
– 2.11 (m, 2H), 1.94 – 1.89 (m,  1H), 1.66 – 1.60 (m, 1H), 1.54 – 1.48 (m, 1H), 1.27 (s, 
6H), 1.26 (s, 6H); 13C NMR (125 MHz, CDCl3)  δ 168.9, 144.9, 139.6, 137.7, 133.4, 
129.8, 129.6, 128.7, 128.4, 127.8, 100.7, 83.6, 76.0, 40.8, 36.3, 31.1, 28.8, 26.4, 25.2, 
155 
 
24.8;  IR (film) νmax = 2978, 2931, 1492, 1447, 1423, 1372, 1305, 1214, 1143, 1084 cm-1;  
HRMS calcd for (C26H32BIO4S)Na+ 601.1051; Found: 601.1046. 
 
 
 
 
1-(phenylsulfonyl)-1,2,3,4,5,6-hexahydrobenzo[e]azulene (183): SM Cross-Coupling 
Procedure C. 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 8 Hz, 2H), 7.39 (t, J = 8 Hz, 
1H), 7.22 (t, J = 8 Hz, 2H), 7.02 (d, J = 8 Hz, 1H), 6.96 (t, J = 8 Hz, 1H), 6.87 (d, J = 8 
Hz, 1H), 6.83 (t, J = 8 Hz, 1H), 4.84 (d, J = 8 Hz, 1H), 2.81 – 2.63 (m, 4H), 2.41 – 2.32 
(m, 2H), 2.27 – 2.22 (m, 2H), 2.18 – 2.11 (m, 1H), 1.84 – 1.76 (m, 1H); 13C NMR (125 
MHz, CDCl3)  δ 151.1, 142.2, 139.0, 134.1, 133.2, 129.0, 128.8, 128.6, 128.4, 127.5, 
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26.9, 125.7, 41.9, 38.2, 34.3, 30.5, 29.6, 24.8;  HRMS calcd for (C20H20O2S)Na+ 
347.1076; Found: 347.1075. 
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3.3  Spectroscopic Data 
  
158 
 
 
  
159 
 
 
  
160 
 
 
  
161 
 
 
  
162 
 
 
  
163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
164 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
165 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
166 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
167 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
168 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
169 
 
 
   
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
170 
 
 
  
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
171 
 
 
 
  
172 
 
 
  
173 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
174 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
175 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
176 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
177 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
178 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
179 
 
 
 
  
180 
 
 
  
181 
 
 
  
182 
 
 
  
183 
 
 
  
184 
 
 
  
185 
 
 
  
186 
 
 
  
187 
 
 
  
188 
 
 
  
189 
 
 
  
190 
 
 
  
191 
 
 
  
192 
 
 
  
193 
 
 
  
194 
 
 
  
195 
 
 
  
196 
 
 
  
197 
 
 
 
  
198 
 
 
  
199 
 
 
  
200 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
201 
 
 
 
  
202 
 
 
  
203 
 
 
 
  
204 
 
 
  
205 
 
 
  
206 
 
 
  
207 
 
 
  
208 
 
 
  
209 
 
 
  
210 
 
 
  
211 
 
 
  
212 
 
 
  
213 
 
 
  
214 
 
 
  
215 
 
 
  
216 
 
 
  
217 
 
 
  
218 
 
 
  
219 
 
 
  
220 
 
 
  
221 
 
 
  
222 
 
 
  
223 
 
 
  
224 
 
 
  
225 
 
 
  
226 
 
 
  
227 
 
 
  
228 
 
 
  
229 
 
 
  
230 
 
 
  
231 
 
 
  
232 
 
 
  
233 
 
 
  
234 
 
 
  
235 
 
 
  
236 
 
 
  
237 
 
 
  
238 
 
 
  
239 
 
 
  
240 
 
 
  
241 
 
 
  
242 
 
 
  
243 
 
 
  
244 
 
 
  
245 
 
 
  
246 
 
 
  
247 
 
 
  
248 
 
 
  
249 
 
 
  
250 
 
 
  
251 
 
 
  
252 
 
 
  
253 
 
 
  
254 
 
 
  
255 
 
 
  
256 
 
 
  
257 
 
 
  
258 
 
 
  
259 
 
 
  
260 
 
 
  
261 
 
 
  
262 
 
 
  
263 
 
 
  
264 
 
  
265 
 
 
  
266 
 
 
  
267 
 
 
  
268 
 
 
  
269 
 
 
  
270 
 
 
  
271 
 
 
  
272 
 
 
  
273 
 
 
  
274 
 
 
  
275 
 
 
  
276 
 
 
  
277 
 
 
  
278 
 
 
  
279 
 
 
  
280 
 
 
  
281 
 
 
  
282 
 
 
  
283 
 
 
  
284 
 
 
 
  
285 
 
 
  
286 
 
 
  
287 
 
 
  
288 
 
 
  
289 
 
 
  
290 
 
 
  
291 
 
 
  
292 
 
 
  
293 
 
 
  
294 
 
 
  
295 
 
 
  
296 
 
 
  
297 
 
 
  
298 
 
 
  
299 
 
 
  
300 
 
 
  
301 
 
 
  
302 
 
 
  
303 
 
 
  
304 
 
 
  
305 
 
 
  
306 
 
 
  
307 
 
 
  
308 
 
 
  
309 
 
 
  
310 
 
 
  
311 
 
 
  
312 
 
 
  
313 
 
 
  
314 
 
 
  
315 
 
 
  
316 
 
 
  
317 
 
 
  
318 
 
 
  
319 
 
 
  
320 
 
 
  
321 
 
 
  
322 
 
 
  
323 
 
 
  
324 
 
 
  
325 
 
 
  
326 
 
 
  
327 
 
 
  
328 
 
 
  
329 
 
 
  
330 
 
 
  
331 
 
 
  
332 
 
 
  
333 
 
 
  
334 
 
 
  
335 
 
 
  
336 
 
 
  
337 
 
 
  
338 
 
 
  
339 
 
 
  
340 
 
 
  
341 
 
 
  
342 
 
 
  
343 
 
 
  
344 
 
 
  
345 
 
CHAPTER FOUR   
References 
1 Beaudry, C. M.; Malerich, J. P.; Trauner, D. “Biosynthetic and Biomimetic 
Electrocyclizations.” Chem. Rev. 2005, 105, 4745-4778. 
 
2 (a) Bishop, L.M.; Barbaraow, J. E.; Bergman, R. G.; Trauner, D. “Catalysis of 6π 
Electrocyclizations.” Angew. Chem. Int. Ed. 2008, 47, 1-5. (b) Bishop, L.M.; Robertson, 
R. E.; Bergman, R. G.; Trauner, D. “On the Development of Catalytic Carba-6π 
Electrocyclizations.” Synthesis. 2010, 13, 2233-2244. 
3 Tang-Qing, Y.; Yao, F; Lei, L.; Qing-Xiang, G. “How to Promote Sluggish 
Electrocylclization of 1,3,5-Hexatrienes by Captodative Substitution.” J. Org. Chem. 
2006, 71, 6157-6164. 
 
4 Greshock, T.J.; Funk, R.L. “Synthesis of Indoles via 6π-Electrocyclic Ring Closures of 
Trienecarbamates.” J. Am. Chem. Soc. 2006, 128, 4946-4947. 
 
5 Magomedov, N.A.; Ruggiero, P. L.; Tang, Y. “Remarkably facile hexatriene 
electrocyclizations as a route to functionalized cyclohexenones via ring expansion of 
cyclobutenones. J. Am. Chem. Soc. 2004, 126, 1624-1625. 
6 Eames, J. “Recent Developments in Enantioselective Deprotonation Mediated by Sub-
Stoichiometric Quantities of Chiral Bases.” Eur. J. Org. Chem. 2002, 393-401. 
 
7 Nakamura, S.; Hirata, N.; Yamada, R.; Kita, T.; Shibata, N.; Toru, T. “Catalytic and 
Highly Enantioselective Reactions of α-Sulfonyl Carbanions with Chiral 
Bis(oxazoline)s.” Chem. Eur. J. 2008, 14, 5519-5527. 
 
8 (a) Jew, S.; Park, H. “Cinchona-based phase-transfer catalysts for asymmetric 
synthesis.” Chem. Comm. 2009, 7090-7103. (b) Hashimoto, T.; Maruoka, K. “Recent 
Development and Application of Chiral Phase-Transfer Catalysts.” Chem. Rev. 2007, 
107, 5656-5682. 
 
9 (a) Wesquet, A.; Kazmaier, U. “Stannylated Allylsulfones as Versatile New Building 
Blocks.” Synlett. 2005, 8, 1271-1274. (b) Wesquet, A.; Kazmaier, U. “Imporoved 
Protocols for the Molybdenum- and Tungsten-Catalyzed Hydrostannations.” Adv. Synth 
Catal. 2009, 351, 1395-1404. 
 
10 Hall, D.G. “Boronic Acids: Preparation, Applications in Organic Synthesis and 
Medicine.” Wiley: 2006. 
 
 
                                                          
346 
 
                                                                                                                                                                             
11 Guennouni, N.; Rasset-Deloge, C.; Carboni, B.; Vaultier, M. “Halosulphonylation of 
Unsaturated Boronic Esters:  Access to New Electron-Deficient Alkenes and Dienes.” 
Synlett. 1992, 581-584. 
 
12 Liu, L.K.; Chi. Y.; Jen, K.Y. “Copper-Catalyzed Additions of Sulfonyl Iodides to 
Simple and Cyclic Alkenes.” J. Org. Chem. 1980, 45, 406-410. 
 
13 Stork, G.; Zhao, K. Tetrahedron Lett. 1989, 30, 2173-2174. 
 
14 (a) Brown, H.C.; Vara Prasad, J.V.N. “Chiral Synthesis via Organoboranes. 9. 
Crystalline “Chelates” from Borinic and Boronic Esters.  A Simple Procedure for 
Upgrading Borinates and Boronates to Materials Approaching 100% Optical Purity.” J. 
Org. Chem. 1986, 51, 4526-4530. (b) Sun, J.; Perfetti, M.T.; Santos, W. L. “A Method 
for the Deprotection of Alkylpinacolyl Boronate Esters.” J. Org. Chem. 2011, 76, 3571-
3575. 
 
15 (a) Kinzel, T.; Zhang, Y.; Buchwald, S.L. “A New Palladium Precatalyst Allows for 
the Fast Suzuki-Miyaura Coupling Reactions of Unstable Polyfluorophenyl and 2-
Heteroaryl Boronic Acids” J. Am. Chem. Soc. 2010, 132, 14073-14075. (b) Biscoe, M.; 
Fors, B.P.; Buchwald, S.L. “A New Class of Easily Activated Palladium Precatalysts for 
Facile C-N Cross-Coupling Reactions and the Low Temperature Oxidative Addition of 
Aryl Chlorides.” J. Am. Chem. Soc. 2008, 130, 6686-6687. 
 
16 Knapp, D.M.; Gillis, E.P.; Burke, M.D. “A General Solution for Unstable Boronic 
Acids: Slow-Release Cross-Coupling from Air-Stable MIDA Boronates.” J. Am. Chem. 
Soc. 2009, 131, 6961-6963. 
 
17 Lloyd-Jones, G.C.; Lenox, A.J.J. “The Slow-Release Strategy in Suzuki-Miyaura 
Coupling.” Isr. J. Chem. 2010, 50, 664-674. 
 
18 (a) Yuen, A.K.L.; Hutton, C. “Deprotection of pinacolyl boronate esters via hydrolysis 
of intermediate potassium trifluoroborates.” Tett. Lett. 2005, 46, 7899-7903. (b) Ting, R.; 
Harwig, C.W.; Lo, J.; Li, Y.; Adam, M.J.; Ruth, T.J.; Perrin, D.M. “Substituent Effects 
on Aryltrifluoroborate Solvolysis in Water: Implications for Suzuki-Miyaura Coupling 
and the Design of Stable 18F-Labeled Aryltrifluoroborates for Use in PET Imaging.” J. 
Org. Chem. 2008, 73, 4662-4670.  
19 Darses, S.; Genet, J.P.  “Potassium Organotrifluoroborates: New Perspectives in 
Organic Synthesis.” Chem. Rev. 2008, 108, 288-325. 
 
20 (a) Molander, G.A.; Ham, J.; Seapy D.G. “Palladium-catalyzed cross-coupling reaction 
of alkenyl bromides with potassium alkyltrifluoroborates.” Tetrahedron, 2007, 63, 768. 
(b) Molander, G. A.; Ito, T.I. “Cross-Coupling Reactions of Potassium 
Alkyltrifluoroborates with Aryl and 1-Alkenyl Trifluoromethanesulfonates.” Org. Lett. 
2001, 3, 393. 
 
 
347 
 
                                                                                                                                                                             
21 Matteson, D.S.; Kim, G.Y. “Asymmetric Alkyldifluroboranes and Their Use in 
Secondary Amine Synthesis.” Org. Lett. 2002, 4, 2153-2155. 
22 Molander, G.A.; Cavalcanti, L.N.; Canturk, B.; Pan, P.S.; Kennedy, L. “Efficient 
Hydrolysis of Organotrifluoroborates via Silica Gel and Water.” J. Org. Chem. 2009, 74, 
7364-7369. 
 
23 (a) Pudikova, A. A.; Gerasimova, N. P.; Moskvichev, Y. A.; Alov, E. M.; Danilova, A. 
S.; Kozlova, O. S. “Cascade Synthesis of New Aryl 2-Phenylallyl Sulfones from α-
Methylstyrene and Aromatic Mono- and Bis-sulfonyl Chlorides.” Russ. J. Org. Chem. 
2010, 46, 353-354. (b) Li, X.; Xu, X.; Zhou, C. “Tetrabutylammonium iodide catalyzed 
allylic sulfonylation of α-methyl styrene derivatives with sulfonylhydrazides.” Chem. 
Comm. 2012, 48, 12240-12242. (c) Guo, H.; Ma, S. “Highly Regio- and Stereoselective 
Palladium(0)-Catalyzed Addition of Organoboronic Acids with 1,2-Allenic Sulfones, 
Sulfoxides, or Alkyl- or Aryl-Substituted Allenes in the Presence of Acetic Acid: An 
Efficient Synthesis of E-Alkenes.” Synthesis, 2007, 17, 2731-2745.  
 
 
24 Fish, P. V. “Stereoselective Construction of Functionalized, Trisubstituted (Z)-
allylsilanes and (Z)-iodoalkenes.” Synth. Commun. 1996, 26, 433-444. 
25 He, J.; Lu, Z.; Chai, G.; Fu, C.; Ma, S. “CuCl-catalyzed stereoselective conjugate 
addition of Grignard reagents to 2,3-allenoates.” Tetrahedron. 2012, 68, 2719-2724. 
26 Gillmann, T.; Weeber, T. “Silver Oxide-Assisted Palladium-Catalyzed Cross Coupling 
of Methyl 2-Halo-2,3-butadieneoates with Arylboronic Acids.” Synlett. 1994, 649-650. 
 
27 Reddy, Y. K.; Falck, J. R. “Asymmetric Total Synthesis of (+)-Fostriecin.” Org. Lett. 
2002, 4, 969-971. 
 
28 Uenishi, J.; Beau, J-M.; Armstrong, R. W.; Kishi, Y. “Dramatic Rate Enhancement of 
Suzuki Diene Synthesis:  Its Application to Palytoxin Synthesis.” J. Am. Chem. Soc. 
1987, 109, 4756-4758.  
 
29 Fuwa, H.; Sasaki, M. “Total Synthesis of (-)-Exiguilide.” Org. Lett. 2010, 12, 584-587. 
 
30 Ohmura, T.; Awwano, T.; Suginome, M.  “Stereospecific Suzuki-Miyaura coupling of 
chiral α-(acylamino)benzylboronic esters with inversion of configuration.” J. Am. Chem. 
Soc. 2001, 132, 13191-13193. 
 
31 Sandrock, D.; Jean-Gerard, L.; Chen, C. Y.; Dreher, S. D.; Molander, G. A. 
“Stereospecific cross-coupling of secondary alkyltrifluoroboratoamides.” J. Am. Chem. 
Soc. 2010, 132, 17109-17110. 
 
32 Moure, A. L.; Mauleon, P.; Gomez Arrayaas, R.; Carretero, J. C. “Formal 
Regiocontrolled Hydroboration of Unbiased Internal Alkynes via Borylation/Allylic 
Alkylation of Terminal Alkynes.” Org. Lett. 2013, 15, 2054-2057. 
 
348 
 
                                                                                                                                                                             
33 Wang, J.; Liu, B.; Zhao, H.; Wang, J. “Rhodium-Catalyzed Cross-Coupling Reaction 
of Carboxylate and Organoboron Compounds via Chelation-Assisted C-C Bond 
Activation.” Organometallics. 2012, 31, 8598-85607. 
 
34 Hussain, M. M.; Walsh, P. J. “Allylic Substitution versus Suzuki Cross-Coupling:  
Capitalizing on Chemoselectivity with Bifunctional Substrates. Angew. Chem. Int. Ed. 
2010, 49, 1843-1837. 
 
35 Hussain, M. M.;  Toribio, J. H.; Carrol, P. J.; Walsch, P. J. “Synthesis of 2-Keto-anti-
1,3-diols by Chemoselective Tandem Oxidation of 2-B(pin)-Substituted Allylic 
Alcohols.” Angew. Chem. Int. Ed. 2011, 50, 6337-6340.  
 
36 Waas, J. R.; Sidduri, A.; Knochel, P. “Preparation and Reactions of 1,1-Zinc, Boron 
and 1,1-Copper, Boron Alkenyl Bimetallics.”  Tett. Lett. 1992, 33, 3717-1720. 
 
37 Man, H-W.; Hiscox, W. C.; Matteson, D. S. “A Highly Enantioselective and 
Diastereoselective Synthesis of Cyclobutanes via Boronic Esters.” Org. Lett. 1999, 1, 
379-381. 
 
38 Mears, R. J.; Whiting, A. “β-Boronate Carbonyl Derivatives:  Synthesis and Evidence 
for the Intervention of Boronate “Ate”-Complexes in Enolate Alkylations.” Tetrahedron. 
1993, 49, 177-186. 
 
39 Matteson, D. S.; Moody, R. J. “Deprotonation of 1,1-Diboronic Esters and Reactions of 
the Carbanions with Alkyl Halides and Carbonyl Compounds.” Organometallics. 1982, 
1, 20-28. 
 
40 Midland, M. M.; Preston, S. B. “Anomalous Behavior  of Tosylates in Elimination 
Reactions.” J. Org. Chem. 1980, 45, 748-749. 
 
41 Pine, S.H.; Shen, G.; Bautista, J.; Sutton, C. Jr.; Yamada, W.; Apodaca.  
“Monoalkylation vs Dialkylation of a Sulfone-Stabilized Carbanion.” J. Am. Chem. Soc. 
1990, 55, 2234-2237. 
 
42 Curtis, A. D. M.; Mears, R. J.; Whiting, A. “The origin of the Stereoselectivity in the 
Aldol Reactions of b-Boronate Carbonyl Derivatives.” Tetrahedron. 1993, 49, 187-198. 
43 Still, W. C.; Kahn, M.; Mitra, A. “Rapid Chromatographic Technique for Preparative 
Separations with Moderate Resolution.” J. Am. Chem. Soc. 1978, 43, 2923-2925. 
 
44 Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. “A Series of Well-Defined 
Metathesis Catalysts-Synthesis of [RuCl2(=CHR’)(PR3)2] and Its Reactions.” 
Angew. Chem. Int. Ed. 1995, 34, 2039-2041. 
 
45 Scholl, M.; Ding, S.; Lee, W. C.; Grubbs, R. H. “Synthesis and Activity of a New 
Generation of Ruthenium-Based Olefin Metathesis Catalysts Coordinated with 1,3-
Dimesityl-4,5-dihydroimidazole-2-ylidene Ligands.” Org. Lett. 1999, 1, 953-956. 
 
349 
 
                                                                                                                                                                             
 
46 Garber, S. B.; Kingsbury, J. S.; gray, B. L.; Hoveyda, A. H. “Efficient and Recyclable 
Monomeric and Dendritic Ru-Based Metathesis Catalysts.” J. Am. Chem. Soc. 2000, 122, 
8168-8179. 
 
47 Brown, R. C. D.; Satcharoen, V. “Ring-Closing Metathesis of Heteroatom-Substituted 
Dienes.” Heterocycles. 2006, 70, 705-736. 
 
48 Renaud, J.; Ouellet, S. G. “Novel Synthesis of Cyclic Alkenylboronates via Ring-
Closing Metathesis.” J. Am. Chem. Soc. 1998, 120, 7995-7996. 
 
49 Ghosh, S.; Ghosh, S.; Sarkar, N. “Factors Influencing Ring Closure through Olefin 
Metathesis – A Perspective.” J. Chem. Sci. 2006, 118, 223-235. 
 
50 Schmidt, B. “Catalysis at the Interface of Ruthenium Carbene and Ruthenium Hydride 
Chemistry:  Organometallic Aspects and Applications to Organic Synthesis.” Eur. J. Org. 
Chem. 2004, 1865-1880. 
 
51 Bourgeois, D.; Pancrazi, A, Nolan, S. P.; Prunet, J. “The Cl2(PCy3)(IMes)Ru(=CHPh) 
catalyst: Olefin Metathesis Versus Isomerization.” J. Organomet. Chem. 2002, 643, 247-
252. 
 
52 McGrath, D. V.; Grubbs, R. H. “The Mechanism of Aqueous Ruthenium(II)-Catalyzed 
Olefin Isomerization.”  Organometallics.  1994, 13, 224-235. 
 
53 Hong, S. H.; Sanders, D. P.; Lee, C. W.; Grubbs, R. H. “Prevention of Undesirable 
Isomerization during Olefin Metathesis.” J. Am. Chem. Soc. 2005, 127, 17160-17161. 
 
54 Fu, G. C.; Grubbs, R. H. “The Application of Catalytic Ring-Closing Olefin Metathesis 
to the Synthesis of Unsaturated Oxygen Heterocycles.” J. Am. Chem. Soc. 1992, 114, 
5426-5427. 
 
55 (a) Morrill, C.; Funk, T. W.; Grubbs, R. H. “Synthesis of Tri-Substituted Vinyl 
Boronates Via Ruthenium-Catalyzed Olefin Cross-Metathesis.” Tett. Lett. 2004, 45, 
7733-7736. (b) Morrill, C.; Grubbs, R. H. “Synthesis of Functionalized Vinyl Boronates 
via Ruthenium-Catalyzed Olefin Cross-Metathesis and Subsequent Conversion to Vinyl 
Halides.” J. Org. Chem. 2003, 68, 6031-6034. 
 
56 Lin, Y. A.; Davis, B. G. “The Allylic Chalcogen Effect in Olefin Metathesis.” Beilstein 
J. Org. Chem. 2010, 6, 1219-1228. 
 
57 Knight, D. J.; Lin, P.; Whitham, G. H. “1,3-rearrangements of Some Allyic 
Sulfphones.” J. Chem. Soc., Perkin Trans. 1987, 1, 2707-2713. 
 
58 Jorgenson, L.; McKerrall, S. J.; Kuttruff, C. A.; Ungeheuer, F.; Felding, J.; Baran, P. S. 
“14-Step Synthesis of (+)-Ingenol from (+)-3-Carene.” Science. 2013, 341, 878-882. 
 
350 
 
                                                                                                                                                                             
 
59 Shade, R. E.; Hyde, A. M.; Olsen, J-C.; Merlic, C. A. “Copper-Promoted Coupling of 
Vinyl Boronates and Alcohols:  A Mild Synthesis of Allyl Vinyl Ethers.” J. Am. Chem. 
Soc. 2010, 132, 1202-1203. 
 
60 Harmata, M. “The (4 + 3)-cycloaddtion Reaction:  Heteroatom-Substituted Allylic 
Cations as Dienophiles.” Chem. Commun. 2010, 46, 8904-8922. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
351 
 
                                                                                                                                                                             
 
 
 
 
 
 
 
VITA 
 
 
 
 Erich Altenhofer was born on January 9th, 1987 in St. Louis, Missouri.  As a 
young man, Erich was influenced by his high school chemistry professor Kenneth 
Kolwyck, and developed a passion for chemistry.  Shortly thereafter, Erich attended 
Missouri State University in 2005 where he majored in chemistry.  In his junior and 
senior years, he became involved in undergraduate research with Dr. Reza Sedaghat-
Herati and quickly discovered he enjoyed organic synthesis.  In 2009, he graduated from 
Missouri State with a Bachelor’s of Science in chemistry, and would continue his 
education the following fall at The University of Missouri-Columbia pursuing a doctorate 
in chemistry.  In 2010, Erich began working with Norman Rabjohn Distinguished 
Professor of Organic Chemistry Michael Harmata.  During his four year stay, Erich 
continued his research in synthetic organic chemistry and graduated in July 2014 with a 
Ph.D. in chemistry.   
